
<html lang="en"     class="pb-page"  data-request-id="50e07ff9-6b2f-4f8d-bd61-e3be655709e5"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2013.56.issue-1;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm301646k"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models" /></meta><meta name="dc.Creator" content="Michael  Soth" /></meta><meta name="dc.Creator" content="Johannes C.  Hermann" /></meta><meta name="dc.Creator" content="Calvin  Yee" /></meta><meta name="dc.Creator" content="Muzaffar  Alam" /></meta><meta name="dc.Creator" content="Jim W.  Barnett" /></meta><meta name="dc.Creator" content="Pamela  Berry" /></meta><meta name="dc.Creator" content="Michelle F.  Browner" /></meta><meta name="dc.Creator" content="Karl  Frank" /></meta><meta name="dc.Creator" content="Sandra  Frauchiger" /></meta><meta name="dc.Creator" content="Seth  Harris" /></meta><meta name="dc.Creator" content="Yang  He" /></meta><meta name="dc.Creator" content="Mohammad  Hekmat-Nejad" /></meta><meta name="dc.Creator" content="Than  Hendricks" /></meta><meta name="dc.Creator" content="Robert  Henningsen" /></meta><meta name="dc.Creator" content="Ramona  Hilgenkamp" /></meta><meta name="dc.Creator" content="Hoangdung  Ho" /></meta><meta name="dc.Creator" content="Ann  Hoffman" /></meta><meta name="dc.Creator" content="Pei-Yuan  Hsu" /></meta><meta name="dc.Creator" content="Dong-Qing  Hu" /></meta><meta name="dc.Creator" content="Andrea  Itano" /></meta><meta name="dc.Creator" content="Saul  Jaime-Figueroa" /></meta><meta name="dc.Creator" content="Alam  Jahangir" /></meta><meta name="dc.Creator" content="Sue  Jin" /></meta><meta name="dc.Creator" content="Andreas  Kuglstatter" /></meta><meta name="dc.Creator" content="Alan K.  Kutach" /></meta><meta name="dc.Creator" content="Cheng  Liao" /></meta><meta name="dc.Creator" content="Stephen  Lynch" /></meta><meta name="dc.Creator" content="John  Menke" /></meta><meta name="dc.Creator" content="Linghao  Niu" /></meta><meta name="dc.Creator" content="Vaishali  Patel" /></meta><meta name="dc.Creator" content="Aruna  Railkar" /></meta><meta name="dc.Creator" content="Douglas  Roy" /></meta><meta name="dc.Creator" content="Ada  Shao" /></meta><meta name="dc.Creator" content="David  Shaw" /></meta><meta name="dc.Creator" content="Sandra  Steiner" /></meta><meta name="dc.Creator" content="Yongliang  Sun" /></meta><meta name="dc.Creator" content="Seng-Lai  Tan" /></meta><meta name="dc.Creator" content="Sandra  Wang" /></meta><meta name="dc.Creator" content="Minh Diem  Vu" /></meta><meta name="dc.Description" content="The Janus kinases (JAKs) are involved in multiple signaling networks relevant to inflammatory diseases, and inhibition of one or more members of this class may modulate disease activity or progress..." /></meta><meta name="Description" content="The Janus kinases (JAKs) are involved in multiple signaling networks relevant to inflammatory diseases, and inhibition of one or more members of this class may modulate disease activity or progress..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 19, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301646k" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301646k" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301646k" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301646k" /></link>
        
    
    

<title>3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301646k" /></meta><meta property="og:title" content="3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0013.jpeg" /></meta><meta property="og:description" content="The Janus kinases (JAKs) are involved in multiple signaling networks relevant to inflammatory diseases, and inhibition of one or more members of this class may modulate disease activity or progression. We optimized a new inhibitor scaffold, 3-amido-5-cyclopropylpyrrolopyrazines, to a potent example with reasonable kinome selectivity, including selectivity for JAK3 versus JAK1, and good biopharmaceutical properties. Evaluation of this analogue in cellular and in vivo models confirmed functional selectivity for modulation of a JAK3/JAK1-dependent IL-2 stimulated pathway over a JAK1/JAK2/Tyk2-dependent IL-6 stimulated pathway." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="The Janus kinases (JAKs) are involved in multiple signaling networks relevant to inflammatory diseases, and inhibition of one or more members of this class may modulate disease activity or progression. We optimized a new inhibitor scaffold, 3-amido-5-cyclopropylpyrrolopyrazines, to a potent example with reasonable kinome selectivity, including selectivity for JAK3 versus JAK1, and good biopharmaceutical properties. Evaluation of this analogue in cellular and in vivo models confirmed functional selectivity for modulation of a JAK3/JAK1-dependent IL-2 stimulated pathway over a JAK1/JAK2/Tyk2-dependent IL-6 stimulated pathway." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0013.jpeg" /></meta><meta name="twitter:title" content="3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301646k"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301646k">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301646k&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301646k&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301646k&amp;href=/doi/10.1021/jm301646k" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 345-356</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3016427" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301691s" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Soth">Michael Soth</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johannes+C.++Hermann">Johannes C. Hermann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Calvin++Yee">Calvin Yee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Muzaffar++Alam">Muzaffar Alam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jim+W.++Barnett">Jim W. Barnett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pamela++Berry">Pamela Berry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle+F.++Browner">Michelle F. Browner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karl++Frank">Karl Frank</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Frauchiger">Sandra Frauchiger</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seth++Harris">Seth Harris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yang++He">Yang He</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mohammad++Hekmat-Nejad">Mohammad Hekmat-Nejad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Than++Hendricks">Than Hendricks</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert++Henningsen">Robert Henningsen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ramona++Hilgenkamp">Ramona Hilgenkamp</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hoangdung++Ho">Hoangdung Ho</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ann++Hoffman">Ann Hoffman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pei-Yuan++Hsu">Pei-Yuan Hsu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dong-Qing++Hu">Dong-Qing Hu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Itano">Andrea Itano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Saul++Jaime-Figueroa">Saul Jaime-Figueroa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alam++Jahangir">Alam Jahangir</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sue++Jin">Sue Jin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Kuglstatter">Andreas Kuglstatter</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+K.++Kutach">Alan K. Kutach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Liao">Cheng Liao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Lynch">Stephen Lynch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Menke">John Menke</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Linghao++Niu">Linghao Niu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vaishali++Patel">Vaishali Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aruna++Railkar">Aruna Railkar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas++Roy">Douglas Roy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ada++Shao">Ada Shao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Shaw">David Shaw</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Steiner">Sandra Steiner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yongliang++Sun">Yongliang Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seng-Lai++Tan">Seng-Lai Tan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandra++Wang">Sandra Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Minh+Diem++Vu">Minh Diem Vu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Hoffmann-La Roche, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Roche Palo Alto, 3431 Hillview Avenue, Palo Alto, California 94304, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 973-235-2717. Fax: 973-235-6263. E-mail: <a href="/cdn-cgi/l/email-protection#f69b9f959e97939ad88599829eb68499959e93d895999b"><span class="__cf_email__" data-cfemail="4a272329222b2f266439253e220a382529222f64292527">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301646k&amp;href=/doi/10.1021%2Fjm301646k" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 345â356</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 9, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 November 2012</li><li><span class="item_label"><b>Published</b> online</span>19 December 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 January 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301646k" title="DOI URL">https://doi.org/10.1021/jm301646k</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D345%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BSoth%252C%2BJohannes%2BC.%2BHermann%252C%2BCalvin%2BYee%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D1%26contentID%3Djm301646k%26title%3D3-Amido%2BPyrrolopyrazine%2BJAK%2BKinase%2BInhibitors%253A%2BDevelopment%2Bof%2Ba%2BJAK3%2Bvs%2BJAK1%2BSelective%2BInhibitor%2Band%2BEvaluation%2Bin%2BCellular%2Band%2Bin%2BVivo%2BModels%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D356%26publicationDate%3DJanuary%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301646k"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5203</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">47</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301646k" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Soth&quot;},{&quot;first_name&quot;:&quot;Johannes&quot;,&quot;last_name&quot;:&quot;C. Hermann&quot;},{&quot;first_name&quot;:&quot;Calvin&quot;,&quot;last_name&quot;:&quot;Yee&quot;},{&quot;first_name&quot;:&quot;Muzaffar&quot;,&quot;last_name&quot;:&quot;Alam&quot;},{&quot;first_name&quot;:&quot;Jim&quot;,&quot;last_name&quot;:&quot;W. Barnett&quot;},{&quot;first_name&quot;:&quot;Pamela&quot;,&quot;last_name&quot;:&quot;Berry&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;F. Browner&quot;},{&quot;first_name&quot;:&quot;Karl&quot;,&quot;last_name&quot;:&quot;Frank&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Frauchiger&quot;},{&quot;first_name&quot;:&quot;Seth&quot;,&quot;last_name&quot;:&quot;Harris&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;He&quot;},{&quot;first_name&quot;:&quot;Mohammad&quot;,&quot;last_name&quot;:&quot;Hekmat-Nejad&quot;},{&quot;first_name&quot;:&quot;Than&quot;,&quot;last_name&quot;:&quot;Hendricks&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;Henningsen&quot;},{&quot;first_name&quot;:&quot;Ramona&quot;,&quot;last_name&quot;:&quot;Hilgenkamp&quot;},{&quot;first_name&quot;:&quot;Hoangdung&quot;,&quot;last_name&quot;:&quot;Ho&quot;},{&quot;first_name&quot;:&quot;Ann&quot;,&quot;last_name&quot;:&quot;Hoffman&quot;},{&quot;first_name&quot;:&quot;Pei-Yuan&quot;,&quot;last_name&quot;:&quot;Hsu&quot;},{&quot;first_name&quot;:&quot;Dong-Qing&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Itano&quot;},{&quot;first_name&quot;:&quot;Saul&quot;,&quot;last_name&quot;:&quot;Jaime-Figueroa&quot;},{&quot;first_name&quot;:&quot;Alam&quot;,&quot;last_name&quot;:&quot;Jahangir&quot;},{&quot;first_name&quot;:&quot;Sue&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Kuglstatter&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;K. Kutach&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Liao&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Lynch&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Menke&quot;},{&quot;first_name&quot;:&quot;Linghao&quot;,&quot;last_name&quot;:&quot;Niu&quot;},{&quot;first_name&quot;:&quot;Vaishali&quot;,&quot;last_name&quot;:&quot;Patel&quot;},{&quot;first_name&quot;:&quot;Aruna&quot;,&quot;last_name&quot;:&quot;Railkar&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;Roy&quot;},{&quot;first_name&quot;:&quot;Ada&quot;,&quot;last_name&quot;:&quot;Shao&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Shaw&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Steiner&quot;},{&quot;first_name&quot;:&quot;Yongliang&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Seng-Lai&quot;,&quot;last_name&quot;:&quot;Tan&quot;},{&quot;first_name&quot;:&quot;Sandra&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Minh&quot;,&quot;last_name&quot;:&quot;Diem Vu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;345-356&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301646k&quot;},&quot;abstract&quot;:&quot;The Janus kinases (JAKs) are involved in multiple signaling networks relevant to inflammatory diseases, and inhibition of one or more members of this class may modulate disease activity or progression. We optimized a new inhibitor scaffold, 3-amido-5-cyclopropylpyrrolopyrazines, to a potent example with reasonable kinome selectivity, including selectivity for JAK3 versus JAK1, and good biopharmaceutical properties. Evaluation of this analogue in cellular and in vivo models confirmed functional selectivity for modulation of a JAK3/JAK1-dependent IL-2 stimulated pathway over a JAK1/JAK2/Tyk2-dependent IL-6 stimulated pathway.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301646k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301646k" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301646k&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301646k" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301646k&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301646k" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301646k&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301646k&amp;href=/doi/10.1021/jm301646k" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301646k" /></input><a href="/doi/pdf/10.1021/jm301646k" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301646k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301646k%26sid%3Dliteratum%253Aachs%26pmid%3D23214979%26genre%3Darticle%26aulast%3DSoth%26date%3D2013%26atitle%3D3-Amido%2BPyrrolopyrazine%2BJAK%2BKinase%2BInhibitors%253A%2BDevelopment%2Bof%2Ba%2BJAK3%2Bvs%2BJAK1%2BSelective%2BInhibitor%2Band%2BEvaluation%2Bin%2BCellular%2Band%2Bin%2BVivo%2BModels%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D1%26spage%3D345%26epage%3D356%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=290969" title="Cell and molecular biology">Cell and molecular biology</a>,</li><li><a href="/action/doSearch?ConceptID=290682" title="Post-translational modification">Post-translational modification</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/1" title="Go to Volume 56, Issue 1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jmcmar.2013.56.issue-1/production/jmcmar.2013.56.issue-1.largecover.jpg" alt="Go to Volume 56, Issue 1"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The Janus kinases (JAKs) are involved in multiple signaling networks relevant to inflammatory diseases, and inhibition of one or more members of this class may modulate disease activity or progression. We optimized a new inhibitor scaffold, 3-amido-5-cyclopropylpyrrolopyrazines, to a potent example with reasonable kinome selectivity, including selectivity for JAK3 versus JAK1, and good biopharmaceutical properties. Evaluation of this analogue in cellular and in vivo models confirmed functional selectivity for modulation of a JAK3/JAK1-dependent IL-2 stimulated pathway over a JAK1/JAK2/Tyk2-dependent IL-6 stimulated pathway.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03727" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03727" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Janus kinase family members (JAK3, JAK2, JAK1, and TYK2) play critical and cooperative roles in transmitting many signaling cascades in response to inflammatory and proliferative signals. For instance, JAK3 acts in concert with JAK1 to relay cytokine signaling through the cytokine receptor common Î³ chain, also known as CD132.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Null mutations in either JAK3 or CD132 are associated with severe combined immunodeficiency (SCID) disorder.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> JAK2 is important in the signaling of hormones and growth factors such as erythropoietin (EPO), through the EPO receptor, as well as granulocyte-macrophage colony stimulating factor (GM-CSF) via its receptor and the common Î² chain IL-3 receptor.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> JAK1, JAK2, and TYK2 are involved in IL-6 signaling.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> Across the pharmaceutical industry, there is high interest in targeting the JAK family of kinases for both oncology and inflammation indications.<a onclick="showRef(event, 'ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref12 ref13 ref14 ref15">(11-15)</a> Within the inflammation arena, Pfizerâs Tofacitinib, <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a JAK3/2/1 inhibitor initially reported as a selective JAK3 inhibitor, has shown promising efficacy results in clinical trials for rheumatoid arthritis (RA).<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a></div><div class="NLM_p">However, it is unclear if blockade of all JAK isozymes is required for optimal efficacy without compromising the risk/benefit profile or if a more isozyme-selective inhibitor would suffice. There are divergent opinions in the literature as to the functional consequences of selective inhibition of JAK3 over JAK1. Recent papers from the Novartis group have questioned whether this type of selectivity profile will be sufficient to efficiently block immunologically relevant pathways mediated by CD132 cytokines.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> The Novartis group reached this conclusion on the basis of cellular data on a highly JAK3-selective compound compared to Tofacitinib <b>1</b>, coupled with extensive biological studies dissecting the roles of JAK3 and JAK1 in IL-2-induced STAT5 phosphorylation (a CD132-dependent process). However, an earlier paper from the Pharmacopeia/Wyeth/Pfizer group concluded that JAK1 inhibition is not required for potent inhibition of IL-2 signaling, and with a JAK3-selective tool compound they demonstrated potent, selective inhibition of IL-2 signaling over cellular pathways requiring JAK-family enzymes other than JAK3.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Thus, it would be important to resolve this discrepancy using structurally distinct scaffolds of JAK inhibitors.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of Tofacitinib (<b>1</b>), profiling hit <b>2</b>, and cyclopropyl analogue <b>3a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Our JAK medicinal chemistry program strategy was to explore a diverse range of series with varying JAK family selectivity profiles as tool compounds to dissect the relative role of each JAK member in inflammatory disease indications. Here, we describe the optimization of a 3-amido-5-cyclopropyl pyrrolopyrazine series to potent JAK inhibitors, culminating in an example with selectivity for JAK3 over JAK1 and properties conducive to oral dosing and testing in an acute PK/PD mouse model. Our optimized compound shows both cellular and in vivo selectivity for inhibition of an IL-2 signaling pathway, most notably against an IL-6 receptor mediated signaling pathway. In addition, the structureâactivity relationships (SAR) around close analogues indicate that improved selectivity for JAK3 over JAK1 does not result in a decrease in potency for inhibition of the IL-2 signaling pathway.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15518" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15518" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The general synthetic scheme for the preparation of 3-amido-5-cyclopropyl pyrrolopyrazines is shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Commercially available 5-bromopyrrolopyrazine was converted in a four-step process to silylethoxymethyl (SEM)-protected aldehyde <b>4</b>. Aldehyde <b>4</b> was subjected to Suzuki conditions to afford cyclopropyl analogue <b>5</b>. Oxidation of the aldehyde moiety afforded acid <b>6</b>, which was coupled to a variety of amines followed by SEM deprotection to afford final compounds <b>3a</b>â<b>t</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Pyrrolopyrazines <b>3a</b>â<b>t</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) formaldehyde, sodium hydroxide, 1,4-dioxane/water, (b) sodium hydroxide, tetrahydrofuran/water, (c) Jones reagent, acetone, (d) 2-silylethoxymethyl chloride, sodium hydride, <i>N</i>,<i>N</i>-dimethylformamide, 0 Â°Cârt, (42%); (ii) cyclopropylboronic acid, palladium diacetate, tricyclohexylphosphine, potassium phosphate, toluene/water, 100 Â°C (81%); (iii) sodium hypochlorite, potassium dihydrogen phosphate, sulfamic acid, 1,4-dioxane/water (87%); (iv) (a) <i>R</i><sup>1</sup>-NH<sub>2</sub>, amide coupling reagent, solvent, (b) trifluoroacetic acid, dichloromethane, (c) ethylene diamine/dichloromethane <i>or</i> sodium acetate/ethanol <i>or</i> triethylamine/MeOH/H<sub>2</sub>O (17â87%).</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Initial Hit and Optimization</h3><div class="NLM_p">The chemical starting point for this work came from a scan of our internal collection of kinase inhibitors for which we have kinome selectivity information. Inhibitor sets annotated by selectivity profiles can be a fruitful source of leads for new kinase programs.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The âhitâ that we decided to pursue was pyrrolopyrazine <b>2</b>, which had been profiled by Kinomescan (now a division of DiscoveRx, formerly a division of Ambit Biosciences)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and showed binding to JAK3, JAK2 and JAK1; however, it showed poor kinome selectivity.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Exploration of trimethoxyphenyl replacements afforded multiple subseries with varying kinome selectivities. This article describes the cyclopropyl subseries.</div><div class="NLM_p">Replacement of the trimethoxyphenyl group of <b>2</b> with a cyclopropyl group to afford <b>3a</b> resulted in a reasonably potent JAK inhibitor (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, first entry). We modeled <b>3a</b> into the ATP-binding site of JAK3 and looked for promising vectors to improve potency and possibly kinome selectivity (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). As both methyls of the amide isopropyl group point toward apparent pockets, we focused our SAR work on further derivatization of these two vectors (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). During our efforts on this program, the crystal structure of <b>1</b> was obtained (and later published by others<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>), showing space-filling of these pockets. SAR studies around <b>1</b> confirmed that these pockets are indeed excellent areas of the protein to fill for potency.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> For the examples in this pyrrolopyrazine series, potency trends are similar across JAK isozymes, with many examples showing some preference for inhibiting JAK3 versus JAK2 and JAK1.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzyme Potencies<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Inhibition of phosphorylation of a biotinylated synthetic peptide catalyzed by JAK1â3; see <a class="ref internalNav" href="#sec3" aria-label="Experimental Section">Experimental Section</a> for details. All enzyme reactions were run at adenosine triphosphate (ATP) concentrations of 1.5 Î¼M. <i>K</i><sub>m</sub>s of these enzymes for ATP under our experimental conditions were determined to be 1.5 Î¼M (JAK3), 6 Î¼M (JAK2), and 20 Î¼M (JAK1).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Mean Â± SEM (standard error of the mean), <i>n</i> â¥ 3 except for <b>3g</b> and <b>3t</b> (<i>n</i> = 2).</p></div></div><div></div></div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Modeled structure of <b>3a</b> in JAK3. Carbon atoms of <b>3a</b> are in cyan, carbon atoms of the JAK3 protein are in orange, oxygen atoms are in red, and nitrogen atoms are colored in blue. Red-colored protein surface indicates protein areas identified for potential exploration and optimization of interactions. All visualizations generated with MOE.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, the âlowerâ pocket is defined in part by leucine (Leu956) and alanine (Ala966) residues. We therefore targeted this region with small hydrophobic groups off of the isopropyl amide (Entries <b>3b</b>â<b>3i</b>). A significant boost in potency was gained by simply replacing the lower methyl group with an ethyl (entry <b>3b</b> vs <b>3a</b>). Further elaboration to isopropyl and racemic cyclopropyl analogues (<b>3c</b> and <b>3d</b>) did not improve potency further; however, <i>tert</i>-butyl analogue <b>3e</b> showed an additional potency boost, bringing the potency down to a 1 nM compound. Replacing one methyl of the <i>tert</i>-butyl group with a hydroxyl group (<b>3f</b>) resulted in a significant potency loss; a nitrile replacement (<b>3h</b>) was more favorable. A cyclohexyl analogue (<b>3i</b>) was tolerated but less potent than the other examples from this exercise to fill the lower pocket. A crystal structure of analogue <b>3e</b> in JAK3 showed excellent space-filling of the lower pocket by the <i>tert</i>-butyl group (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of <b>3e</b> in JAK3 (PDB accession no. <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVD">4HVD</a>, 1.85 Ã resolution), demonstrating filling of the lower pocket by the <i>tert</i>-butyl group. Carbon atoms of <b>3e</b> are in yellow, carbon atoms of the JAK3 protein are in orange, oxygen atoms are in red, and nitrogen atoms are colored in blue. Molecular surface of <b>3e</b> is colored cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Beyond potency considerations, the other noteworthy effect of filling the lower pocket is an improved selectivity for JAK3 versus JAK1. The larger groups (<i>tert</i>-butyl analogues and cyclohexyl) show 10â50-fold selectivity.</div><div class="NLM_p">Interestingly, the hydroxyl-containing enantiomers <b>3f</b> and <b>3g</b> showed similar potencies against JAK3 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Crystal structures for both of these compounds bound to JAK3 were obtained and showed a similar space-filling, i.e., the ligands were free to shift in the pocket to obtain optimal binding (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structures of <b>3f</b> (PDB accession no. <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVG">4HVG</a>, 2.75 Ã resolution) and <b>3g</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVH">4HVH</a>, 2.3 Ã) in JAK3, superimposed. Carbon atoms of <b>3f</b> are in cyan, carbon atoms of <b>3g</b> are in orange, oxygen atoms are in red, and nitrogen atoms are colored in blue. The assignment of methyl and hydroxyl in the tertiary alcohol moiety is tentative at the current resolution. Meshes are colored according to ligand carbon atom color and show the molecular surface for each ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the second vector, leading to the âupper pocketâ, a modeling exercise highly prioritized a bis-amide motif as having low energy conformations most likely to fill the space available. The first simple examples <b>3j</b>â<b>m</b> did not show potency improvements over the parent <b>3a</b>; however, a crystal structure of compound <b>3k</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) confirmed the expected binding motif and encouraged us to try further substitution, specifically with nitrile side chains, as a nitrile group in this pocket was observed to be particularly beneficial for potency by the Pfizer group in their development of compound <b>1</b>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The nitrile group is also beneficial for our series (examples <b>3n</b>, <b>3p</b>). Comparison of methyl analogue <b>3o</b> to cyano analogue <b>3n</b> suggests that the potency boost is not due to simple space-filling. A recent paper from the Pfizer group attempts to explain the potency benefits of a nitrile group in this area of the protein.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> For our scaffold, the most promising side chains from this second exercise combined well with the most promising side chains of the first exercise (examples <b>3q</b>â<b>t</b>), yielding highly potent inhibitors. The potencies of these compounds were comparable to Tofacitinib <b>1</b>. Importantly, while compounds <b>3q</b>â<b>t</b> all show similar potencies against JAK3, the <i>tert</i>-butyl example <b>3q</b> is >10-fold selective against JAK1 while the cyclopropyl examples <b>3r</b>â<b>t</b> are not selective against JAK1. This selectivity discrepancy among very closely related compounds allows for a useful interpretation of cellular data later in the manuscript.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray crystal structure of <b>3k</b> in JAK3 (PDB accession no. <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVI">4HVI</a>, 2.4 Ã resolution), demonstrating filling of the upper pocket by the tertiary amide. Carbon atoms of <b>3k</b> are in yellow, carbon atoms of the JAK3 protein are in orange, oxygen atoms are in red, and nitrogen atoms are colored in blue. Molecular surface of <b>3k</b> is colored cyan. Gray-colored mesh shows the molecular surface and shape of the binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Kinome Selectivity</h3><div class="NLM_p">We profiled our compounds by Caliper screening against a 48 kinase panel (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Caliper profiling measures percent inhibition of phosphorylation of a peptide substrate; the data in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> is represented by heat maps, assigning <50% inhibition as completely green and >95% inhibition as completely red. We pick six examples here to demonstrate the key selectivity learnings. For purposes of fair comparison, the concentration at which compounds were profiled reflects their JAK3 potency: for the less potent entries <b>3a</b> and <b>3f</b>, profiling was performed at 10 Î¼M; for the more potent entries <b>3e</b>, <b>3h</b>, and <b>3q</b>, profiling was performed at 1 Î¼M. For entry <b>3p</b>, which has an intermediate potency, we include both 10 and 1 Î¼M data.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Kinome Selectivity Profiles for Select Examples<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0012.gif" alt="" id="GRAPHIC-d388e971-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">% inhibition of phosphorylation of substrates at the indicated test compound concentrations, using a ProfilerPro Kit 1 (P/N 760373) supplied by Caliper Lifesciences. In these heat maps, <50% inhibition is assigned as completely green and >95% inhibition is assigned as completely red.</p></div></div><div></div></div><div class="NLM_p">Entries <b>3e</b> and <b>3h,</b> which fill the lower pocket with either the <i>tert-</i>butyl group or the closely related cyano analogue, show selectivity improvements relative to parent <b>3a</b>. These selectivity improvements are easily explainable by analysis of the protein in the areas filled. The lower pocket is in part defined by Ala966, which is a variable residue across the kinome and is often larger for other kinases, i.e., for other kinases there is not room for an optimal fit of the <i>tert</i>-butyl group. Indeed, the profiled kinases that are most strongly âhitâ by entries <b>3e</b> and <b>3h</b> all contain alanine in this position.</div><div class="NLM_p last">It is more difficult to interpret the selectivity data for entry <b>3p</b>, which presumably fills the upper pocket with the cyanoazetidine amide group, because its JAK3 potency lies between that of <b>3a</b> and <b>3e</b>/<b>h</b> and so it is difficult to decide which analogue is the appropriate comparator. However, the upper pocket is mostly defined by a main-chain Î²-sheet, with side chains pointing away and unlikely to be key determinants of selectivity. What is clear is that the <i>combination</i> of the <i>tert</i>-butyl side chain with the cyanoazetidine amide is optimal for kinome selectivity (entry <b>3q</b>). The added selectivity of <b>3q</b> over <b>3e</b> does not necessarily mean that the cyanoazetidine group introduces specific binding interactions that favor JAK3. The added selectivity of <b>3q</b> over <b>3e</b> may simply be due to a tighter fit of a ligand optimized to JAK3 versus other kinases, i.e., the presence of the cyanoazetidine group restricts freedom of movement for the ligand within kinase pockets, disfavoring alternative ligand arrangements within other kinases. This idea is supported by the earlier noted observation that smaller ligands have freedom of movement within these pockets (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Freedom of ligand movement could also explain the reduced selectivity of tertiary alcohol <b>3f</b> compared to <b>3e</b> and <b>3h</b>. The polar hydroxyl group of <b>3f</b> is likely more amenable to alternative, water-exposed binding conformations.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Cellular Activity and Biopharmaceutical Properties</h3><div class="NLM_p">Select examples were tested in cell-based assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). These assays measure the inhibition of phosphorylation of downstream signal transducer and activator of transcription (STAT) proteins, either in human peripheral blood mononuclear cells (PBMCs) or in human whole blood (HWB), upon treatment with varying stimuli (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The different cellular stimuli used induce phosphorylation of STATs by either dual JAK3/1 (IL-2 stimulus, STAT5a phosphorylation in T-cells), JAK2 (GM-CSF stimulus, STAT5a phosphorylation in monocytes), or dual JAK2/1 (IFN-Î³ stimulus, STAT1 phosphorylation in monocytes) containing pathways.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cellular and HWB Potencies for Select Compounds<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="center" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="Â±">PBMC (IL-2) IC<sub>50</sub>(Î¼M)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">PBMC (GM-CSF) IC<sub>50</sub>(Î¼M)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="Â±">PBMC (IFN-Î³) IC<sub>50</sub>(Î¼M)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="Â±">HWB (IL-2) IC<sub>50</sub>(Î¼M)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3e</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.211Â Â±Â 0.069</td><td class="colsep0 rowsep0" align="center">5.48Â Â±Â 0.96</td><td class="colsep0 rowsep0" align="char" char="Â±">3.38Â Â±Â 0.47</td><td class="colsep0 rowsep0" align="char" char="Â±">2.46Â Â±Â 0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3f</b></td><td class="colsep0 rowsep0" align="char" char="Â±">2.23Â Â±Â 0.56</td><td class="colsep0 rowsep0" align="center">>30</td><td class="colsep0 rowsep0" align="char" char="Â±">13.2Â Â±Â 0.3</td><td class="colsep0 rowsep0" align="char" char="Â±">15.7Â Â±Â 2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3h</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.214Â Â±Â 0.081</td><td class="colsep0 rowsep0" align="center">1.42Â Â±Â 0.33</td><td class="colsep0 rowsep0" align="char" char="Â±">2.57Â Â±Â 0.47</td><td class="colsep0 rowsep0" align="char" char="Â±">1.09Â Â±Â 0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3n</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.553Â Â±Â 0.048</td><td class="colsep0 rowsep0" align="center">2.03Â Â±Â 0.32</td><td class="colsep0 rowsep0" align="char" char="Â±">2.26Â Â±Â 0.084</td><td class="colsep0 rowsep0" align="char" char="Â±">5.02Â Â±Â 0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3p</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.328Â Â±Â 0.054</td><td class="colsep0 rowsep0" align="center">8.90Â Â±Â 2.16</td><td class="colsep0 rowsep0" align="char" char="Â±">2.54Â Â±Â 0.15</td><td class="colsep0 rowsep0" align="char" char="Â±">0.805Â Â±Â 0.241</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3q</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.031Â Â±Â 0.003</td><td class="colsep0 rowsep0" align="center">0.188Â Â±Â 0.059</td><td class="colsep0 rowsep0" align="char" char="Â±">0.291Â Â±Â 0.079</td><td class="colsep0 rowsep0" align="char" char="Â±">1.008Â Â±Â 0.125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3r</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.030Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="center">0.206Â Â±Â 0.022</td><td class="colsep0 rowsep0" align="char" char="Â±">0.141Â Â±Â 0.015</td><td class="colsep0 rowsep0" align="char" char="Â±">0.511Â Â±Â 0.047</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3t</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.028Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="center">0.321Â Â±Â 0.104</td><td class="colsep0 rowsep0" align="char" char="Â±">0.102Â Â±Â 0.011</td><td class="colsep0 rowsep0" align="char" char="Â±">1.15Â Â±Â 0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.028Â Â±Â 0.001</td><td class="colsep0 rowsep0" align="center">0.184Â Â±Â 0.019</td><td class="colsep0 rowsep0" align="char" char="Â±">0.170Â Â±Â 0.012</td><td class="colsep0 rowsep0" align="char" char="Â±">0.054Â Â±Â 0.003</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Inhibition of phosphorylation of STAT5a or STAT1 in PBMCs or HWB. The IL-2 readouts are gated to CD3-expressing T-cells; the GM-CSF and IFN-Î³ readouts are gated to CD14-expressing monocytes.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Mean Â± SEM (standard error of the mean), <i>n</i> â¥ 3 except for <b>3n</b> HWB value (<i>n</i> = 2).</p></div></div></div><div class="NLM_p">Only examples with high enzyme potency (10 nM or better) against at least one relevant isoform achieved sub-Î¼M cellular potencies. Many of the compounds tested show cellular potencies comparable to those seen for compound <b>1</b>, although HWB potencies are less, presumably because of higher protein binding. For example, in our protein binding assays (human), compound <b>1</b> showed a free fraction of 99% while compound <b>3q</b> showed a free fraction of only 3%. Cellular selectivities within this panel are also comparable to those observed for <b>1</b>, with moderate selectivities seen for inhibition of IL-2 signaling versus GM-CSF and IFN-Î³ signaling.</div><div class="NLM_p">Importantly, the examples with higher selectivity for JAK3 versus JAK1 still show potent inhibition of IL-2 signaling. Compound <b>3q</b> was equally potent in the IL-2 assay compared to its close analogue <b>3t</b>, which has a similar JAK3 enzyme potency but no selectivity against JAK1. These results cannot be explained by the cellular permeabilities of these compounds, which are comparable in our Caco-2 permeability assay (data not shown). We conclude that for these close comparators, loss of JAK1 potency did not affect potency in the IL-2 cellular assay and that a more selective inhibition of JAK3 catalytic function can be realized while still efficiently attenuating IL-2-induced STAT5a phosphorylation.</div><div class="NLM_p">The in vitro biopharmaceutical properties for compounds in this series varied depending on the amide side chain. Our early screening funnel focused on solubilities and microsomal stabilities, which both tended toward low for purely aliphatic side chains and improved for more polar examples. At various stages in the optimization process, select compounds were more deeply characterized. In vitro properties and in vivo rat pharmacokinetics (PK) for compounds <b>3f</b>, <b>3h</b>, and <b>3q</b> are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Tertiary alcohol <b>3f</b> was an early example with good in vitro properties translating to reasonable in vivo rat exposures, indicating that the core 3-amido pyrrolopyrazine is a drug-like scaffold and encouraging further optimization. Nitrile <b>3h</b> and bis-amide <b>3q</b> were designed and synthesized later in the optimization exercise and were two of our best examples with respect to the balance of properties with high enzyme and cellular potencies as well as kinome selectivities. Nitrile <b>3h</b> had poor solubility, and bis-amide <b>3q</b> had lower permeability and higher efflux in our Caco-2 assay (a common issue for the bis-amides); however, both compounds showed oral bioavailability in rat. Compound <b>3q</b> was chosen for further study, as its superior solubility was likely to be more conducive to increasing exposures with higher doses in in vivo experiments.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro and in Vivo Properties of Select Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="5" align="center">in vitro</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">solubility<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><br /></br>(Î¼g/mL)</th><th class="colsep0 rowsep0" align="center" char="/">Caco<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><br /></br>AB/BA</th><th class="colsep0 rowsep0" align="center" char=".">proteinÂ binding<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a><br /></br>(% free)</th><th class="colsep0 rowsep0" align="center">microsomal stability<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3f</b></td><td class="colsep0 rowsep0" align="center">55.7</td><td class="colsep0 rowsep0" align="char" char="/">11.3/16.4</td><td class="colsep0 rowsep0" align="char" char=".">11.6</td><td class="colsep0 rowsep0" align="left">Cl<sub>int</sub>Â (human)Â 32.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="char" char="/">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="left">Cl<sub>int</sub>Â (rat)Â 38.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3h</b></td><td class="colsep0 rowsep0" align="center"><1</td><td class="colsep0 rowsep0" align="char" char="/">17.8/15.3</td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="left">Cl<sub>int</sub>Â (human)Â 27.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="char" char="/">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="left">Cl<sub>int</sub>Â (rat)Â 50.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3q</b></td><td class="colsep0 rowsep0" align="center">32.7</td><td class="colsep0 rowsep0" align="char" char="/">2.1/24.6</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="left">Cl<sub>int</sub>Â (human)Â 40.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="center">Â </td><td class="colsep0 rowsep0" align="char" char="/">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="left">Cl<sub>int</sub>Â (rat)Â 51.5</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="7" align="center">in vivo rat (HanoverâWistar)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a>,<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">Vd<sub>ss</sub>(mL/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/kgÂ min)</th><th class="colsep0 rowsep0" align="center" char=".">% <i>F</i></th><th class="colsep0 rowsep0" align="center" char=".">AUC (ngÂ·h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3f</b></td><td class="colsep0 rowsep0" align="char" char=".">4.4</td><td class="colsep0 rowsep0" align="char" char=".">1010</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">1090</td><td class="colsep0 rowsep0" align="char" char=".">429</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.5Â mg/kg IV</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2Â mg/kg PO</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3h</b></td><td class="colsep0 rowsep0" align="char" char=".">0.66</td><td class="colsep0 rowsep0" align="char" char=".">1221</td><td class="colsep0 rowsep0" align="char" char=".">26.1</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">506</td><td class="colsep0 rowsep0" align="char" char=".">200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">0.5Â mg/kg IV</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2Â mg/kg PO</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3q</b></td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">1063</td><td class="colsep0 rowsep0" align="char" char=".">14.6</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">1195</td><td class="colsep0 rowsep0" align="char" char=".">398</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1Â mg/kg IV</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5Â mg/kg PO</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">LYSA (Lyophilized solubility assay).</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Permeability in measured Caco-2 cells AB (apical to basolateral) and BA (basolateral to apical) movement of 10 Î¼M test compound (50 Î¼M test compound for <b>3q</b>) in 7 days cultured Caco-2 cells (cm/s Ã 10<sup>â6</sup>), pH 7.4 on both sides.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">Equilibrium dialysis, male and female human plasma.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Liver microsomal intrinsic clearance (Î¼L/min/mg protein).</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Doses were IV (intravenous) and PO (per os); mean values of 2â3 rats per sample time.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last"><i>C</i><sub>max</sub>, AUC and % <i>F</i> were determined after the oral dose and Cl, Vd<sub>ss</sub>, and <i>t</i><sub>1/2</sub> were determined from the IV dose.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Further Functional Characterization of Compound <b>3q</b></h3><div class="NLM_p">As described above, compound <b>3q</b> was highly potent in both our JAK3 enzyme and IL-2 stimulated cellular assays, showed selectivity for inhibition of JAK3 versus JAK1, had one of the cleanest Caliper selectivity profiles tested for this series, and appeared suitable for in vivo studies. We chose this compound for further characterization, including expanded kinome selectivity profiling. Compound <b>3q</b> was sent to Kinomescan to test for compound binding against their entire kinase panel. The Kinomescan platform measures percent displacement of bait ligands by test compound. At 1 Î¼M test compound concentration, compound <b>3q</b> displaces >90% of ligand for only 41 out of 385 wild-type kinases tested (profiling data is included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Kinomescan also determined <i>K</i><sub>d</sub>s for <b>3q</b> against the kinase domains of JAK3 (<i>K</i><sub>d</sub> 0.12 nM), JAK2 (<i>K</i><sub>d</sub> 0.18 nM), JAK1 (<i>K</i><sub>d</sub> 12 nM), and Tyk2 (<i>K</i><sub>d</sub> 16 nM). In these assays, compound <b>3q</b> shows very strong binding to JAK3 (and JAK2), with high selectivity (100x) against both JAK1 and Tyk2.</div><div class="NLM_p">We expanded our human PBMC assays panels for compounds <b>3q</b>, <b>3t</b>, and Tofacitinib <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). We added two variations stimulating with IL-6, examining STAT3 phosphorylation in T-cells and monocytes, which is known to depend on JAK1, JAK2, and Tyk2. Notably, compound <b>3q</b> showed a 40-fold selectivity for inhibition of the IL-2 readout versus the IL-6 readout in T-cells and a 30-fold selectivity for inhibition versus the IL-6 readout in monocytes. Compounds <b>3t</b> and Tofacitinib <b>1</b> also showed selectivity for inhibition of the IL-2 readout but to a lesser degree against IL-6 for either readout. Our conclusion is that increased functional selectivity to inhibit IL-2 signaling versus IL-6 signaling is possible with increased enzyme-level selectivity to inhibit JAK3 versus JAK1.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Further Cellular Profiling of <b>3q</b>, <b>3t</b>, and <b>1</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col><col align="char" char="Â±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char="Â±">PBMCÂ (IL-2)Â IC<sub>50</sub>Â (Î¼M)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="Â±">PBMCÂ (GM-CSF)Â IC<sub>50</sub>Â (Î¼M)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="Â±">PBMCÂ (IFN-Î³)Â IC<sub>50</sub>Â (Î¼M)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="Â±">PBMCÂ (IL-6)Â IC<sub>50</sub>Â (Î¼M)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (CD3)</th><th class="colsep0 rowsep0" align="center" char="Â±">PBMCÂ (IL-6)Â IC<sub>50</sub>Â (Î¼M)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (CD14)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3q</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.031Â Â±Â 0.003</td><td class="colsep0 rowsep0" align="char" char="Â±">0.188Â Â±Â 0.059</td><td class="colsep0 rowsep0" align="char" char="Â±">0.291Â Â±Â 0.079</td><td class="colsep0 rowsep0" align="char" char="Â±">1.2Â Â±Â 0.6</td><td class="colsep0 rowsep0" align="char" char="Â±">0.864Â Â±Â 0.206<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3t</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.028Â Â±Â 0.002</td><td class="colsep0 rowsep0" align="char" char="Â±">0.321Â Â±Â 0.104</td><td class="colsep0 rowsep0" align="char" char="Â±">0.102Â Â±Â 0.011</td><td class="colsep0 rowsep0" align="char" char="Â±">0.255Â Â±Â 0.135<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="Â±">0.175Â Â±Â 0.065<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char="Â±">0.028Â Â±Â 0.001</td><td class="colsep0 rowsep0" align="char" char="Â±">0.184Â Â±Â 0.019</td><td class="colsep0 rowsep0" align="char" char="Â±">0.170Â Â±Â 0.012</td><td class="colsep0 rowsep0" align="char" char="Â±">0.38Â Â±Â 0.20</td><td class="colsep0 rowsep0" align="char" char="Â±">0.238Â Â±Â 0.07<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Inhibition of phosphorylation of STAT5a, STAT1, or STAT3 in PBMCs. The IL-2 readouts are gated to CD3-expressing T-cells; the GM-CSF and IFN-Î³ readouts are gated to CD14-expressing monocytes. The IL-6 readouts are gated to either CD3-expressing T-cells or to CD14-expressing monocytes, as noted.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Mean Â± SEM (standard error of the mean), <i>n</i> â¥ 3 except for the IL-6 PBMC data noted with footnote <a class="ref internalNav" href="#t5fn3" aria-label="c">c</a>.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last"><i>n</i> = 2 data.</p></div></div></div><div class="NLM_p">We also examined the functional effects of compound <b>3q</b> on human T-cell response. Compound <b>3q</b> inhibits the proliferation of human CD4 and CD8 T cells in a dose-dependent manner upon stimulation by anti-CD3/anti-CD28 antibody-coated beads partially mimicking the activation signals brought to a T-cell by an antigen-presenting cell (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for details). Thus, compound <b>3q</b> is active in both mechanistic and functional cell-based assays using T-cells, one of the major cell types in which JAK3 is potentially relevant.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Finally, an acute pharmacokinetic/pharmacodynamic (PK/PD) mouse model was developed to measure the inhibition of JAK family dependent signaling in vivo. As a bridging study between this model and our human cellular assays, we first evaluated compound <b>3q</b> in mouse whole blood (MWB) assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Compound <b>3q</b> potently inhibits IL-2 stimulated STAT5 phosphorylation in mouse whole blood (MWB), with selectivity against GM-CSF and IL-6 stimulated readouts, as observed in human PBMCs. In our MWB assays, compound <b>3q</b> did not show selectivity for inhibiting the IL-2 readout versus the IFN-Î³ readout, suggesting a potential for species difference of IFN-Î³ signaling in human and mouse systems. For comparison purposes, we also evaluated compound <b>3t</b> and Tofacitinib <b>1</b> in the MWB assays. All three compounds showed selectivity for inhibition of the IL-2 assay vs the IL-6 assay, with the rank order of selectivity corresponding to the rank order of selectivity for JAK3 versus JAK1 (i.e., <b>3q</b> is more selective than <b>1</b> and <b>3t</b>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Mouse Whole Blood (MWB) Potencies for Selected Compounds<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">MWB (IL-2) IC<sub>50</sub>(Î¼M)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">MWBÂ (GM-CSF) IC<sub>50</sub>(Î¼M)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">MWB (IFN-Î³) IC<sub>50</sub>(Î¼M)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">MWB (IL-6) IC<sub>50</sub>(Î¼M)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3q</b></td><td class="colsep0 rowsep0" align="center">0.18Â (0.02)</td><td class="colsep0 rowsep0" align="center">1.1Â (0.24)</td><td class="colsep0 rowsep0" align="center">0.17Â (0.03)</td><td class="colsep0 rowsep0" align="center">9.9Â (1.0)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3t</b></td><td class="colsep0 rowsep0" align="center">0.14Â (0.02)</td><td class="colsep0 rowsep0" align="center">0.85Â (0.09)</td><td class="colsep0 rowsep0" align="center">0.11Â (0.01)</td><td class="colsep0 rowsep0" align="center">2.01Â (0.16)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">0.05Â (0.01)</td><td class="colsep0 rowsep0" align="center">2.04Â (0.39)</td><td class="colsep0 rowsep0" align="center">0.18Â (0.04)</td><td class="colsep0 rowsep0" align="center">1.72Â (0.11)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Inhibition of phosphorylation of STAT5a, STAT1 or STAT3 in MWB.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Mean (SEM (standard error of the mean)), <i>n</i> â¥ 4.</p></div></div></div><div class="NLM_p">In the acute PK/PD mouse model, animals were orally treated with different doses of compound <b>3q</b> (0.3 to 100 mg/kg) and whole blood was collected 2 h later, ex vivo stimulated with IL-2, GM-CSF, or IL-6, and the appropriate STAT phosphorylation was measured by flow cytometry. Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> shows response versus dose curves for the three different stimulations plus the measured plasma concentrations of <b>3q</b> for each dose. Compound <b>3q</b> prevented IL-2-driven STAT5 phosphorylation in a dose- and concentration-dependent manner, with approximately 50% inhibition observed at the 10 mg/kg dose (plasma concentration â¼480 nM). Complete inhibition of IL-2-driven STAT5 phosphorylation was achieved at the 30 mg/kg dose (plasma concentration â¼2087 nM). Compound <b>3q</b> also inhibited GM-CSF-driven STAT5 phosphorylation in a dose- and concentration-dependent manner, but a complete inhibition of STAT5 phosphorylation in blood monocytes was not achieved with the maximum dose tested of 100 mg/kg (plasma concentration â¼6597 nM). Lastly, when whole blood from mice treated with compound <b>3q</b> was stimulated with IL-6 ex vivo, only 15% inhibition was observed of IL-6-driven pSTAT3 phosphorylation at the maximum tested dose of 100 mg/kg. Thus, the PK/PD results clearly show that target engagement can be achieved after oral administration of compound <b>3q</b> and that compound <b>3q</b> is JAK3 selective in vivo, as judged by higher potency inhibiting JAK1/JAK3- vs JAK2- or JAK1/JAK2/TYK2-driven signaling in whole blood assays.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of STAT phosphorylation in mice treated with compound <b>3q</b> in an acute PK/PD model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Discussion and Exploratory siRNA Studies</h3><div class="NLM_p">We were able to optimize a new chemical series, 3-amidopyrrolopyrazines, into highly potent JAK inhibitors with reasonable kinome selectivity profiles. Structurally related examples with similar potencies against JAK3 but differing potencies against JAK1 show similar cellular potencies in an IL-2 induced STAT5 phosphorylation assay. Our results suggest that JAK3 plays an essential role in IL-2 induced STAT5 phosphorylation. At first glance, this conclusion appears to contradict that reached by the Novartis group, which showed that selective depletion of JAK1 by siRNA in T-cells is more detrimental to IL-2 signaling than depletion of JAK3.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We found similar results in our own siRNA work (see below).</div><div class="NLM_p">Novartis also published their own JAK3-selective compound, which shows poor activity in a similar IL-2 dependent cellular assay. Novartisâs JAK3-selective compound is significantly more selective than compound <b>3q</b> against JAK1 at the enzyme level (based on comparison with Tofacitinib as control) and, unlike compound <b>3q</b>, also shows high selectivity against JAK2. The compound published by the Pharmacopeia group, with which they concluded that JAK1 inhibition is not required for potent inhibition of IL-2 signaling, has enzyme selectivities similar to compound <b>3q</b>. These observations suggest at least two possible explanations for compound <b>3q</b>âs retained potency for inhibiting IL-2 signaling. One possibility is that <b>3q</b>âs level of selectivity against JAK1 is simply not high enough to have a strong differential effect in this particular cellular context. A second possibility is that JAK2 may also play a role in IL-2 signaling.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><div class="NLM_p">We performed siRNA knockdown studies on JAK3, JAK2, and JAK1 in primary T-cells, looking for effects on IL-2 induced STAT5 phosphorylation (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Our findings for JAK1 (strong involvement in STAT5 phosphorylation) and JAK3 (weaker involvement in STAT5 phosphorylation) qualitatively agree with the findings of the Novartis group. The Novartis group did not include JAK2 in their published studies; in our work, we found no effect of JAK2 depletion on IL-2 induced STAT5 phosphorylation at the siRNA concentrations tested. Thus, inhibition of JAK2 by compound <b>3q</b> is unlikely to be the driver for activity in our IL-2 cellular assays.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. siRNA depletion studies on JAK1â3 in primary T-cells. Human primary T cells were transfected with siRNAs targeting JAK1, JAK2, JAK3, or scramble siRNA (Ctrl RNA) by Amaxa electrophoresis, and IL-2 induced phosphorylation of STAT5 was determined by flow cytometric analysis. The intensity of pSTAT5 (%) was normalized to control scramble siRNA treatment group represented as percentage (%). The experiment was repeated in three independent experiments on three different donors. Gene knockdown confirmation studies are included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We cannot discount the possibility that the diminished JAK1 inhibitory activity of compound <b>3q</b> remains a significant driver of potency against IL-2 signaling. However, our results do confirm that improved selectivity for IL-2 signaling over IL-6 signaling, with retention of IL-2 cellular potency, is achievable for JAK3 inhibitors with improved selectivity against JAK1. Importantly, the cellular potencies and selectivities for our most highly optimized compound <b>3q</b> was translated to in vivo potency and selectivity in an acute PK/PD mouse model. Compound <b>3q</b> may therefore be an excellent tool compound for further dissecting the roles of these different pathways in other in vivo models.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88043" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88043" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p last">Reagents and solvents were obtained from commercial suppliers and were used without further purification. <sup>1</sup>H NMR measurements were recorded at 300 MHz using a Bruker AMX 300 instrument. Chromatographic purifications were performed with automated chromatography systems using prepacked silica gel cartidges supplied by Thomson Instrumental Co. or by TeleDyne Isco Inc. Melting points recorded were uncorrected. Purity and characterization of compounds were established by a variety of elemental analysis, LC/MS, and NMR analytical techniques, and purities were >95% for all final products.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Bromo-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carbaldehyde (<b>4</b>)</h3><div class="NLM_p">To a partial suspension of 2-bromo-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine (5.0 g, 25 mmol) in 100 mL of 1,4-dioxane was added 2 M aqueous sodium hydroxide solution (25 mL, 50 mmol) and 37% aqueous formaldehyde solution (19 mL, 250 mmol). The dark homogeneous reaction mixture was stirred at 25 Â°C for 16 h, and then the organic solvent was removed under reduced pressure. The aqueous residue was adjusted to pH 7 with 1 M aqueous hydrochloric acid and then extracted twice with ethyl acetate. The combined organic phases were concentrated to afford 2.60 g of (2-bromo-5-hydroxymethyl-pyrrolo[2,3-<i>b</i>]pyrazin-7-yl)-methanol as an orange solid. Upon standing, a thick brown precipitate formed in the aqueous phase. The precipitate was collected by filtration and dried. The brown solid was extracted with three 200 mL portions of hot 10% methanol/ethyl acetate. The extracts were combined and evaporated to provide an additional 3.05 g of (2-bromo-5-hydroxymethyl-pyrrolo[2,3-<i>b</i>]pyrazin-7-yl)-methanol as an orange solid. The overall yield was 5.65 g (87%) of crude (2-bromo-5-hydroxymethyl-pyrrolo[2,3-<i>b</i>]pyrazin-7-yl)-methanol, which was carried directly to the next step. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 8.42 (s, 1 H), 7.97 (s, 1 H), 6.91 (br s, 1 H), 5.59 (br s, 2 H), 5.13 (br s, 1 H), 4.65 (br s, 2 H). MS (EI/CI) <i>m</i>/<i>z</i>: 258, 260 (M + H).</div><div class="NLM_p">To a suspension of the above-prepared (2-bromo-5-hydroxymethyl-pyrrolo[2,3-<i>b</i>]pyrazin-7-yl)-methanol (5.65 g, 21.9 mmol) in 150 mL of tetrahydrofuran was added a solution of 2 M aqueous sodium hydroxide solution (33 mL, 66 mmol). The mixture was stirred for 16 h, and then the organic layer was removed under reduced pressure. The aqueous residue was adjusted to pH 4 with 1 M aqueous hydrochloric acid. The resulting precipitate was collected via filtration and rinsed with water to afford 3.68 g of (2-bromo-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazin-7-yl)-methanol as a yellow solid. The filtrate was extracted twice with ethyl acetate, and the combined organic phases were concentrated under reduced pressure to provide an additional 0.92 g of (2-bromo-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazin-7-yl)-methanol as a yellow solid. The overall yield was 4.60 g (92%) of crude (2-bromo-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazin-7-yl)-methanol, which was carried directly to the next step. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 12.20 (br s, 1 H), 8.35 (s, 1 H), 7.87 (s, 1 H), 4.98 (t, <i>J</i> = 5.3 Hz, 1 H), 4.63 (d, <i>J</i> = 4.9 Hz, 2 H). MS (EI/CI) <i>m</i>/<i>z</i>: 228, 230 (M + H).</div><div class="NLM_p">A stock solution of Jones reagent (2.67 M) was prepared by carefully adding concentrated sulfuric acid (2.3 mL) to chromium trioxide (2.67 g) and then diluting with water to a final volume of 10 mL. To a partial suspension of the above-prepared (2-bromo-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazin-7-yl)-methanol (4.60 g, 20.1 mmol) in 300 mL of acetone was slowly added the Jones reagent (9.0 mL, 24 mmol). During the addition, the starting material gradually dissolved and a thick green precipitate formed. The reaction mixture was stirred for 15 min and then quenched with 2 mL of 2-propanol and filtered through Celite 545, rinsing with acetone. The filtrate was concentrated to provide 4.76 g (â104%â) of crude 2-bromo-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carbaldehyde as a yellowâorange solid, which was carried directly to the next step. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 13.36 (br s, 1 H), 10.04 (s, 1 H), 8.80 (s, 1 H), 8.55 (s, 1 H). MS (EI/CI) <i>m</i>/<i>z</i>: 226, 228 (M + H).</div><div class="NLM_p last">To a solution of the above-prepared crude 2-bromo-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carbaldehyde (4.7 g) in 50 mL of <i>N</i>,<i>N</i>-dimethylformamide at 0 Â°C was added sodium hydride (60% in mineral oil, 1.2 g, 30 mmol). The reaction mixture was stirred at 25 Â°C for 30 min and then cooled to 0 Â°C. The mixture was then treated with 2-(trimethylsilyl)ethoxymethyl chloride (4.3 mL, 24 mmol). The reaction mixture was allowed to warm to 25 Â°C, stirred for 1 h, and then quenched with water and extracted three times with ethyl acetate. The combined organics were sequentially washed with three portions of water and a saturated aqueous sodium chloride solution and then dried over magnesium sulfate, filtered, and concentrated. The residue was purified by silica gel chromatography (20â30% ethyl acetate/hexanes) to afford 3.82 g (51%; 42% over four steps) of 2-bromo-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carbaldehyde (<b>4</b>) as a yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 10.07 (d, <i>J</i> = 0.8 Hz, 1 H), 8.97 (s, 1 H), 8.65 (s, 1 H), 5.71 (s, 2 H), 3.53â3.61 (m, 2 H), 0.79â0.88 (m, 2 H), â0.09 (s, 9 H). MS (EI/CI) <i>m</i>/<i>z</i>: 356, 358 (M + H).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Cyclopropyl-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carbaldehyde (<b>5</b>)</h3><div class="NLM_p last">A mixture of 2-bromo-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carbaldehyde (0.330 g, 0.930 mmol), cyclopropylboronic acid (0.120 g, 1.40 mmol), tricyclohexylphosphine (0.026 g, 0.09 mmol), palladium(II) acetate (0.010 g, 0.046 mmol), potassium phosphate tribasic (0.630 g, 2.97 mmol), 4 mL of toluene, and 0.5 mL of water was flushed with argon for 5 min. The reaction mixture was stirred at 100 Â°C for 18 h and then allowed to cool and filtered through a pad of Celite 545, rinsing with ethyl acetate. The filtrate was concentrated under reduced pressure, and the residue was purified by silica gel chromatography (10% ethyl acetate/hexanes) to afford 0.240 g (81%) of 2-cyclopropyl-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carbaldehyde (<b>5</b>) as a yellow powder. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ ppm 10.38 (s, 1 H), 8.26 (s, 1 H), 8.22 (s, 1 H), 5.68 (s, 2 H), 3.53â3.61 (m, 2 H), 2.26â2.36 (m, 1 H), 1.09â1.24 (m, 4 H), 0.89â0.97 (m, 2 H), â0.04 (s, 9 H). MS (EI/CI) <i>m</i>/<i>z</i> 318 (M + H).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-Cyclopropyl-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carboxylic Acid (<b>6</b>)</h3><div class="NLM_p last">To a mixture of 2-cyclopropyl-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carbaldehyde (0.24 g, 0.75 mmol) in 10 mL of 1,4-dioxane and 2 mL of water at 0 Â°C was added sulfamic acid (0.44 g, 4.5 mmol) and then dropwise a solution of 80% sodium chlorite (0.09 g, 0.8 mmol) and potassium dihydrogen phosphate (1.22 g, 9.00 mmol) in 6 mL of water. The reaction mixture was allowed to warm to 25 Â°C and stirred for 2 h and then partitioned between water and ethyl acetate. The organic phase was washed with a saturated aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The residue was triturated with hexanes to obtain 0.22 g (87%) of 2-cyclopropyl-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carboxylic acid as a light-yellow powder (<b>6</b>). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ ppm 8.37 (s, 1 H), 8.28 (s, 1 H), 5.65â5.70 (m, 2 H), 3.52â3.63 (m, 2 H), 2.20â2.32 (m, 1 H), 1.13â1.22 (m, 4 H), 0.88â0.98 (m, 2 H), â0.03 (s, 9 H). MS (EI/CI) <i>m</i>/<i>z</i> 334 (M + H).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-Cyclopropyl-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carboxylic Acid [(<i>R</i>)-1-(3-Cyano-azetidine-1-carbonyl)-2,2-dimethyl-propyl]-amide (<b>3q</b>)</h3><div class="NLM_p">A solution of [(<i>R</i>)-1-(3-cyano-azetidine-1-carbonyl)-2,2-dimethyl-propyl]-carbamic acid <i>tert</i>-butyl ester (see preparation below) (0.093 g, 0.32 mmol) in 3 mL of dichloromethane at 0â5 Â°C was treated with 1 mL of trifluoroacetic acid. The reaction solution was allowed to warm to 25 Â°C and stirred for 3 h and then concentrated to afford crude (<i>R</i>)-1-(3-cyano-azetidine-1-carbonyl)-2,2-dimethyl-propyl-ammonium trifluoroacetate as a colorless glass, which was used directly in the next step.</div><div class="NLM_p">A solution of 2-cyclopropyl-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carboxylic acid (0.070 g, 0.21 mmol) in 2 mL of acetonitrile was treated with <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetramethyluronium tetrafluoroborate (0.081 g, 0.25 mmol), the above-prepared crude (<i>R</i>)-1-(3-cyano-azetidine-1-carbonyl)-2,2-dimethyl-propyl-ammonium trifluoroacetate, and <i>N</i>,<i>N</i>-diisopropylethylamine (0.13 mL, 0.74 mmol). The reaction mixture was stirred at 25 Â°C for 16 h and then was diluted with water and extracted with ethyl acetate. The organic phase was washed with a saturated aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated. The residue was purified by silica gel chromatography (0â5% methanol/dichloromethane) to afford 0.092 g (85%) of 2-cyclopropyl-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carboxylic acid [(<i>R</i>)-1-(3-cyano-azetidine-1-carbonyl)-2,2-dimethyl-propyl]-amide as a colorless semisolid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) Î´ ppm 8.93 (d, <i>J</i> = 9.1 Hz, 1 H), 8.30 (s, 1 H), 8.17 (s, 1 H), 5.59â5.68 (m, 2 H), 4.74â4.97 (m, 1 H), 4.16â4.58 (m, 4 H), 3.45â3.58 (m, 3 H), 2.16â2.26 (m, 1 H), 1.32â1.41 (m, 1 H), 1.07â1.20 (m, 12 H), 0.86â0.95 (m, 2 H), â0.09 to â0.02 (m, 9 H). MS (EI/CI) <i>m</i>/<i>z</i> 511 (M + H).</div><div class="NLM_p last">A solution of the above-prepared 2-cyclopropyl-5-(2-trimethylsilanyl-ethoxymethyl)-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carboxylic acid [(<i>R</i>)-1-(3-cyano-azetidine-1-carbonyl)-2,2-dimethyl-propyl]-amide (0.092 g, 0.18 mmol) in 2 mL of dichloromethane was treated with 0.6 mL of trifluoroacetic acid. The reaction solution was stirred at 25 Â°C for 2 h and was then neutralized by addition of a saturated aqueous sodium bicarbonate solution. The resultant mixture was extracted three times with ethyl acetate, and the combined organic phases were washed with saturated sodium chloride solution, dried over sodium sulfate, filtered, and concentrated. The residue was redissolved in 8 mL of ethanol, and the resulting solution was treated with sodium acetate (0.30 g, 3.6 mmol). The mixture was stirred at 50 Â°C for 20 h, allowed to cool, and then treated with water and ethyl acetate. Layers were separated, the aqueous phase was extracted twice with ethyl acetate, and the combined organic layers were washed with a saturated aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated. The residue was purified by silica gel chromatography (0â5% methanol/dichloromethane) to afford 0.052 g (75%) of 2-cyclopropyl-5<i>H</i>-pyrrolo[2,3-<i>b</i>]pyrazine-7-carboxylic acid [(<i>R</i>)-1-(3-cyano-azetidine-1-carbonyl)-2,2-dimethyl-propyl]-amide as an off-white solid; mp 181â183 Â°C. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 12.63 (br s, 1 H), 8.63â8.73 (m, 1 H), 8.40â8.44 (m, 1 H), 8.26â8.34 (m, 1 H), 4.41â4.68 (m, 2 H), 4.26â4.36 (m, 1 H), 3.98â4.24 (m, 2 H), 3.74â3.91 (m, 1 H), 2.26â2.39 (m, 1 H), 1.14â1.26 (m, 1 H), 1.04 (s, 11 H), 0.92â0.99 (m, 1 H). MS (EI/CI) <i>m</i>/<i>z</i> 381 (M + H). Analysis Calculated for C<sub>20</sub>H<sub>24</sub>N<sub>6</sub>O<sub>2</sub>Â·(0.16H<sub>2</sub>O): C, 62.67; H, 6.39; N, 21.92. Found: C, 62.65; H, 6.39; N, 21.63. [Î±]<sup>28</sup><sub>D</sub> (<i>c</i> = 0.5, methanol) â149.6 <sup>o</sup>.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> [(<i>R</i>)-1-(3-Cyano-azetidine-1-carbonyl)-2,2-dimethyl-propyl]-carbamic Acid <i>tert</i>-Butyl Ester</h3><div class="NLM_p last">A solution of <i>N</i>-<i>tert</i>-butoxycarbonyl-<span class="smallcaps smallerCapital">d</span>-<i>tert</i>-leucine (0.500 g, 2.16 mmol), <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetramethyluronium tetrafluoroborate (0.83 g, 2.6 mmol), and 3-cyanoazetidinium chloride (0.270 g, 2.28 mmol) in 22 mL of dichloromethane was treated with <i>N</i>,<i>N</i>-diisopropylethylamine (0.94 mL, 5.4 mmol), and the reaction mixture was stirred at 25 Â°C for 16 h. The mixture was then treated with water and extracted twice with ethyl acetate. The combined organic layers were washed with a saturated aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated. The residue was purified by silica gel chromatography (20% ethyl acetate/hexanes) to afford 0.39 g (61%) of [(<i>R</i>)-1-(3-cyano-azetidine-1-carbonyl)-2,2-dimethyl-propyl]-carbamic acid <i>tert</i>-butyl ester as a white solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ ppm 6.75â6.89 (m, 1 H), 4.28â4.57 (m, 2 H), 3.93â4.21 (m, 2 H), 3.67â3.88 (m, 2 H), 1.31â1.45 (m, 9 H), 0.91 (d, <i>J</i> = 3.3 Hz, 9 H). MS (EI/CI) <i>m</i>/<i>z</i> 318 (M + Na).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Biological Methods</h3><div id="sec3_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> JAK1â3 Kinase Inhibition</h4><div class="NLM_p last">The ability of compounds to inhibit Janus kinase enzymes 1, 2, or 3 was determined by a kinase filtration assay. JAK1 was purchased from Invitrogen and JAK2 and 3 proteins were prepared in house. Briefly, 6 nM JAK1 (866â1154 amino acids), 1 nM JAK2 (JAK2-SF21c 828â1132), or 0.1 nM of JAK3 enzyme (810â1124 amino acids) were preincubated with compound at room temperature for 10 min in 50 mM HEPES buffer and 10 mM magnesium chloride (MgCl<sub>2</sub>) that was supplemented with 1 mM dithiothreitol (DTT) and 1 mg/mL bovine serum albumin (BSA). The kinase reactions for all of the enzymes were initiated by the addition of a substrate cocktail that contained 1.5 Î¼M adenosine triphosphate (ATP), 0.025 Î¼Ci ATP-Î³-P<sup>33</sup>, and 0.2 mM of biotinylated synthetic peptide (Biomer Technology: Biotin-KAIETDKEYYTVKD) at a final volume of 40 Î¼L. The reaction was carried out at room temperature for 30 min for JAK2 and JAK3, and for 1 h for JAK1. Reactions were quenched by transferring 25 Î¼L to a filter plate (Millipore MABVN0B50, 1.2 Î¼M pore size) containing 100 Î¼L of prepared 10% streptavidin beads in 1Ã PBS (Mg and Ca<sup>2+</sup> free) and 100 mM ethylene diamine tetra-acetic acid (EDTA). The bead/terminated solution was mixed and incubated for 30 min at room temperature. Using a vacuum manifold, plates were washed three times with 240 Î¼L of 2 M aqueous sodium chloride solution, three times with 2 M aqueous sodium chloride +1% phosphoric acid solution, and twice with water. The plates were then dried in a 60 Â°C oven for 1 h. Finally, 70 Î¼L of Microscint-20 was added and sealed. Resulting P<sup>33</sup> incorporation was determined by counting the plate in a Packard TopCount.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Inhibition of STAT Phosphorylation in Peripheral Blood Mononuclear Cells (PBMCs) or Human Whole Blood (HWB)</h4><div class="NLM_p last">PBMCs or HWB isolated from healthy volunteers were incubated with compounds for 30 min at 37 Â°C. The PBMCs or HWB were then treated with either 100 ng/mL IL-2 or 20 pg/mL GM-CSF or 100 ng/mL IFNÎ³ or 100 ng/mL IL-6, and the PBMCs or HWB were incubated for an additional 20 min at 37 Â°C. PBMCs or HWB were lysed and/or fixed and permeabilized (perm buffer III, BD Bioscience) and then stained with anti-CD3 FITC and anti-CD14 PE and either anti-pSTAT5 or anti-pSTAT1 or anti-pSTAT3. Flow cytometry analysis was performed using an LSRII instrument (BD Bioscience). Data analysis was done using Flowjo software. IC<sub>50</sub> values were generated using ActivityBase software.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Experimental Animals</h4><div class="NLM_p last">All procedures using animals and in vivo procedures were approved by Rocheâs Institutional Animal Care and Use Committee (IACUC), and performed according to guidelines established by the Guide for the Care and Use of Laboratory Animals by National Research Council and by Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC), and American Veterinary Medical Association Guidelines on Euthanasia (2007). Animals used for the present studies were adult female C57BL/6 mice (Jackson Laboratory, Bar Harbor, Maine) and female Wistar/Han rats (Charles River, Hollister, CA).</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Inhibition of STAT Phosphorylation in Mouse Whole Blood (MWB)</h4><div class="NLM_p last">Whole blood from healthy C57BL/6 mice (<i>n</i> = 20) was collected in heparinized tubes and pooled then incubated with compound <b>3q</b> at different concentrations (0.003 Î¼M to 100 Î¼M) for 30 min at 37 Â°C. Blood cells were stimulated for 20 min at 37 Â°C with recombinant mouse IL-2, GM-CSF or IL-6 (eBioscience) at EC90 concentration, which was previously determined using that respective cytokine batch. Red blood cells were then lysed with 1X Lyse/Fix solution (BD Bioscience) for 20 min at room temperature. Cells were pelleted, resuspended in Phosflow Perm Buffer III (BD Bioscience), and left on ice for 30 min. Cells were washed twice using 1Ã Perm/Wash buffer then resuspended in a volume of 100 Î¼L prior to staining with fluorochrome-conjugated antimouse antibodies (BD Bioscience): staining A = anti-TCRÎ² PE, anti-CD4 FITC, anti-CD25 PerCP-Cy5.5, and anti-pSTAT5 AF647; staining B = anti-CD11b FITC, anti-TCRÎ² PE, anti-B220 PerCP-Cy5, and anti-pSTAT5 AF647; staining C = anti-CD11b FITC, anti-TCRÎ² PE, anti-B220 PerCP-Cy5, and anti-pSTAT3 AF647. Flow cytometry sample acquisition and data analysis were performed using an LSRII instrument and Flowjo software, respectively. IC<sub>50</sub> values were generated using ActivityBase software.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Microsomal Stability</h4><div class="NLM_p last">Microsome preparations prepared from male and female rat or human livers were obtained from BD Biosciences (Woburn, MA). Test compounds were diluted from 10 mM stock solutions in DMSO; incubations contained <1% residual DMSO. Incubations were performed in 96-well deep-well plates with a final incubation volume of 600 Î¼L. Incubations contained 1â2 Î¼M test compound, 0.5 mg/mL liver microsomes, and NADPH regenerating system. Aliquots of 50 Î¼L were removed at time points from 1 to 45 min, quenched in acetonitrile containing internal standard, and cooled prior to centrifugation and analysis by LC-MS/MS. The natural log of the ratio of the test compound peak area to the internal standard peak area was plotted against incubation time, and the slope of a linear fit of the initial rate of compound disappearance was used to calculate the intrinsic clearance.<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/jm-2012-01646k_m001.gif" alt="" /></img></span></div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Pharmacokinetics</h4><div class="NLM_p last">Male Wistar/Han (CRL:WI) rats (Charles River Laboratories, Hollister, CA or Raleigh, NC) used in these studies weighed between 180 and 300 g and were surgically implanted with cannulas in the jugular and/or femoral veins. All studies were conducted under IACUC approved protocols, and animals were allowed free access to food and water. Single intravenous bolus doses were administered into the tail vein or into the jugular cannula of dual-cannulated animals; the remaining cannulas were used for blood collection. Single oral doses were administered by gavage. Blood was collected into tubes containing EDTA at typically 0.08 (IV only), 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h after dosing. Plasma concentrations were determined by a liquid chromatography/tandem mass spectrometry method (LC/MS/MS) following protein precipitation with acetonitrile.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> In Vivo Mouse PK/PD Model</h4><div class="NLM_p last">Adult (10â12 weeks old) C57BL/6 mice were randomized into experimental groups (<i>n</i> = 5/group) including control vehicle group and compound <b>3q</b> treated groups (0.3, 1, 3, 10, 30, and 100 mg/kg). According to their respective group, mice received a single oral suspension dose of compound <b>3q</b> prepared in aqueous vehicle or vehicle alone containing 0.9% NaCl, 0.5% sodium carboxymethyl cellulose, 0.4% polysorbate 80, and 0.9% benzyl alcohol. Two hours after treatment by oral gavage, mice were euthanized with CO<sub>2</sub> asphyxiation for collecting whole blood in heparinized tubes. Whole blood from the respective mice was then ex vivo stimulated with IL-2, GM-CSF, or IL-6 at EC<sub>90</sub> concentration. The subsequent experimental steps (from red blood cell lysis step to flow cytometry analysis) were similar to that used in the MWB assay, as previously described in this manuscript.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Human T Cell siRNA Transfection and Activation Assay</h4><div class="NLM_p last">Primary human T cells were enriched from PBMC by using Pan T Cell Isolation Kit II (Miltenyi Biotec GmbH, Germany) and resuspended in PRMI-1640 culture medium supplemented with 10% FBS (Invitrogen, Carlsbad, CA). T cells were transfected with siRNAs targeting JAK1, JAK2, JAK3, or scramble control siRNA (Invitrogen) with Amaxa P3 Primary Cell 4D-Nucleofector X kit (Lonza Cologne GmbH, Germany) according to manufacturerâs protocol using program âFI-115â in 4D-Necleofector (Lonza). Transfected cells were transferred into 12-well plate and allowed 48 h of incubation at 37 Â°C followed by stimulation with IL2 (100 ng/mL, R&D Systems) for 20 min. Cells were fixed with 1.5% formaldehyde for 10 min at room temperature and then permeabilized with BD Phosflow Perm Buffer III at 4 Â°C overnight. Fixed and permeabilized cells were washed with FACS staining buffer (PBS with 2% FBS) twice, stained with FITC antihuman CD3 and Alexa Fluor 647 anti-STAT5 (pY694), and quantitated for pSTAT5 fluorescence intensity gated on CD3<sup>+</sup> T cell population.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Protein Crystallography</h4><div class="NLM_p last">JAK3 kinase domain (amino acids 811â1124, C1040S/C1048S) at 10â15 mg/mL in 50 mM HEPES (pH 8.0), 0.5 M NaCl, 20% glycerol, 5 mM DTT, 0.05% <i>n</i>-octyl-Î²-<span class="smallcaps smallerCapital">d</span>-glucoside was incubated on ice for 1 h with 50 mM DTT, 0.75 mM inhibitor in DMSO, and 0.26% phenylurea (originally identified from Hampton Research Silver Bullet F10, later also described by others<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a>). For crystallization by vapor diffusion in hanging drops at 20 Â°C, 700 nL of JAK3âinhibitor complex solution was mixed with 300 nL of 24â34% PEG 3350, 0.1 M MES (pH 6.0), 0.2 M MgCl<sub>2</sub>, and 150 nL of crystal seed solution. Crystals typically appeared overnight as rods or bipyramidal prisms. They were cryoprotected by gradually adding glycerol to 20% and flash-cooled in liquid nitrogen. Synchrotron data collection was provided by Reciprocal Space Consulting, LLC (Oakland, California) at beamline 9â2 of the Stanford Synchrotron Radiation Laboratory (Palo Alto, California) and beamline 5.0.2 of the Advanced Light Source (Berkeley, California) using ADSC Quantum 315 CCD detectors. The diffraction images were processed with DENZO, and the intensities were scaled with SCALEPACK.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The structure of the first JAK3âligand complex was solved with the molecular replacement program PHASER<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> using the crystal structure of JAK3 kinase domain in complex with a staurosporine analogue<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (PDB accession no. <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YVJ">1YVJ</a>) as search model. The solution found was a JAK3 monomer in space group <i>P</i>2<sub>1</sub>2<sub>1</sub>2 with the unit cell dimensions Î± = 47 Ã, Î² = 76 Ã and Î³ = 90 Ã. The same crystal form has also been obtained for a similar JAK3 kinase domain variant.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The model was refined against the experimental data, and electron density maps were calculated using REFMAC5.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(31)</a> Subsequent JAK3âligand structures were determined by rigid body refinement. The structure models were built with the graphics software COOT.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(32)</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33"><a href="/doi/suppl/10.1021/jm301646k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures and analytical data for final compounds <b>3a</b>â<b>3p</b> and <b>3r</b>â<b>3t</b>, Kinomescan selectivity data for compound <b>3q</b>, CD4 and CD8 cell proliferation studies, response versus plasma concentration curves for the mouse acute PK/PD model studies, and gene knockdown confirmation studies for the siRNA study. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301646k/suppl_file/jm301646k_si_001.pdf">jm301646k_si_001.pdf (689.81 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Protein crystal structure coordinates and structure factors are deposited in the RCSB Protein Data Bank with the accession numbers <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVD">4HVD</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVG">4HVG</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVH">4HVH</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVI">4HVI</a>.</p><div class="testing" data-doi="10.1021/jm301646k" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56810" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56810" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Soth</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a1ccc8c2c9c0c4cd8fd2ced5c9e1d3cec2c9c48fc2cecc"><span class="__cf_email__" data-cfemail="74191d171c1511185a071b001c34061b171c115a171b19">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johannes C. Hermann</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Calvin Yee</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Muzaffar Alam</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jim W. Barnett</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pamela Berry</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle F. Browner</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karl Frank</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Frauchiger</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seth Harris</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang He</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mohammad Hekmat-Nejad</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Than Hendricks</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert Henningsen</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ramona Hilgenkamp</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hoangdung Ho</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ann Hoffman</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pei-Yuan Hsu</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong-Qing Hu</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Itano</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Saul Jaime-Figueroa</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alam Jahangir</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sue Jin</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Kuglstatter</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan K. Kutach</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Liao</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Lynch</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Menke</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linghao Niu</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vaishali Patel</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aruna Railkar</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas Roy</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ada Shao</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Shaw</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Steiner</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongliang Sun</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seng-Lai Tan</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandra Wang</span> - <span class="hlFld-Affiliation affiliation">Roche Palo Alto, 3431 Hillview
Avenue, Palo Alto, California 94304, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minh Diem Vu</span> - <span class="hlFld-Affiliation affiliation">Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25304" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25304" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 32 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Takeshita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munakata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span> </span><span class="NLM_article-title">Cloning of the Î³ chain of the human IL-2 receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x"> (</span><span class="NLM_issue">5068</span><span class="NLM_x">) </span> <span class="NLM_fpage">379</span><span class="NLM_x">â</span> <span class="NLM_lpage">382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1992&pages=379-382&issue=5068&author=T.+Takeshitaauthor=H.+Asaoauthor=K.+Ohtaniauthor=N.+Ishiiauthor=S.+Kumakiauthor=N.+Tanakaauthor=H.+Munakataauthor=M.+Nakamuraauthor=K.+Sugamura&title=Cloning+of+the+%CE%B3+chain+of+the+human+IL-2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeshita%26aufirst%3DT.%26aulast%3DAsao%26aufirst%3DH.%26aulast%3DOhtani%26aufirst%3DK.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DKumaki%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DMunakata%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DSugamura%26aufirst%3DK.%26atitle%3DCloning%2520of%2520the%2520%25CE%25B3%2520chain%2520of%2520the%2520human%2520IL-2%2520receptor%26jtitle%3DScience%26date%3D1992%26volume%3D257%26issue%3D5068%26spage%3D379%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Rochman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spolski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span> </span><span class="NLM_article-title">New insights into the regulation of T cells by Î³c family cytokines</span> <span class="citation_source-journal">Nature Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">480</span><span class="NLM_x">â</span> <span class="NLM_lpage">490</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1038%2Fnri2580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=19543225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=480-490&issue=7&author=Y.+Rochmanauthor=R.+Spolskiauthor=W.+J.+Leonard&title=New+insights+into+the+regulation+of+T+cells+by+%CE%B3c+family+cytokines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the regulation of T cells by Î³c family cytokines</span></div><div class="casAuthors">Rochman, Yrina; Spolski, Rosanne; Leonard, Warren J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">480-490</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Common cytokine receptor Î³-chain (Î³c) family cytokines have crucial roles in the development, proliferation, survival and differentiation of multiple cell lineages of both the innate and adaptive immune systems.  In this Review, the authors focus on the current understanding of the distinct and overlapping effects of interleukin-2 (IL-2), IL-7, IL-9, IL-15 and IL-21, as well as the IL-7-related cytokine thymic stromal lymphopoietin (TSLP), on the survival and proliferation of conventional Î±Î² T cells, Î³Î´ T cells and regulatory T cells.  This knowledge potentially allows for the therapeutic manipulation of immune responses for the treatment of cancer, autoimmunity, allergic diseases and immunodeficiency, as well as for vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6GBlSyD8_NLVg90H21EOLACvtfcHk0lhTrcFwyNfoqA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D&md5=a6c7285b05193002b89be7233d11f271</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnri2580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2580%26sid%3Dliteratum%253Aachs%26aulast%3DRochman%26aufirst%3DY.%26aulast%3DSpolski%26aufirst%3DR.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DNew%2520insights%2520into%2520the%2520regulation%2520of%2520T%2520cells%2520by%2520%25CE%25B3c%2520family%2520cytokines%26jtitle%3DNature%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26issue%3D7%26spage%3D480%26epage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Macchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacco, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frattini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugazio, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vezzoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarangelo, L. D.</span><span> </span><span class="NLM_article-title">Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x"> (</span><span class="NLM_issue">6544</span><span class="NLM_x">) </span> <span class="NLM_fpage">65</span><span class="NLM_x">â</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=65-68&issue=6544&author=P.+Macchiauthor=A.+Villaauthor=S.+Gilianiauthor=M.+G.+Saccoauthor=A.+Frattiniauthor=F.+Portaauthor=A.+G.+Ugazioauthor=J.+A.+Johnstonauthor=F.+Candottiauthor=J.+J.+O%E2%80%99Sheaauthor=P.+Vezzoniauthor=L.+D.+Notarangelo&title=Mutations+of+Jak-3+gene+in+patients+with+autosomal+severe+combined+immune+deficiency+%28SCID%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacchi%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DA.%26aulast%3DGiliani%26aufirst%3DS.%26aulast%3DSacco%26aufirst%3DM.%2BG.%26aulast%3DFrattini%26aufirst%3DA.%26aulast%3DPorta%26aufirst%3DF.%26aulast%3DUgazio%26aufirst%3DA.%2BG.%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DCandotti%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DVezzoni%26aufirst%3DP.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26atitle%3DMutations%2520of%2520Jak-3%2520gene%2520in%2520patients%2520with%2520autosomal%2520severe%2520combined%2520immune%2520deficiency%2520%2528SCID%2529%26jtitle%3DNature%26date%3D1995%26volume%3D377%26issue%3D6544%26spage%3D65%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Russell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayebi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedy, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migone, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markert, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span> </span><span class="NLM_article-title">Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x"> (</span><span class="NLM_issue">5237</span><span class="NLM_x">) </span> <span class="NLM_fpage">797</span><span class="NLM_x">â</span> <span class="NLM_lpage">800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=797-800&issue=5237&author=S.+M.+Russellauthor=N.+Tayebiauthor=H.+Nakajimaauthor=M.+C.+Riedyauthor=J.+L.+Robertsauthor=M.+J.+Amanauthor=T.+S.+Migoneauthor=M.+Noguchiauthor=M.+L.+Markertauthor=R.+H.+Buckleyauthor=J.+J.+O%E2%80%99Sheaauthor=W.+J.+Leonard&title=Mutation+of+Jak3+in+a+patient+with+SCID%3A+essential+role+of+Jak3+in+lymphoid+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DS.%2BM.%26aulast%3DTayebi%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DRiedy%26aufirst%3DM.%2BC.%26aulast%3DRoberts%26aufirst%3DJ.%2BL.%26aulast%3DAman%26aufirst%3DM.%2BJ.%26aulast%3DMigone%26aufirst%3DT.%2BS.%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DMarkert%26aufirst%3DM.%2BL.%26aulast%3DBuckley%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DMutation%2520of%2520Jak3%2520in%2520a%2520patient%2520with%2520SCID%253A%2520essential%2520role%2520of%2520Jak3%2520in%2520lymphoid%2520development%26jtitle%3DScience%26date%3D1995%26volume%3D270%26issue%3D5237%26spage%3D797%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Noguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblatt, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovich, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span> </span><span class="NLM_article-title">Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">147</span><span class="NLM_x">â</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1993&pages=147-157&issue=1&author=M.+Noguchiauthor=H.+Yiauthor=H.+M.+Rosenblattauthor=A.+H.+Filipovichauthor=S.+Adelsteinauthor=W.+S.+Modiauthor=O.+W.+McBrideauthor=W.+J.+Leonard&title=Interleukin-2+receptor+gamma+chain+mutation+results+in+X-linked+severe+combined+immunodeficiency+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DRosenblatt%26aufirst%3DH.%2BM.%26aulast%3DFilipovich%26aufirst%3DA.%2BH.%26aulast%3DAdelstein%26aufirst%3DS.%26aulast%3DModi%26aufirst%3DW.%2BS.%26aulast%3DMcBride%26aufirst%3DO.%2BW.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DInterleukin-2%2520receptor%2520gamma%2520chain%2520mutation%2520results%2520in%2520X-linked%2520severe%2520combined%2520immunodeficiency%2520in%2520humans%26jtitle%3DCell%26date%3D1993%26volume%3D73%26issue%3D1%26spage%3D147%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Witthuhn, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quelle, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">227</span><span class="NLM_x">â</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1993&pages=227-236&issue=2&author=B.+A.+Witthuhnauthor=F.+W.+Quelleauthor=O.+Silvennoinenauthor=T.+Yiauthor=B.+Tangauthor=O.+Miuraauthor=J.+N.+Ihle&title=JAK2+associates+with+the+erythropoietin+receptor+and+is+tyrosine+phosphorylated+and+activated+following+stimulation+with+erythropoietin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWitthuhn%26aufirst%3DB.%2BA.%26aulast%3DQuelle%26aufirst%3DF.%2BW.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DTang%26aufirst%3DB.%26aulast%3DMiura%26aufirst%3DO.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJAK2%2520associates%2520with%2520the%2520erythropoietin%2520receptor%2520and%2520is%2520tyrosine%2520phosphorylated%2520and%2520activated%2520following%2520stimulation%2520with%2520erythropoietin%26jtitle%3DCell%26date%3D1993%26volume%3D74%26issue%3D2%26spage%3D227%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Quelle, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witthuhn, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inhorn, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyajima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">4335</span><span class="NLM_x">â</span> <span class="NLM_lpage">4341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=8007942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADyaK2cXksFSkt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=4335-4341&issue=7&author=F.+W.+Quelleauthor=N.+Satoauthor=B.+A.+Witthuhnauthor=R.+C.+Inhornauthor=M.+Ederauthor=A.+Miyajimaauthor=J.+D.+Griffinauthor=J.+N.+Ihle&title=JAK2+associates+with+the+beta+c+chain+of+the+receptor+for+granulocyte-macrophage+colony-stimulating+factor%2C+and+its+activation+requires+the+membrane-proximal+region"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">JAK2 associates with the Î²c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region</span></div><div class="casAuthors">Quelle, Frederick W.; Sato, Noriko; Witthuhn, Bruce A.; Inhorn, Roger C.; Eder, Matthias; Miyajima, Atsushi; Griffin, James D.; Ihle, James N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4335-41</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">The high-affinity receptor for granulocyte-macrophage colony-stimulating factor (GM-CSF) consists of a unique Î± chain and a Î²c subunit that is shared with the receptors for interleukin-3 (IL-3) and IL-5.  Two regions of the Î²c chain have been defined; these include a membrane-proximal region of the cytoplasmic domain that is required for mitogenesis and a membrane-distal region that is required for activation of Ras, Raf-1, mitogen-activated protein kinase, and S6 kinase.  Recent studies have implicated the cytoplasmic protein tyrosine kinase JAK2 in signaling through a no. of the cytokine receptors, including the IL-3 and erythropoietin receptors.  In the studies described here, the authors demonstrate that GM-CSF stimulation of cells induces the tyrosine phosphorylation of JAK2 and activates its in vitro kinase activity.  Mutational anal. of the Î²c chain demonstrates that only the membrane-proximal 62 amino acids of the cytosolic domain are required for JAK2 activation.  Thus, JAK2 activation is correlated with induction of mitogenesis but does not, alone, activate the Ras pathway.  Carboxyl truncations of the Î± chain, which inactivate the receptor for mitogenesis, are unable to mediate GM-CSF-induced JAK2 activation.  Using baculovirus-expressed proteins, the authors further demonstrate that JAK2 phys. assocs. with the Î²c chain but not with the Î± chain.  Apparently, the JAK family of kinases are crit. to coupling cytokine binding to tyrosine phosphorylation and ultimately mitogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplCgSCu6SfKLVg90H21EOLACvtfcHk0lh256_lJ0xsnA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFSkt78%253D&md5=ab70a0456dcad5523fddd63b9bd23a5f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuelle%26aufirst%3DF.%2BW.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DWitthuhn%26aufirst%3DB.%2BA.%26aulast%3DInhorn%26aufirst%3DR.%2BC.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DMiyajima%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJAK2%2520associates%2520with%2520the%2520beta%2520c%2520chain%2520of%2520the%2520receptor%2520for%2520granulocyte-macrophage%2520colony-stimulating%2520factor%252C%2520and%2520its%2520activation%2520requires%2520the%2520membrane-proximal%2520region%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1994%26volume%3D14%26issue%3D7%26spage%3D4335%26epage%3D4341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">LÃ¼tticken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegenka, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemiecki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpur, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taga, T.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x"> (</span><span class="NLM_issue">5143</span><span class="NLM_x">) </span> <span class="NLM_fpage">89</span><span class="NLM_x">â</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=89-92&issue=5143&author=C.+L%C3%BCttickenauthor=U.+M.+Wegenkaauthor=J.+Yuanauthor=J.+Buschmannauthor=C.+Schindlerauthor=A.+Ziemieckiauthor=A.+G.+Harpurauthor=A.+F.+Wilksauthor=K.+Yasukawaauthor=T.+Taga&title=Association+of+transcription+factor+APRF+and+protein+kinase+Jak1+with+the+interleukin-6+signal+transducer+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25BCtticken%26aufirst%3DC.%26aulast%3DWegenka%26aufirst%3DU.%2BM.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DJ.%26aulast%3DSchindler%26aufirst%3DC.%26aulast%3DZiemiecki%26aufirst%3DA.%26aulast%3DHarpur%26aufirst%3DA.%2BG.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DYasukawa%26aufirst%3DK.%26aulast%3DTaga%26aufirst%3DT.%26atitle%3DAssociation%2520of%2520transcription%2520factor%2520APRF%2520and%2520protein%2520kinase%2520Jak1%2520with%2520the%2520interleukin-6%2520signal%2520transducer%2520gp130%26jtitle%3DScience%26date%3D1994%26volume%3D263%26issue%3D5143%26spage%3D89%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Narazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witthuhn, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taga, T.</span><span> </span><span class="NLM_article-title">Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2285</span><span class="NLM_x">â</span> <span class="NLM_lpage">2289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=2285-2289&issue=6&author=M.+Narazakiauthor=B.+A.+Witthuhnauthor=K.+Yoshidaauthor=O.+Silvennoinenauthor=K.+Yasukawaauthor=J.+N.+Ihleauthor=T.+Kishimotoauthor=T.+Taga&title=Activation+of+JAK2+kinase+mediated+by+the+interleukin+6+signal+transducer+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNarazaki%26aufirst%3DM.%26aulast%3DWitthuhn%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DYasukawa%26aufirst%3DK.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26aulast%3DKishimoto%26aufirst%3DT.%26aulast%3DTaga%26aufirst%3DT.%26atitle%3DActivation%2520of%2520JAK2%2520kinase%2520mediated%2520by%2520the%2520interleukin%25206%2520signal%2520transducer%2520gp130%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26issue%3D6%26spage%3D2285%26epage%3D2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Guschin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briscoe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witthuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, I. M.</span><span> </span><span class="NLM_article-title">A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1421</span><span class="NLM_x">â</span> <span class="NLM_lpage">1429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=1421-1429&issue=7&author=D.+Guschinauthor=N.+Rogersauthor=J.+Briscoeauthor=B.+Witthuhnauthor=D.+Watlingauthor=F.+Hornauthor=S.+Pellegriniauthor=K.+Yasukawaauthor=P.+Heinrichauthor=G.+R.+Starkauthor=J.+N.+Ihleauthor=I.+M.+Kerr&title=A+major+role+for+the+protein+tyrosine+kinase+JAK1+in+the+JAK%2FSTAT+signal+transduction+pathway+in+response+to+interleukin-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuschin%26aufirst%3DD.%26aulast%3DRogers%26aufirst%3DN.%26aulast%3DBriscoe%26aufirst%3DJ.%26aulast%3DWitthuhn%26aufirst%3DB.%26aulast%3DWatling%26aufirst%3DD.%26aulast%3DHorn%26aufirst%3DF.%26aulast%3DPellegrini%26aufirst%3DS.%26aulast%3DYasukawa%26aufirst%3DK.%26aulast%3DHeinrich%26aufirst%3DP.%26aulast%3DStark%26aufirst%3DG.%2BR.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26aulast%3DKerr%26aufirst%3DI.%2BM.%26atitle%3DA%2520major%2520role%2520for%2520the%2520protein%2520tyrosine%2520kinase%2520JAK1%2520in%2520the%2520JAK%252FSTAT%2520signal%2520transduction%2520pathway%2520in%2520response%2520to%2520interleukin-6%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26issue%3D7%26spage%3D1421%26epage%3D1429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShea, J. J.</span><span> </span><span class="NLM_article-title">Janus kinases in immune cell signaling</span> <span class="citation_source-journal">Immunol Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">273</span><span class="NLM_x">â</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&issue=1&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+kinases+in+immune+cell+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0ljgoyQM6UfROw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520kinases%2520in%2520immune%2520cell%2520signaling%26jtitle%3DImmunol%2520Rev.%26date%3D2009%26volume%3D228%26issue%3D1%26spage%3D273%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShea, J. J.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of Janus kinases</span> <span class="citation_source-journal">Immunol Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">â</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1111%2Fj.1600-065X.2008.00644.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=18613833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2008&pages=132-142&author=M.+Pesuauthor=A.+Laurenceauthor=N.+Kishoreauthor=S.+H.+Zwillichauthor=G.+Chanauthor=J.+J.+O%E2%80%99Shea&title=Therapeutic+targeting+of+Janus+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Janus kinases</span></div><div class="casAuthors">Pesu, Marko; Laurence, Arian; Kishore, Nandini; Zwillich, Samuel H.; Chan, Gary; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytokines play pivotal roles in immunity and inflammation, and targeting cytokines and their receptors is an effective means of treating such disorders.  Type I and II cytokine receptors assoc. with Janus family kinases (JAKs) to effect intracellular signaling.  These structurally unique protein kinases play essential and specific roles in immune cell development and function.  One JAK, JAK3, has particularly selective functions.  Mutations of this kinase underlie severe combined immunodeficiency, indicative of its crit. role in the development and function of lymphocytes.  Because JAK3 appears not to have functions outside of hematopoietic cells, this kinase has been viewed as an excellent therapeutic target for the development of a new class of immunosuppressive drugs.  In fact, several companies are developing JAK3 inhibitors, and Phase II studies are underway.  Mutations of Tyk2 cause autosomal recessive hyperIgE syndrome, and in principle, Tyk2 inhibitors might also be useful as immunosuppressive drugs.  JAK2 gain-of-function mutations (V617F) underlie a subset of disorders collectively referred to as myeloproliferative diseases and phase 2 trials using JAK inhibitors are underway in this setting.  Thus, we are learning a great deal about the feasibility and effectiveness of targeting Janus kinases, and it appears likely that this will be a fruitful strategy in a variety of settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-VTmlwlhcv7Vg90H21EOLACvtfcHk0lj57qieK2JyCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D&md5=73dc15932d0eaa312bc2588bdbce404c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00644.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00644.x%26sid%3Dliteratum%253Aachs%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DTherapeutic%2520targeting%2520of%2520Janus%2520kinases%26jtitle%3DImmunol%2520Rev.%26date%3D2008%26volume%3D223%26spage%3D132%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Vijayakrishnan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataramanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulati, P.</span><span> </span><span class="NLM_article-title">Treating inflammation with the Janus kinase inhibitor CP-690,550</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">25</span><span class="NLM_x">â</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=25-34&issue=1&author=L.+Vijayakrishnanauthor=R.+Venkataramananauthor=P.+Gulati&title=Treating+inflammation+with+the+Janus+kinase+inhibitor+CP-690%2C550"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVijayakrishnan%26aufirst%3DL.%26aulast%3DVenkataramanan%26aufirst%3DR.%26aulast%3DGulati%26aufirst%3DP.%26atitle%3DTreating%2520inflammation%2520with%2520the%2520Janus%2520kinase%2520inhibitor%2520CP-690%252C550%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26issue%3D1%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardanani, A.</span><span> </span><span class="NLM_article-title">JAK inhibitors in myeloproliferative neoplasms: rationale, current data and perspective</span> <span class="citation_source-journal">Blood Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">229</span><span class="NLM_x">â</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1016%2Fj.blre.2011.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=21742423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVGmsrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=229-237&issue=5&author=A.+Tefferiauthor=A.+Pardanani&title=JAK+inhibitors+in+myeloproliferative+neoplasms%3A+rationale%2C+current+data+and+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">JAK inhibitors in myeloproliferative neoplasms: Rationale, current data and perspective</span></div><div class="casAuthors">Tefferi, A.; Pardanani, A.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">229-237</span>CODEN:
                <span class="NLM_cas:coden">BLOREB</span>;
        ISSN:<span class="NLM_cas:issn">0268-960X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  JAK-STAT is an appealing but also problematic drug target in BCR-ABL1-neg. myeloproliferative neoplasms (MPN) - it is appealing because the majority of patients with MPN harbor gain-of-function JAK2 or MPL mutations - it is problematic because currently available JAK inhibitors do not distinguish between oncogenic and physiol. JAK-STAT activation.  Furthermore, JAK-STAT-relevant mutations in MPN do not always constitute the predominant or ancestral mutant clone.  Such complexities undermine the value of JAK-STAT as a robust drug target in MPN and partly explain the hitherto lack of histol. or mol. remissions assocd. with currently available JAK inhibitors.  Most of these drugs were, however, effective in alleviating constitutional symptoms and reducing spleen size; the mechanism of action in this instance includes drug-induced down-regulation of inflammatory cytokine activity.  In addn., non-specific myelosuppression contributes to both their salutary and detrimental effects on peripheral blood count.  Non-hematol. side effects include gastrointestinal disturbances, asymptomatic elevation of liver and pancreatic enzymes, peripheral neuropathy and hyperacute relapse of symptoms during treatment interruption.  It is our impression that many more JAK inhibitors need to be evaluated in order to identify the best-in-class in terms of efficacy, toxicity and suitability for future combination treatment programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_9cluqxFTkLVg90H21EOLACvtfcHk0lj57qieK2JyCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVGmsrbI&md5=6526aeabc9ebe50786992c03c4352899</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.blre.2011.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.blre.2011.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DPardanani%26aufirst%3DA.%26atitle%3DJAK%2520inhibitors%2520in%2520myeloproliferative%2520neoplasms%253A%2520rationale%252C%2520current%2520data%2520and%2520perspective%26jtitle%3DBlood%2520Rev.%26date%3D2011%26volume%3D25%26issue%3D5%26spage%3D229%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">QuintÃ¡s-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">127</span><span class="NLM_x">â</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=127-140&issue=2&author=A.+Quint%C3%A1s-Cardamaauthor=H.+Kantarjianauthor=J.+Cortesauthor=S.+Verstovsek&title=Janus+kinase+inhibitors+for+the+treatment+of+myeloproliferative+neoplasias+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuint%25C3%25A1s-Cardama%26aufirst%3DA.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DJanus%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasias%2520and%2520beyond%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D2%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kremer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breedveld, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerbini, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span> </span><span class="NLM_article-title">The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1895</span><span class="NLM_x">â</span> <span class="NLM_lpage">1905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1002%2Fart.24567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=19565475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlKktLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=1895-1905&issue=7&author=J.+M.+Kremerauthor=B.+J.+Bloomauthor=F.+C.+Breedveldauthor=J.+H.+Coombsauthor=M.+P.+Fletcherauthor=D.+Grubenauthor=S.+Krishnaswamiauthor=R.+Burgos-Vargasauthor=B.+Wilkinsonauthor=C.+A.+Zerbiniauthor=S.+H.+Zwillich&title=The+safety+and+efficacy+of+a+JAK+inhibitor+in+patients+with+active+rheumatoid+arthritis%3A+Results+of+a+double-blind%2C+placebo-controlled+phase+IIa+trial+of+three+dosage+levels+of+CP-690%2C550+versus+placebo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo</span></div><div class="casAuthors">Kremer, Joel M.; Bloom, Bradley J.; Breedveld, Ferdinand C.; Coombs, John H.; Fletcher, Mark P.; Gruben, David; Krishnaswami, Sriram; Burgos-Vargas, Ruben; Wilkinson, Bethanie; Zerbini, Cristiano A. F.; Zwillich, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1895-1905</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To det. the efficacy, safety, and tolerability of 3 different dosages of CP-690,550, a potent, orally active JAK inhibitor, in patients with active rheumatoid arthritis (RA) in whom methotrexate, etanercept, infliximab, or adalimumab caused an inadequate or toxic response.  Patients (n = 264) were randomized equally to receive placebo, 5 mg of CP-690,550,15 mg of CP-690,550, or 30 mg of CP-690,550 twice daily for 6 wk, and were followed up for an addnl. 6 wk after treatment.  The primary efficacy end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at 6 wk.  By week 6, the ACR20 response rates were 70.5%, 81.2%, and 76.8% in the 5 mg, 15 mg, and 30 mg twice daily groups, resp., compared with 29.2% in the placebo group (P < 0.001).  Improvements in disease activity in CP-690,550-treated patients compared with placebo were seen in all treatment groups as early as week 1.  ACR50 and ACR70 response rates significantly improved in all treatment groups by week 4.  The most common adverse events reported were headache and nausea.  The infection rate in both the 15 mg twice daily group and the 30 mg twice daily group was 30.4% (vs. 26.2% in the placebo group).  No opportunistic infections or deaths occurred.  Increases in mean low-d. lipoprotein cholesterol and high-d. lipoprotein cholesterol levels, and increases in mean serum creatinine level (0.04-0.06 mg/dL) were seen in all CP-690,550 treatment arms.  Our findings indicate that CP-690,550 is efficacious in the treatment of RA, resulting in rapid, statistically significant, and clin. meaningful redns. in the signs and symptoms of RA.  Further studies of CP-690,550 in RA are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBhxBhh_mG7rVg90H21EOLACvtfcHk0lj57qieK2JyCQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlKktLg%253D&md5=ab5fb34e43d8643871560c67bbbca07d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fart.24567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24567%26sid%3Dliteratum%253Aachs%26aulast%3DKremer%26aufirst%3DJ.%2BM.%26aulast%3DBloom%26aufirst%3DB.%2BJ.%26aulast%3DBreedveld%26aufirst%3DF.%2BC.%26aulast%3DCoombs%26aufirst%3DJ.%2BH.%26aulast%3DFletcher%26aufirst%3DM.%2BP.%26aulast%3DGruben%26aufirst%3DD.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DWilkinson%26aufirst%3DB.%26aulast%3DZerbini%26aufirst%3DC.%2BA.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26atitle%3DThe%2520safety%2520and%2520efficacy%2520of%2520a%2520JAK%2520inhibitor%2520in%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%253A%2520Results%2520of%2520a%2520double-blind%252C%2520placebo-controlled%2520phase%2520IIa%2520trial%2520of%2520three%2520dosage%2520levels%2520of%2520CP-690%252C550%2520versus%2520placebo%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26issue%3D7%26spage%3D1895%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Fleischmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanik, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallenstein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B. E.l</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span> </span><span class="NLM_article-title">Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">617</span><span class="NLM_x">â</span> <span class="NLM_lpage">629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1002%2Fart.33383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=21952978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVGjurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=617-629&issue=3&author=R.+Fleischmannauthor=M.+Cutoloauthor=M.+C.+Genoveseauthor=E.+B.+Leeauthor=K.+S.+Kanikauthor=S.+Sadisauthor=C.+A.+Connellauthor=D.+Grubenauthor=S.+Krishnaswamiauthor=G.+Wallensteinauthor=B.+E.l+Wilkinsonauthor=S.+H.+Zwillich&title=Phase+IIb+dose-ranging+study+of+the+oral+JAK+inhibitor+tofacitinib+%28CP-690%2C550%29+or+adalimumab+monotherapy+versus+placebo+in+patients+with+active+rheumatoid+arthritis+with+an+inadequate+response+to+disease-modifying+antirheumatic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs</span></div><div class="casAuthors">Fleischmann, Roy; Cutolo, Maurizio; Genovese, Mark C.; Lee, Eun Bong; Kanik, Keith S.; Sadis, Seth; Connell, Carol A.; Gruben, David; Krishnaswami, Sriram; Wallenstein, Gene; Wilkinson, Bethanie E.; Zwillich, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">617-629</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : To compare the efficacy, safety, and tolerability of 5 doses of oral tofacitinib (CP-690,550) or adalimumab monotherapy with placebo for the treatment of active rheumatoid arthritis (RA) in patients with an inadequate response to disease-modifying antirheumatic drugs.  Methods : In this 24-wk, double-blind, phase IIb study, patients with RA (n = 384) were randomized to receive placebo, tofacitinib at 1, 3, 5, 10, or 15 mg administered orally twice a day, or adalimumab at 40 mg injected s.c. every 2 wk (total of 6 injections) followed by oral tofacitinib at 5 mg twice a day for 12 wk.  The primary end point was the responder rate according to the American College of Rheumatol. 20% improvement criteria (ACR20) at week 12.  Results : Treatment with tofacitinib at a dose of â¥3 mg twice a day resulted in a rapid response with significant efficacy when compared to placebo, as indicated by the primary end point (ACR20 response at week 12), achieved in 39.2% (3 mg; P â¤ 0.05), 59.2% (5 mg; P < 0.0001), 70.5% (10 mg; P < 0.0001), and 71.9% (15 mg; P < 0.0001) in the tofacitinib group and 35.9% of patients in the adalimumab group (P = 0.105), compared with 22.0% of patients receiving placebo.  Improvements were sustained at week 24, according to the ACR20, ACR50, and ACR70 response rates as well as classifications of remission according to the 3-variable Disease Activity Score in 28 joints (DAS28) using C-reactive protein and the 4-variable DAS28 using the erythrocyte sedimentation rate.  The most common treatment-emergent adverse events (AEs) in patients across all tofacitinib treatment arms (n = 272) were urinary tract infection (7.7%), diarrhea (4.8%), headache (4.8%), and bronchitis (4.8%).  Conclusion : Tofacitinib monotherapy at â¥3 mg twice a day was efficacious in the treatment of patients with active RA over 24 wk and demonstrated a manageable safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuu7Uf_SwBXbVg90H21EOLACvtfcHk0ljmytCWqmHRNw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVGjurs%253D&md5=99d7be4fd115ffa87410dcbd6c6ea860</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fart.33383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.33383%26sid%3Dliteratum%253Aachs%26aulast%3DFleischmann%26aufirst%3DR.%26aulast%3DCutolo%26aufirst%3DM.%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DLee%26aufirst%3DE.%2BB.%26aulast%3DKanik%26aufirst%3DK.%2BS.%26aulast%3DSadis%26aufirst%3DS.%26aulast%3DConnell%26aufirst%3DC.%2BA.%26aulast%3DGruben%26aufirst%3DD.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DWallenstein%26aufirst%3DG.%26aulast%3DWilkinson%26aufirst%3DB.%2BE.l%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26atitle%3DPhase%2520IIb%2520dose-ranging%2520study%2520of%2520the%2520oral%2520JAK%2520inhibitor%2520tofacitinib%2520%2528CP-690%252C550%2529%2520or%2520adalimumab%2520monotherapy%2520versus%2520placebo%2520in%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%2520with%2520an%2520inadequate%2520response%2520to%2520disease-modifying%2520antirheumatic%2520drugs%26jtitle%3DArthritis%2520Rheum.%26date%3D2012%26volume%3D64%26issue%3D3%26spage%3D617%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchetto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vangrevelinghe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">284</span><span class="NLM_x">â</span> <span class="NLM_lpage">288</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101157q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=284-288&issue=1&author=G.+Thomaauthor=F.+Nuningerauthor=R.+Falchettoauthor=E.+Hermesauthor=G.+A.+Tavaresauthor=E.+Vangrevelingheauthor=H.-G.+Zerwes&title=Identification+of+a+potent+Janus+kinase+3+inhibitor+with+high+selectivity+within+the+Janus+kinase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm101157q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101157q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DNuninger%26aufirst%3DF.%26aulast%3DFalchetto%26aufirst%3DR.%26aulast%3DHermes%26aufirst%3DE.%26aulast%3DTavares%26aufirst%3DG.%2BA.%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DIdentification%2520of%2520a%2520potent%2520Janus%2520kinase%25203%2520inhibitor%2520with%2520high%2520selectivity%2520within%2520the%2520Janus%2520kinase%2520family%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D1%26spage%3D284%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Haan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolvering, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raulf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DrÃ¼ckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Jak1 has a dominant role over Jak3 in signal transduction through Î³c-containing cytokine receptors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">314</span><span class="NLM_x">â</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1016%2Fj.chembiol.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=21439476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=314-323&issue=3&author=C.+Haanauthor=C.+Rolveringauthor=F.+Raulfauthor=M.+Kappauthor=P.+Dr%C3%BCckesauthor=G.+Thomaauthor=I.+Behrmannauthor=H.-G.+Zerwes&title=Jak1+has+a+dominant+role+over+Jak3+in+signal+transduction+through+%CE%B3c-containing+cytokine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through Î³c-Containing Cytokine Receptors</span></div><div class="casAuthors">Haan, Claude; Rolvering, Catherine; Raulf, Friedrich; Kapp, Manuela; Drueckes, Peter; Thoma, Gebhard; Behrmann, Iris; Zerwes, Hans-Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (Î³c) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression.  Jak1 cooperates with Jak3 in signaling through Î³c-contg. receptors.  Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors.  We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system.  The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation.  Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor.  Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUv04vX29Zk7Vg90H21EOLACvtfcHk0ljmytCWqmHRNw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D&md5=0109f316cfe0bee40f80a79f244e6ba5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DHaan%26aufirst%3DC.%26aulast%3DRolvering%26aufirst%3DC.%26aulast%3DRaulf%26aufirst%3DF.%26aulast%3DKapp%26aufirst%3DM.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DJak1%2520has%2520a%2520dominant%2520role%2520over%2520Jak3%2520in%2520signal%2520transduction%2520through%2520%25CE%25B3c-containing%2520cytokine%2520receptors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26issue%3D3%26spage%3D314%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Lin, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appell, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlmeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimble, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symanowicz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrocklage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lussier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelling, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewet, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xuan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krykbaev, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidl, K. J.</span><span> </span><span class="NLM_article-title">Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2283</span><span class="NLM_x">â</span> <span class="NLM_lpage">2293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1002%2Fart.27536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=20506481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOiu7jP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=2283-2293&issue=8&author=T.+H.+Linauthor=M.+Hegenauthor=E.+Quadrosauthor=C.+L.+Nickerson-Nutterauthor=K.+C.+Appellauthor=A.+G.+Coleauthor=Y.+Shaoauthor=S.+Tamauthor=M.+Ohlmeyerauthor=B.+Wangauthor=D.+G.+Goodwinauthor=E.+F.+Kimbleauthor=J.+Quinteroauthor=M.+Gaoauthor=P.+Symanowiczauthor=C.+Wrocklageauthor=J.+Lussierauthor=S.+H.+Schellingauthor=A.+G.+Hewetauthor=D.+Xuanauthor=R.+Krykbaevauthor=J.+Togiasauthor=X.+Xuauthor=R.+Harrisonauthor=T.+Mansourauthor=M.+Collinsauthor=J.+D.+Clarkauthor=M.+L.+Webbauthor=K.+J.+Seidl&title=Selective+functional+inhibition+of+JAK-3+is+sufficient+for+efficacy+in+collagen-induced+arthritis+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice</span></div><div class="casAuthors">Lin, Tsung H.; Hegen, Martin; Quadros, Elizabeth; Nickerson-Nutter, Cheryl L.; Appell, Kenneth C.; Cole, Andrew G.; Shao, Yuefei; Tam, Steve; Ohlmeyer, Michael; Wang, Bojing; Goodwin, Debra G.; Kimble, Earl F.; Quintero, Jorge; Gao, Min; Symanowicz, Peter; Wrocklage, Christopher; Lussier, Jennifer; Schelling, Scott H.; Hewet, Amha G.; Xuan, Dejun; Krykbaev, Rustem; Togias, Jenny; Xu, Xin; Harrison, Richard; Mansour, Tarek; Collins, Mary; Clark, James D.; Webb, Maria L.; Seidi, Katherine J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2283-2293</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. All Î³-chain cytokines signal through JAK-3 and JAK-1 acting in tandem.  We undertook this study to det. whether the JAK-3 selective inhibitor WYE-151650 would be sufficient to disrupt cytokine signaling and to ameliorate autoimmune disease pathol. without inhibiting other pathways mediated by JAK-1, JAK-2, and Tyk-2.  Methods. JAK-3 kinase selective compds. were characterized by kinase assay and JAK-3-dependent (interleukin-2 [IL-2]) and -independent (IL-6, granulocyte-macrophage colony-stimulating factor [GM-CSF]) cell-based assays measuring proliferation or STAT phosphorylation.  In vivo, off-target signaling was measured by IL-22- and erythropoietin (EPO)-mediated models, while on-target signaling was measured by IL-2-mediated signaling.  Efficacy of JAK-3 inhibitors was detd. using delayed-type hypersensitivity (DTH) and collagen-induced arthritis (CIA) models in mice.  Results. In vitro, WYE-151650 potently suppressed IL-2-induced STAT-5 phosphorylation and cell proliferation, while exhibiting 10-29-fold less activity against JAK-3-independent IL-6- or GM-CSF-induced STAT phosphorylation.  Ex vivo, WYE-151650 suppressed IL-2-induced STAT phosphorylation, but not IL-6-induced STAT phosphorylation, as measured in whole blood.  In vivo, WYE-151650 inhibited JAK-3-mediated IL-2-induced interferon-Î³ prodn. and decreased the natural killer cell population in mice, while not affecting IL-22-induced serum amyloid A prodn. or EPO-induced reticulocytosis.  WYE-151650 was efficacious in mouse DTH and CIA models.  Conclusion. In vitro, ex vivo, and in vivo assays demonstrate that WYE-151650 is efficacious in mouse CIA despite JAK-3 selectivity.  These data question the need to broadly inhibit JAK-1-, JAK-2-, or Tyk-2-dependent cytokine pathways for efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogcss6tt3iw7Vg90H21EOLACvtfcHk0lgW4uE299H08A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOiu7jP&md5=7fd4f4dae47df1d1a33d3fc0edf5e13d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fart.27536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27536%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.%2BH.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DQuadros%26aufirst%3DE.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DAppell%26aufirst%3DK.%2BC.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DGoodwin%26aufirst%3DD.%2BG.%26aulast%3DKimble%26aufirst%3DE.%2BF.%26aulast%3DQuintero%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DSymanowicz%26aufirst%3DP.%26aulast%3DWrocklage%26aufirst%3DC.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DSchelling%26aufirst%3DS.%2BH.%26aulast%3DHewet%26aufirst%3DA.%2BG.%26aulast%3DXuan%26aufirst%3DD.%26aulast%3DKrykbaev%26aufirst%3DR.%26aulast%3DTogias%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DWebb%26aufirst%3DM.%2BL.%26aulast%3DSeidl%26aufirst%3DK.%2BJ.%26atitle%3DSelective%2520functional%2520inhibition%2520of%2520JAK-3%2520is%2520sufficient%2520for%2520efficacy%2520in%2520collagen-induced%2520arthritis%2520in%2520mice%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26issue%3D8%26spage%3D2283%26epage%3D2293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Goldstein., D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">High-throughput kinase profiling as a platform for drug discovery</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">391</span><span class="NLM_x">â</span> <span class="NLM_lpage">397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=391-397&issue=5&author=D.+M.+Goldstein.author=N.+S.+Grayauthor=P.+P.+Zarrinkar&title=High-throughput+kinase+profiling+as+a+platform+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein.%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DHigh-throughput%2520kinase%2520profiling%2520as%2520a%2520platform%2520for%2520drug%2520discovery%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26issue%3D5%26spage%3D391%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, I. I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">William, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span><span class="NLM_x">â</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&issue=3&author=M.+A.+Fabianauthor=I.+I.+I.+Biggsauthor=H.+Williamauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lgW4uE299H08A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DI.%2BI.%2BI.%26aulast%3DWilliam%26aufirst%3DH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNature%2520Biotechnol.%26date%3D2005%26volume%3D23%26issue%3D3%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">Out of 293 wild-type kinases tested at Kinomescan, compound <b>2</b> at 10 Î¼M showed >90% bait ligand displacement for 156 kinases, including JAK1â3 (kinase domains) at the percentages indicated: JAK1 (100%), JAK2 (99%), and JAK3 (98%).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Chrencik, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korniski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">413</span><span class="NLM_x">â</span> <span class="NLM_lpage">433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&issue=3&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26issue%3D3%26spage%3D413%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudlacz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lillie, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">8468</span><span class="NLM_x">â</span> <span class="NLM_lpage">8484</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&issue=24&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=S.-P.+Changauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Lillieauthor=K.+S.+Magnusonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%2C550%3A+a+potent+and+selective+Janus+kinase+%28JAK%29+inhibitor+for+the+treatment+of+autoimmune+diseases+and+organ+transplant+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span></div><div class="casAuthors">Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H.; Brown, Matthew F.; Casavant, Jeffrey M.; Chang, Shang-Poa; Doty, Jonathan L.; Elliott, Eileen A.; Fisher, Michael B.; Hines, Michael; Kent, Craig; Kudlacz, Elizabeth M.; Lillie, Brett M.; Magnuson, Kelly S.; McCurdy, Sandra P.; Munchhof, Michael J.; Perry, Bret D.; Sawyer, Perry S.; Strelevitz, Timothy J.; Subramanyam, Chakrapani; Sun, Jianmin; Whipple, David A.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8468-8484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a crit. need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis.  Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines important for various T cell functions.  Blockade of the JAK1/JAK3-STAT pathway with a small mol. was anticipated to provide therapeutic immunosuppression/immunomodulation.  The Pfizer compd. library was screened against the catalytic domain of JAK3 resulting in the identification of a pyrrolopyrimidine-based series of inhibitors represented by the hexahydrocarbazolyl pyrrolopyrimidine CP-352,664.  Synthetic analogs of CP-352,664 were screened against the JAK enzymes and evaluated in an IL-2 induced T cell blast proliferation assay.  Select compds. were evaluated in rodent efficacy models of allograft rejection and destructive inflammatory arthritis.  Optimization within this chem. series led to identification of the cyanoacetylpiperidinylamino pyrrolopyrimidine CP-690,550, a potential first-in-class JAK inhibitor for treatment of autoimmune diseases and organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFS_8DSHkDbVg90H21EOLACvtfcHk0lh4e83NrzUIBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP&md5=c1d31ce42ab3f1c1f3029c6f4f48df1a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DChang%26aufirst%3DS.-P.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%252C550%253A%2520a%2520potent%2520and%2520selective%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%2520and%2520organ%2520transplant%2520rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D24%26spage%3D8468%26epage%3D8484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span>Molecular Operating Environment (MOE), <span class="NLM_edition">2011.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+2011.10%3B+Chemical+Computing+Group+Inc.%3A+1010+Sherbooke+St.+West%2C+Suite+%23910%2C+Montreal%2C+QC%2C+Canada%2C+H3A+2R7%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohbo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span> </span><span class="NLM_article-title">Physical association of Jak1 and Jak2 tyrosine kinases with the interleukin 2 receptor Î² and Î³ chains</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">7271</span><span class="NLM_x">â</span> <span class="NLM_lpage">7275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=7271-7275&author=N.+Tanakaauthor=H.+Asaoauthor=K.+Ohboauthor=N.+Ishiiauthor=T.+Takeshitaauthor=M.+Nakamuraauthor=H.+Sasakiauthor=K.+Sugamura&title=Physical+association+of+Jak1+and+Jak2+tyrosine+kinases+with+the+interleukin+2+receptor+%CE%B2+and+%CE%B3+chains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DAsao%26aufirst%3DH.%26aulast%3DOhbo%26aufirst%3DK.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DTakeshita%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DSugamura%26aufirst%3DK.%26atitle%3DPhysical%2520association%2520of%2520Jak1%2520and%2520Jak2%2520tyrosine%2520kinases%2520with%2520the%2520interleukin%25202%2520receptor%2520%25CE%25B2%2520and%2520%25CE%25B3%2520chains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D7271%26epage%3D7275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span>. In  <span class="citation_source-book">Macromolecular Crystallography, Part A</span>; <span class="NLM_contrib-group">Carter, C. W. J.; Sweet, R. M.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">307</span><span class="NLM_x">â</span> <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.+W.+J.+Carter&author=R.+M.+Sweet&title=Macromolecular+Crystallography%2C+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26btitle%3DMacromolecular%2520Crystallography%252C%2520Part%2520A%26aulast%3DCarter%26aufirst%3DC.%2BW.%2BJ.%26pub%3DAcademic%2520Press%26date%3D1997%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Likelihood-enhanced fast translation functions</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">â</span> <span class="NLM_lpage">464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1107%2FS0907444905001617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=15805601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVeisrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=458-464&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Likelihood-enhanced+fast+translation+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Likelihood-enhanced fast translation functions</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">D61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-464</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">This paper is a companion to a recent paper on fast rotation functions [Storoni et al. (2004), Acta Cryst. D60, 432-438], which showed how a Taylor-series expansion of the max.-likelihood rotation function leads to improved likelihood-enhanced fast rotation functions.  In a similar manner, it is shown here how linear and quadratic Taylor-series expansions and least-squares approxns. of the max.-likelihood translation function lead to likelihood-enhanced translation functions, which can be calcd. by FFT and which are more sensitive to the correct translation than the traditional correlation-coeff. fast translation function.  These likelihood-enhanced translation targets for mol.-replacement searches have been implemented in the program Phaser using the Computational Crystallog. Toolbox (cctbx).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDd3wovyUbWLVg90H21EOLACvtfcHk0lh4e83NrzUIBA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVeisrY%253D&md5=bac9cc121bcc0d5cd314955a0e65e746</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444905001617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905001617%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DLikelihood-enhanced%2520fast%2520translation%2520functions%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2005%26volume%3D61%26spage%3D458%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">â</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Boggon%2C+T.+J.%3B+Li%2C+Y.%3B+Manley%2C+P.+W.%3B+Eck%2C+M.+J.Blood+2005%2C+106%2C+996%E2%80%931002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D996%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">â</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. ÏA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial Î±-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lgmHDno-Ktm1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: Model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">â</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+Model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lgmHDno-Ktm1w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520Model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':[],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref32':['cit32'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 47 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Prithwish Ghosh, Na Yeon Kwon, Sangil Han, Saegun Kim, Sang Hoon Han, Neeraj Kumar Mishra, Young Hoon Jung, Sang J. Chung, <span class="NLM_string-name hlFld-ContribAuthor">In Su Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Site-Selective CâH Alkylation of Diazine N-Oxides Enabled by Phosphonium Ylides. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (16)
                                     , 6488-6493. <a href="https://doi.org/10.1021/acs.orglett.9b02365" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b02365</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b02365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b02365%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSite-Selective%252BC%2525E2%252580%252593H%252BAlkylation%252Bof%252BDiazine%252BN-Oxides%252BEnabled%252Bby%252BPhosphonium%252BYlides%26aulast%3DGhosh%26aufirst%3DPrithwish%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D09072019%26date%3D02082019%26volume%3D21%26issue%3D16%26spage%3D6488%26epage%3D6493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mohamed
S. A. Elsayed, Jeffery J. Nielsen, Sungtae Park, Jeongho Park, Qingyang Liu, Chang H. Kim, Yves Pommier, Keli Agama, Philip S. Low, <span class="NLM_string-name hlFld-ContribAuthor">Mark Cushman</span>. </span><span class="cited-content_cbyCitation_article-title">Application of Sequential Palladium Catalysis for the Discovery of Janus Kinase Inhibitors in the Benzo[c]pyrrolo[2,3-h][1,6]naphthyridin-5-one (BPN) Series. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (23)
                                     , 10440-10462. <a href="https://doi.org/10.1021/acs.jmedchem.8b00510" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00510</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00510%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BSequential%252BPalladium%252BCatalysis%252Bfor%252Bthe%252BDiscovery%252Bof%252BJanus%252BKinase%252BInhibitors%252Bin%252Bthe%252BBenzo%25255Bc%25255Dpyrrolo%25255B2%25252C3-h%25255D%25255B1%25252C6%25255Dnaphthyridin-5-one%252B%252528BPN%252529%252BSeries%26aulast%3DElsayed%26aufirst%3DMohamed%2BS.%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31032018%26date%3D21112018%26volume%3D61%26issue%3D23%26spage%3D10440%26epage%3D10462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A. T.  Blaskovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Unusual Amino Acids in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 10807-10836. <a href="https://doi.org/10.1021/acs.jmedchem.6b00319" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnusual%252BAmino%252BAcids%252Bin%252BMedicinal%252BChemistry%26aulast%3DBlaskovich%26aufirst%3DMark%2BA.%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02032016%26date%3D30092016%26date%3D22122016%26date%3D02092016%26volume%3D59%26issue%3D24%26spage%3D10807%26epage%3D10836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luc J.  Farmer</span>, <span class="hlFld-ContribAuthor ">Mark W.  Ledeboer</span>, <span class="hlFld-ContribAuthor ">Thomas  Hoock</span>, <span class="hlFld-ContribAuthor ">Michael J.  Arnost</span>, <span class="hlFld-ContribAuthor ">Randy S.  Bethiel</span>, <span class="hlFld-ContribAuthor ">Youssef L.  Bennani</span>, <span class="hlFld-ContribAuthor ">James J.  Black</span>, <span class="hlFld-ContribAuthor ">Christopher L.  Brummel</span>, <span class="hlFld-ContribAuthor ">Ananthsrinivas  Chakilam</span>, <span class="hlFld-ContribAuthor ">Warren A.  Dorsch</span>, <span class="hlFld-ContribAuthor ">Bin  Fan</span>, <span class="hlFld-ContribAuthor ">John E.  Cochran</span>, <span class="hlFld-ContribAuthor ">Summer  Halas</span>, <span class="hlFld-ContribAuthor ">Edmund M.  Harrington</span>, <span class="hlFld-ContribAuthor ">James K.  Hogan</span>, <span class="hlFld-ContribAuthor ">David  Howe</span>, <span class="hlFld-ContribAuthor ">Hui  Huang</span>, <span class="hlFld-ContribAuthor ">Dylan H.  Jacobs</span>, <span class="hlFld-ContribAuthor ">Leena M.  Laitinen</span>, <span class="hlFld-ContribAuthor ">Shengkai  Liao</span>, <span class="hlFld-ContribAuthor ">Sudipta  Mahajan</span>, <span class="hlFld-ContribAuthor ">Valerie  Marone</span>, <span class="hlFld-ContribAuthor ">Gabriel  Martinez-Botella</span>, <span class="hlFld-ContribAuthor ">Pamela  McCarthy</span>, <span class="hlFld-ContribAuthor ">David  Messersmith</span>, <span class="hlFld-ContribAuthor ">Mark  Namchuk</span>, <span class="hlFld-ContribAuthor ">Luke  Oh</span>, <span class="hlFld-ContribAuthor ">Marina S.  Penney</span>, <span class="hlFld-ContribAuthor ">Albert C.  Pierce</span>, <span class="hlFld-ContribAuthor ">Scott A.  Raybuck</span>, <span class="hlFld-ContribAuthor ">Arthur  Rugg</span>, <span class="hlFld-ContribAuthor ">Francesco G.  Salituro</span>, <span class="hlFld-ContribAuthor ">Kumkum  Saxena</span>, <span class="hlFld-ContribAuthor ">Dean  Shannon</span>, <span class="hlFld-ContribAuthor ">Dina  Shlyakter</span>, <span class="hlFld-ContribAuthor ">Lora  Swenson</span>, <span class="hlFld-ContribAuthor ">Shi-Kai  Tian</span>, <span class="hlFld-ContribAuthor ">Christopher  Town</span>, <span class="hlFld-ContribAuthor ">Jian  Wang</span>, <span class="hlFld-ContribAuthor ">Tiansheng  Wang</span>, <span class="hlFld-ContribAuthor ">M. Woods  Wannamaker</span>, <span class="hlFld-ContribAuthor ">Raymond J.  Winquist</span>, and <span class="hlFld-ContribAuthor ">Harmon J.  Zuccola</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (18)
                                     , 7195-7216. <a href="https://doi.org/10.1021/acs.jmedchem.5b00301" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00301%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BVX-509%252B%252528Decernotinib%252529%25253A%252BA%252BPotent%252Band%252BSelective%252BJanus%252BKinase%252B3%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BAutoimmune%252BDiseases%26aulast%3DFarmer%26aufirst%3DLuc%2BJ.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D20022015%26date%3D10092015%26date%3D24092015%26date%3D31072015%26volume%3D58%26issue%3D18%26spage%3D7195%26epage%3D7216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Tan</span>, <span class="hlFld-ContribAuthor ">Koshi  Akahane</span>, <span class="hlFld-ContribAuthor ">Randall  McNally</span>, <span class="hlFld-ContribAuthor ">Kathleen M. S. E.  Reyskens</span>, <span class="hlFld-ContribAuthor ">Scott B.  Ficarro</span>, <span class="hlFld-ContribAuthor ">Suhu  Liu</span>, <span class="hlFld-ContribAuthor ">Grit S.  Herter-Sprie</span>, <span class="hlFld-ContribAuthor ">Shohei  Koyama</span>, <span class="hlFld-ContribAuthor ">Michael J.  Pattison</span>, <span class="hlFld-ContribAuthor ">Katherine  Labella</span>, <span class="hlFld-ContribAuthor ">Liv  Johannessen</span>, <span class="hlFld-ContribAuthor ">Esra A.  Akbay</span>, <span class="hlFld-ContribAuthor ">Kwok-Kin  Wong</span>, <span class="hlFld-ContribAuthor ">David A.  Frank</span>, <span class="hlFld-ContribAuthor ">Jarrod A.  Marto</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Look</span>, <span class="hlFld-ContribAuthor ">J. Simon C.  Arthur</span>, <span class="hlFld-ContribAuthor ">Michael J.  Eck</span>, and <span class="hlFld-ContribAuthor ">Nathanael S.  Gray</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Selective Covalent Janus Kinase 3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (16)
                                     , 6589-6606. <a href="https://doi.org/10.1021/acs.jmedchem.5b00710" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00710%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BSelective%252BCovalent%252BJanus%252BKinase%252B3%252BInhibitors%26aulast%3DTan%26aufirst%3DLi%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D07052015%26date%3D18082015%26date%3D27082015%26date%3D10082015%26volume%3D58%26issue%3D16%26spage%3D6589%26epage%3D6606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atli  Thorarensen</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Banker</span>, <span class="hlFld-ContribAuthor ">Andrew  Fensome</span>, <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>, <span class="hlFld-ContribAuthor ">Brian  Juba</span>, <span class="hlFld-ContribAuthor ">Fabien  Vincent</span>, <span class="hlFld-ContribAuthor ">Robert M.  Czerwinski</span>, and <span class="hlFld-ContribAuthor ">Agustin  Casimiro-Garcia</span>  . </span><span class="cited-content_cbyCitation_article-title">ATP-Mediated Kinome Selectivity: The Missing Link in Understanding the Contribution of Individual JAK Kinase Isoforms to Cellular Signaling. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (7)
                                     , 1552-1558. <a href="https://doi.org/10.1021/cb5002125" title="DOI URL">https://doi.org/10.1021/cb5002125</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb5002125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb5002125%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DATP-Mediated%252BKinome%252BSelectivity%25253A%252BThe%252BMissing%252BLink%252Bin%252BUnderstanding%252Bthe%252BContribution%252Bof%252BIndividual%252BJAK%252BKinase%252BIsoforms%252Bto%252BCellular%252BSignaling%26aulast%3DThorarensen%26aufirst%3DAtli%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D19032014%26date%3D12052014%26date%3D28052014%26date%3D18072014%26date%3D12052014%26volume%3D9%26issue%3D7%26spage%3D1552%26epage%3D1558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fiona I.  McGonagle</span>, <span class="hlFld-ContribAuthor ">Helen F.  Sneddon</span>, <span class="hlFld-ContribAuthor ">Craig  Jamieson</span>, and <span class="hlFld-ContribAuthor ">Allan J. B.  Watson</span>  . </span><span class="cited-content_cbyCitation_article-title">Molar Efficiency: A Useful Metric To Gauge Relative Reaction Efficiency in Discovery Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2014,</strong> <em>2 </em>
                                    (3)
                                     , 523-532. <a href="https://doi.org/10.1021/sc4004532" title="DOI URL">https://doi.org/10.1021/sc4004532</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/sc4004532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fsc4004532%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DMolar%252BEfficiency%25253A%252BA%252BUseful%252BMetric%252BTo%252BGauge%252BRelative%252BReaction%252BEfficiency%252Bin%252BDiscovery%252BMedicinal%252BChemistry%26aulast%3DMcGonagle%26aufirst%3DFiona%2BI.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D06112013%26date%3D28112013%26date%3D06122013%26date%3D03032014%26date%3D02122013%26volume%3D2%26issue%3D3%26spage%3D523%26epage%3D532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuying  Li</span>, <span class="hlFld-ContribAuthor ">Fang  Guo</span>, <span class="hlFld-ContribAuthor ">Tinggui  Chen</span>, <span class="hlFld-ContribAuthor ">Liwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Anthraquinone derivative C10 inhibits proliferation and cell cycle progression in colon cancer cells via the Jak2/Stat3 signaling pathway. </span><span class="cited-content_cbyCitation_journal-name">Toxicology and Applied Pharmacology</span><span> <strong>2021,</strong> <em>418 </em>, 115481. <a href="https://doi.org/10.1016/j.taap.2021.115481" title="DOI URL">https://doi.org/10.1016/j.taap.2021.115481</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.taap.2021.115481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.taap.2021.115481%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520and%2520Applied%2520Pharmacology%26atitle%3DAnthraquinone%252Bderivative%252BC10%252Binhibits%252Bproliferation%252Band%252Bcell%252Bcycle%252Bprogression%252Bin%252Bcolon%252Bcancer%252Bcells%252Bvia%252Bthe%252BJak2%25252FStat3%252Bsignaling%252Bpathway%26aulast%3DLi%26aufirst%3DYuying%26date%3D2021%26volume%3D418%26spage%3D115481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joanna  WÄtÅy</span>, <span class="hlFld-ContribAuthor ">Adriana  Miller</span>, <span class="hlFld-ContribAuthor ">Henryk  KozÅowski</span>, <span class="hlFld-ContribAuthor ">Magdalena  RowiÅska-Å»yrek</span>. </span><span class="cited-content_cbyCitation_article-title">Peptidomimetics â An infinite reservoir of metal binding motifs in metabolically stable and biologically active molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Inorganic Biochemistry</span><span> <strong>2021,</strong> <em>217 </em>, 111386. <a href="https://doi.org/10.1016/j.jinorgbio.2021.111386" title="DOI URL">https://doi.org/10.1016/j.jinorgbio.2021.111386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jinorgbio.2021.111386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jinorgbio.2021.111386%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Inorganic%2520Biochemistry%26atitle%3DPeptidomimetics%252B%2525E2%252580%252593%252BAn%252Binfinite%252Breservoir%252Bof%252Bmetal%252Bbinding%252Bmotifs%252Bin%252Bmetabolically%252Bstable%252Band%252Bbiologically%252Bactive%252Bmolecules%26aulast%3DW%25C4%2585t%25C5%2582y%26aufirst%3DJoanna%26date%3D2021%26volume%3D217%26spage%3D111386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuefei  Jin</span>, <span class="hlFld-ContribAuthor ">Wangquan  Ji</span>, <span class="hlFld-ContribAuthor ">Haiyan  Yang</span>, <span class="hlFld-ContribAuthor ">Shuaiyin  Chen</span>, <span class="hlFld-ContribAuthor ">Weiguo  Zhang</span>, <span class="hlFld-ContribAuthor ">Guangcai  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-020-00454-7" title="DOI URL">https://doi.org/10.1038/s41392-020-00454-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-020-00454-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-020-00454-7%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DEndothelial%252Bactivation%252Band%252Bdysfunction%252Bin%252BCOVID-19%25253A%252Bfrom%252Bbasic%252Bmechanisms%252Bto%252Bpotential%252Btherapeutic%252Bapproaches%26aulast%3DJin%26aufirst%3DYuefei%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Liu</span>, <span class="hlFld-ContribAuthor ">Junping  Zhou</span>, <span class="hlFld-ContribAuthor ">Meijuan  Xu</span>, <span class="hlFld-ContribAuthor ">Taowei  Yang</span>, <span class="hlFld-ContribAuthor ">Minglong  Shao</span>, <span class="hlFld-ContribAuthor ">Xian  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhiming  Rao</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Biocatalytic Preparation of Enantiopure Unusual Î±-Amino Acids from Î±-Hydroxy Acids via a Hydrogen-Borrowing Dual-Enzyme Cascade. </span><span class="cited-content_cbyCitation_journal-name">Catalysts</span><span> <strong>2020,</strong> <em>10 </em>
                                    (12)
                                     , 1470. <a href="https://doi.org/10.3390/catal10121470" title="DOI URL">https://doi.org/10.3390/catal10121470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/catal10121470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcatal10121470%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysts%26atitle%3DOne-Pot%252BBiocatalytic%252BPreparation%252Bof%252BEnantiopure%252BUnusual%252B%2525CE%2525B1-Amino%252BAcids%252Bfrom%252B%2525CE%2525B1-Hydroxy%252BAcids%252Bvia%252Ba%252BHydrogen-Borrowing%252BDual-Enzyme%252BCascade%26aulast%3DLiu%26aufirst%3DFei%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D12%26spage%3D1470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  Xu</span>, <span class="hlFld-ContribAuthor ">Ran  Cheng</span>, <span class="hlFld-ContribAuthor ">YunâCheng  Luo</span>, <span class="hlFld-ContribAuthor ">MingâKuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xingang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">trans
              âSelective Aryldifluoroalkylation of Endocyclic Enecarbamates and Enamides by Nickel Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (42)
                                     , 18900-18906. <a href="https://doi.org/10.1002/ange.202008498" title="DOI URL">https://doi.org/10.1002/ange.202008498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202008498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202008498%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3Dtrans%252B%2525E2%252580%252590Selective%252BAryldifluoroalkylation%252Bof%252BEndocyclic%252BEnecarbamates%252Band%252BEnamides%252Bby%252BNickel%252BCatalysis%26aulast%3DXu%26aufirst%3DChang%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D42%26spage%3D18900%26epage%3D18906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  Xu</span>, <span class="hlFld-ContribAuthor ">Ran  Cheng</span>, <span class="hlFld-ContribAuthor ">YunâCheng  Luo</span>, <span class="hlFld-ContribAuthor ">MingâKuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xingang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">trans
              âSelective Aryldifluoroalkylation of Endocyclic Enecarbamates and Enamides by Nickel Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (42)
                                     , 18741-18747. <a href="https://doi.org/10.1002/anie.202008498" title="DOI URL">https://doi.org/10.1002/anie.202008498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202008498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202008498%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3Dtrans%252B%2525E2%252580%252590Selective%252BAryldifluoroalkylation%252Bof%252BEndocyclic%252BEnecarbamates%252Band%252BEnamides%252Bby%252BNickel%252BCatalysis%26aulast%3DXu%26aufirst%3DChang%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D42%26spage%3D18741%26epage%3D18747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Qianqian  Yu</span>, <span class="hlFld-ContribAuthor ">Yanfei  Cai</span>, <span class="hlFld-ContribAuthor ">Yun  Chen</span>, <span class="hlFld-ContribAuthor ">Hui  Liu</span>, <span class="hlFld-ContribAuthor ">Wenqing  Liang</span>, <span class="hlFld-ContribAuthor ">Jian  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Theoretical Exploring Selective-Binding Mechanisms of JAK3 by 3D-QSAR, Molecular Dynamics Simulation and Free Energy Calculation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2020,</strong> <em>7 </em><a href="https://doi.org/10.3389/fmolb.2020.00083" title="DOI URL">https://doi.org/10.3389/fmolb.2020.00083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2020.00083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2020.00083%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DTheoretical%252BExploring%252BSelective-Binding%252BMechanisms%252Bof%252BJAK3%252Bby%252B3D-QSAR%25252C%252BMolecular%252BDynamics%252BSimulation%252Band%252BFree%252BEnergy%252BCalculation%26aulast%3DZhu%26aufirst%3DJingyu%26date%3D2020%26date%3D2020%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. F.  Sagitova</span>, <span class="hlFld-ContribAuthor ">L. N.  Sobenina</span>, <span class="hlFld-ContribAuthor ">B. A.  Trofimov</span>. </span><span class="cited-content_cbyCitation_article-title">From Acylethynylpyrroles to Pyrrolo[1,2-a]pyrazines in One Step. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>56 </em>
                                    (2)
                                     , 225-233. <a href="https://doi.org/10.1134/S1070428020020082" title="DOI URL">https://doi.org/10.1134/S1070428020020082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428020020082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428020020082%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFrom%252BAcylethynylpyrroles%252Bto%252BPyrrolo%25255B1%25252C2-a%25255Dpyrazines%252Bin%252BOne%252BStep%26aulast%3DSagitova%26aufirst%3DE.%2BF.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D2%26spage%3D225%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>, <span class="hlFld-ContribAuthor ">Michael  Forster</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent Janus Kinase 3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 225-256. <a href="https://doi.org/10.1007/7355_2020_96" title="DOI URL">https://doi.org/10.1007/7355_2020_96</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2020_96&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2020_96%26sid%3Dliteratum%253Aachs%26atitle%3DCovalent%252BJanus%252BKinase%252B3%252BInhibitors%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2020%26date%3D2020%26spage%3D225%26epage%3D256%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DProteinkinase%252BInhibitors%26aulast%3DLaufer%26aufirst%3DStefan%26date%3D2021%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arina  Afanasyeva</span>, <span class="hlFld-ContribAuthor ">Chioko  Nagao</span>, <span class="hlFld-ContribAuthor ">Kenji  Mizuguchi</span>. </span><span class="cited-content_cbyCitation_article-title"><p>Developing a Kinase-Specific Target Selection Method Using a Structure-Based Machine Learning Approach</p>. </span><span class="cited-content_cbyCitation_journal-name">Advances and Applications in Bioinformatics and Chemistry</span><span> <strong>2020,</strong> <em>Volume 13 </em>, 27-40. <a href="https://doi.org/10.2147/AABC.S278900" title="DOI URL">https://doi.org/10.2147/AABC.S278900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2147/AABC.S278900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2147%2FAABC.S278900%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvances%2520and%2520Applications%2520in%2520Bioinformatics%2520and%2520Chemistry%26atitle%3D%25253Cp%25253EDeveloping%252Ba%252BKinase-Specific%252BTarget%252BSelection%252BMethod%252BUsing%252Ba%252BStructure-Based%252BMachine%252BLearning%252BApproach%25253C%25252Fp%25253E%26aulast%3DAfanasyeva%26aufirst%3DArina%26date%3D2020%26date%3D2020%26volume%3DVolume%252013%26spage%3D27%26epage%3D40" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesca  Musumeci</span>, <span class="hlFld-ContribAuthor ">Chiara  Greco</span>, <span class="hlFld-ContribAuthor ">Ilaria  Giacchello</span>, <span class="hlFld-ContribAuthor ">Anna Lucia  Fallacara</span>, <span class="hlFld-ContribAuthor ">Munjed M.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Giancarlo  Grossi</span>, <span class="hlFld-ContribAuthor ">Chiara  Brullo</span>, <span class="hlFld-ContribAuthor ">Silvia  Schenone</span>. </span><span class="cited-content_cbyCitation_article-title">An Update on JAK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (10)
                                     , 1806-1832. <a href="https://doi.org/10.2174/0929867325666180327093502" title="DOI URL">https://doi.org/10.2174/0929867325666180327093502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180327093502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180327093502%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DAn%252BUpdate%252Bon%252BJAK%252BInhibitors%26aulast%3DMusumeci%26aufirst%3DFrancesca%26date%3D2019%26volume%3D26%26issue%3D10%26spage%3D1806%26epage%3D1832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanja  Narancic</span>, <span class="hlFld-ContribAuthor ">Sarah A.  Almahboub</span>, <span class="hlFld-ContribAuthor ">Kevin E.  OâConnor</span>. </span><span class="cited-content_cbyCitation_article-title">Unnatural amino acids: production and biotechnological potential. </span><span class="cited-content_cbyCitation_journal-name">World Journal of Microbiology and Biotechnology</span><span> <strong>2019,</strong> <em>35 </em>
                                    (4)
                                     <a href="https://doi.org/10.1007/s11274-019-2642-9" title="DOI URL">https://doi.org/10.1007/s11274-019-2642-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11274-019-2642-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11274-019-2642-9%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Journal%2520of%2520Microbiology%2520and%2520Biotechnology%26atitle%3DUnnatural%252Bamino%252Bacids%25253A%252Bproduction%252Band%252Bbiotechnological%252Bpotential%26aulast%3DNarancic%26aufirst%3DTanja%26date%3D2019%26date%3D2019%26volume%3D35%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ben  Sprangers</span>, <span class="hlFld-ContribAuthor ">Jacques  Pirenne</span>, <span class="hlFld-ContribAuthor ">Chantal  Mathieu</span>, <span class="hlFld-ContribAuthor ">Mark  Waer</span>. </span><span class="cited-content_cbyCitation_article-title">Other Forms of Immunosuppression. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 313-332. <a href="https://doi.org/10.1016/B978-0-323-53186-3.00020-6" title="DOI URL">https://doi.org/10.1016/B978-0-323-53186-3.00020-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-323-53186-3.00020-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-323-53186-3.00020-6%26sid%3Dliteratum%253Aachs%26atitle%3DOther%252BForms%252Bof%252BImmunosuppression%26aulast%3DSprangers%26aufirst%3DBen%26date%3D2019%26spage%3D313%26epage%3D332%26pub%3DElsevier%26atitle%3DKidney%252BTransplantation%252B-%252BPrinciples%252Band%252BPractice%26date%3D2019%26volume%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heying  Pei</span>, <span class="hlFld-ContribAuthor ">Linhong  He</span>, <span class="hlFld-ContribAuthor ">Mingfeng  Shao</span>, <span class="hlFld-ContribAuthor ">Zhuang  Yang</span>, <span class="hlFld-ContribAuthor ">Yan  Ran</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Minghai  Tang</span>, <span class="hlFld-ContribAuthor ">Taijin  Wang</span>, <span class="hlFld-ContribAuthor ">Yanqiu  Gong</span>, <span class="hlFld-ContribAuthor ">Xiaoxin  Chen</span>, <span class="hlFld-ContribAuthor ">Shengyong  Yang</span>, <span class="hlFld-ContribAuthor ">Mingli  Xiang</span>, <span class="hlFld-ContribAuthor ">Lijuan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a highly selective JAK3 inhibitor for the treatment of rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2018,</strong> <em>8 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-018-23569-y" title="DOI URL">https://doi.org/10.1038/s41598-018-23569-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-018-23569-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-018-23569-y%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252Ba%252Bhighly%252Bselective%252BJAK3%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252Brheumatoid%252Barthritis%26aulast%3DPei%26aufirst%3DHeying%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haneesh  Jasuja</span>, <span class="hlFld-ContribAuthor ">Navriti  Chadha</span>, <span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Maninder  Kaur</span>, <span class="hlFld-ContribAuthor ">Malkeet Singh  Bahia</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Putative dual inhibitors of Janus kinase 1 and 3 (JAK1/3): Pharmacophore based hierarchical virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2018,</strong> <em>76 </em>, 109-117. <a href="https://doi.org/10.1016/j.compbiolchem.2018.07.009" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2018.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2018.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2018.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DPutative%252Bdual%252Binhibitors%252Bof%252BJanus%252Bkinase%252B1%252Band%252B3%252B%252528JAK1%25252F3%252529%25253A%252BPharmacophore%252Bbased%252Bhierarchical%252Bvirtual%252Bscreening%26aulast%3DJasuja%26aufirst%3DHaneesh%26date%3D2018%26volume%3D76%26spage%3D109%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raju  Tiwari</span>, <span class="hlFld-ContribAuthor ">Mahendra  Nath</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Ï-extended pyrrolo[1,2-a]pyrazinoporphyrins: Synthesis, photophysical properties and mercuric ion recognition. </span><span class="cited-content_cbyCitation_journal-name">Dyes and Pigments</span><span> <strong>2018,</strong> <em>152 </em>, 161-170. <a href="https://doi.org/10.1016/j.dyepig.2018.01.041" title="DOI URL">https://doi.org/10.1016/j.dyepig.2018.01.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.dyepig.2018.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.dyepig.2018.01.041%26sid%3Dliteratum%253Aachs%26jtitle%3DDyes%2520and%2520Pigments%26atitle%3DNovel%252B%2525CF%252580-extended%252Bpyrrolo%25255B1%25252C2-a%25255Dpyrazinoporphyrins%25253A%252BSynthesis%25252C%252Bphotophysical%252Bproperties%252Band%252Bmercuric%252Bion%252Brecognition%26aulast%3DTiwari%26aufirst%3DRaju%26date%3D2018%26volume%3D152%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Hu</span>, <span class="hlFld-ContribAuthor ">Jianjun  Lv</span>, <span class="hlFld-ContribAuthor ">Mengzhen  Han</span>, <span class="hlFld-ContribAuthor ">Zhi  Yang</span>, <span class="hlFld-ContribAuthor ">Tian  Li</span>, <span class="hlFld-ContribAuthor ">Shuai  Jiang</span>, <span class="hlFld-ContribAuthor ">Yang  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">STAT3: The art of multi-tasking of metabolic and immune functions in obesity. </span><span class="cited-content_cbyCitation_journal-name">Progress in Lipid Research</span><span> <strong>2018,</strong> <em>70 </em>, 17-28. <a href="https://doi.org/10.1016/j.plipres.2018.04.002" title="DOI URL">https://doi.org/10.1016/j.plipres.2018.04.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.plipres.2018.04.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.plipres.2018.04.002%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Lipid%2520Research%26atitle%3DSTAT3%25253A%252BThe%252Bart%252Bof%252Bmulti-tasking%252Bof%252Bmetabolic%252Band%252Bimmune%252Bfunctions%252Bin%252Bobesity%26aulast%3DHu%26aufirst%3DWei%26date%3D2018%26volume%3D70%26spage%3D17%26epage%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maninder  Kaur</span>, <span class="hlFld-ContribAuthor ">Pankaj Kumar  Singh</span>, <span class="hlFld-ContribAuthor ">Manjinder  Singh</span>, <span class="hlFld-ContribAuthor ">Renu  Bahadur</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics and integrated pharmacophore-based identification of dual 
                $$\hbox {JAK3/PI3K}\delta $$
                
                    
                        
                            JAK3/PI3K
                            Î´
                        
                    
                
             inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2018,</strong> <em>22 </em>
                                    (1)
                                     , 95-112. <a href="https://doi.org/10.1007/s11030-017-9794-z" title="DOI URL">https://doi.org/10.1007/s11030-017-9794-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-017-9794-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-017-9794-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DMolecular%252Bdynamics%252Band%252Bintegrated%252Bpharmacophore-based%252Bidentification%252Bof%252Bdual%252B%252524%252524%25255Chbox%252B%25257BJAK3%25252FPI3K%25257D%25255Cdelta%252B%252524%252524%252BJAK3%25252FPI3K%252B%2525CE%2525B4%252Binhibitors%26aulast%3DKaur%26aufirst%3DManinder%26date%3D2018%26date%3D2017%26volume%3D22%26issue%3D1%26spage%3D95%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maninder  Kaur</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3). </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2017,</strong> <em>35 </em>
                                    (14)
                                     , 3043-3060. <a href="https://doi.org/10.1080/07391102.2016.1240108" title="DOI URL">https://doi.org/10.1080/07391102.2016.1240108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2016.1240108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2016.1240108%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DLigand-based%252Band%252Be-pharmacophore%252Bmodeling%25252C%252B3D-QSAR%252Band%252Bhierarchical%252Bvirtual%252Bscreening%252Bto%252Bidentify%252Bdual%252Binhibitors%252Bof%252Bspleen%252Btyrosine%252Bkinase%252B%252528Syk%252529%252Band%252Bjanus%252Bkinase%252B3%252B%252528JAK3%252529%26aulast%3DKaur%26aufirst%3DManinder%26date%3D2017%26date%3D2016%26volume%3D35%26issue%3D14%26spage%3D3043%26epage%3D3060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Forster</span>, <span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in JAK3 inhibition: Isoform selectivity by covalent cysteine targeting. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (18)
                                     , 4229-4237. <a href="https://doi.org/10.1016/j.bmcl.2017.07.079" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.07.079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.07.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.07.079%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRecent%252Badvances%252Bin%252BJAK3%252Binhibition%25253A%252BIsoform%252Bselectivity%252Bby%252Bcovalent%252Bcysteine%252Btargeting%26aulast%3DForster%26aufirst%3DMichael%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4229%26epage%3D4237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maninder  Kaur</span>, <span class="hlFld-ContribAuthor ">Manjinder  Singh</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Oxindole-based SYK and JAK3 dual inhibitors for rheumatoid arthritis: designing, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (11)
                                     , 1193-1211. <a href="https://doi.org/10.4155/fmc-2017-0037" title="DOI URL">https://doi.org/10.4155/fmc-2017-0037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0037%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DOxindole-based%252BSYK%252Band%252BJAK3%252Bdual%252Binhibitors%252Bfor%252Brheumatoid%252Barthritis%25253A%252Bdesigning%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DKaur%26aufirst%3DManinder%26date%3D2017%26volume%3D9%26issue%3D11%26spage%3D1193%26epage%3D1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cody A.  Moore</span>, <span class="hlFld-ContribAuthor ">Carlo J.  Iasella</span>, <span class="hlFld-ContribAuthor ">Raman  Venkataramanan</span>, <span class="hlFld-ContribAuthor ">Fadi G.  Lakkis</span>, <span class="hlFld-ContribAuthor ">Randall B.  Smith</span>, <span class="hlFld-ContribAuthor ">John F.  McDyer</span>, <span class="hlFld-ContribAuthor ">Adriana  Zeevi</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Ensor</span>. </span><span class="cited-content_cbyCitation_article-title">Janus kinase inhibition for immunosuppression in solid organ transplantation: Is there a role in complex immunologic challenges?. </span><span class="cited-content_cbyCitation_journal-name">Human Immunology</span><span> <strong>2017,</strong> <em>78 </em>
                                    (2)
                                     , 64-71. <a href="https://doi.org/10.1016/j.humimm.2016.12.005" title="DOI URL">https://doi.org/10.1016/j.humimm.2016.12.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.humimm.2016.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.humimm.2016.12.005%26sid%3Dliteratum%253Aachs%26jtitle%3DHuman%2520Immunology%26atitle%3DJanus%252Bkinase%252Binhibition%252Bfor%252Bimmunosuppression%252Bin%252Bsolid%252Borgan%252Btransplantation%25253A%252BIs%252Bthere%252Ba%252Brole%252Bin%252Bcomplex%252Bimmunologic%252Bchallenges%25253F%26aulast%3DMoore%26aufirst%3DCody%2BA.%26date%3D2017%26volume%3D78%26issue%3D2%26spage%3D64%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Heterocycles with Applications in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 13-33. <a href="https://doi.org/10.1016/bs.aihch.2016.03.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.03.004%26sid%3Dliteratum%253Aachs%26atitle%3DSaturated%252BHeterocycles%252Bwith%252BApplications%252Bin%252BMedicinal%252BChemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2017%26spage%3D13%26epage%3D33%26pub%3DElsevier%26atitle%3DHeterocyclic%252BChemistry%252Bin%252Bthe%252B21st%252BCentury%252B-%252BA%252BTribute%252Bto%252BAlan%252BKatritzky%26date%3D2017%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting-Ting  Yao</span>, <span class="hlFld-ContribAuthor ">Jiang-Feng  Xie</span>, <span class="hlFld-ContribAuthor ">Xing-Guo  Liu</span>, <span class="hlFld-ContribAuthor ">Jing-Li  Cheng</span>, <span class="hlFld-ContribAuthor ">Cheng-Yuan  Zhu</span>, <span class="hlFld-ContribAuthor ">Jin-Hao  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiao-Wu  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Integration of pharmacophore mapping and molecular docking in sequential virtual screening: towards the discovery of novel JAK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (17)
                                     , 10353-10360. <a href="https://doi.org/10.1039/C6RA24959K" title="DOI URL">https://doi.org/10.1039/C6RA24959K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA24959K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA24959K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DIntegration%252Bof%252Bpharmacophore%252Bmapping%252Band%252Bmolecular%252Bdocking%252Bin%252Bsequential%252Bvirtual%252Bscreening%25253A%252Btowards%252Bthe%252Bdiscovery%252Bof%252Bnovel%252BJAK2%252Binhibitors%26aulast%3DYao%26aufirst%3DTing-Ting%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D17%26spage%3D10353%26epage%3D10360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyungmi  Kim</span>, <span class="hlFld-ContribAuthor ">Mi Kyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Hyunah  Choo</span>, <span class="hlFld-ContribAuthor ">Youhoon  Chong</span>. </span><span class="cited-content_cbyCitation_article-title">Novel JAK1-selective benzimidazole inhibitors with enhanced membrane permeability. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (14)
                                     , 3213-3215. <a href="https://doi.org/10.1016/j.bmcl.2016.05.078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.05.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.05.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.05.078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252BJAK1-selective%252Bbenzimidazole%252Binhibitors%252Bwith%252Benhanced%252Bmembrane%252Bpermeability%26aulast%3DKim%26aufirst%3DHyungmi%26date%3D2016%26volume%3D26%26issue%3D14%26spage%3D3213%26epage%3D3215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>, <span class="hlFld-ContribAuthor ">Michael  Forster</span>, <span class="hlFld-ContribAuthor ">Ellen  Pfaffenrot</span>, <span class="hlFld-ContribAuthor ">Silke M.  Bauer</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Hinge-Binding Motifs for Janus Kinaseâ3 Inhibitors: A Comprehensive Structure-Activity Relationship Study on Tofacitinib Bioisosteres. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (11)
                                     , 2516-2527. <a href="https://doi.org/10.1002/cmdc.201402252" title="DOI URL">https://doi.org/10.1002/cmdc.201402252</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402252%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNovel%252BHinge-Binding%252BMotifs%252Bfor%252BJanus%252BKinase%2525E2%252580%2525853%252BInhibitors%25253A%252BA%252BComprehensive%252BStructure-Activity%252BRelationship%252BStudy%252Bon%252BTofacitinib%252BBioisosteres%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D11%26spage%3D2516%26epage%3D2527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Javier  de Vicente</span>, <span class="hlFld-ContribAuthor ">Remy  Lemoine</span>, <span class="hlFld-ContribAuthor ">Mark  Bartlett</span>, <span class="hlFld-ContribAuthor ">Johannes C.  Hermann</span>, <span class="hlFld-ContribAuthor ">Mohammad  Hekmat-Nejad</span>, <span class="hlFld-ContribAuthor ">Robert  Henningsen</span>, <span class="hlFld-ContribAuthor ">Sue  Jin</span>, <span class="hlFld-ContribAuthor ">Andreas  Kuglstatter</span>, <span class="hlFld-ContribAuthor ">Hongju  Li</span>, <span class="hlFld-ContribAuthor ">Allen J.  Lovey</span>, <span class="hlFld-ContribAuthor ">John  Menke</span>, <span class="hlFld-ContribAuthor ">Linghao  Niu</span>, <span class="hlFld-ContribAuthor ">Vaishali  Patel</span>, <span class="hlFld-ContribAuthor ">Ann  Petersen</span>, <span class="hlFld-ContribAuthor ">Lina  Setti</span>, <span class="hlFld-ContribAuthor ">Ada  Shao</span>, <span class="hlFld-ContribAuthor ">Parcharee  Tivitmahaisoon</span>, <span class="hlFld-ContribAuthor ">Minh Diem  Vu</span>, <span class="hlFld-ContribAuthor ">Michael  Soth</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold hopping towards potent and selective JAK3 inhibitors: Discovery of novel C-5 substituted pyrrolopyrazines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (21)
                                     , 4969-4975. <a href="https://doi.org/10.1016/j.bmcl.2014.09.031" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.09.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.09.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DScaffold%252Bhopping%252Btowards%252Bpotent%252Band%252Bselective%252BJAK3%252Binhibitors%25253A%252BDiscovery%252Bof%252Bnovel%252BC-5%252Bsubstituted%252Bpyrrolopyrazines%26aulast%3Dde%2BVicente%26aufirst%3DJavier%26date%3D2014%26volume%3D24%26issue%3D21%26spage%3D4969%26epage%3D4975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gebhard  Thoma</span>, <span class="hlFld-ContribAuthor ">Peter  DrÃ¼ckes</span>, <span class="hlFld-ContribAuthor ">Hans-GÃ¼nter  Zerwes</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibitors of the Janus kinase Jak3âAre they effective?. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (19)
                                     , 4617-4621. <a href="https://doi.org/10.1016/j.bmcl.2014.08.046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.08.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.08.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.08.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSelective%252Binhibitors%252Bof%252Bthe%252BJanus%252Bkinase%252BJak3%2525E2%252580%252594Are%252Bthey%252Beffective%25253F%26aulast%3DThoma%26aufirst%3DGebhard%26date%3D2014%26volume%3D24%26issue%3D19%26spage%3D4617%26epage%3D4621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W  Dymock</span>, <span class="hlFld-ContribAuthor ">Eugene Guorong  Yang</span>, <span class="hlFld-ContribAuthor ">Yuyi  Chu-Farseeva</span>, <span class="hlFld-ContribAuthor ">Lianbin  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (12)
                                     , 1439-1471. <a href="https://doi.org/10.4155/fmc.14.92" title="DOI URL">https://doi.org/10.4155/fmc.14.92</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.92%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BJAK%252Binhibitors%26aulast%3DDymock%26aufirst%3DBrian%2BW%26date%3D2014%26volume%3D6%26issue%3D12%26spage%3D1439%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haneesh  Jasuja</span>, <span class="hlFld-ContribAuthor ">Navriti  Chadha</span>, <span class="hlFld-ContribAuthor ">Maninder  Kaur</span>, <span class="hlFld-ContribAuthor ">Om  Silakari</span>. </span><span class="cited-content_cbyCitation_article-title">Dual inhibitors of Janus kinase 2 and 3 (JAK2/3): designing by pharmacophore- and docking-based virtual screening approach. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2014,</strong> <em>18 </em>
                                    (2)
                                     , 253-267. <a href="https://doi.org/10.1007/s11030-013-9497-z" title="DOI URL">https://doi.org/10.1007/s11030-013-9497-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-013-9497-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-013-9497-z%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDual%252Binhibitors%252Bof%252BJanus%252Bkinase%252B2%252Band%252B3%252B%252528JAK2%25252F3%252529%25253A%252Bdesigning%252Bby%252Bpharmacophore-%252Band%252Bdocking-based%252Bvirtual%252Bscreening%252Bapproach%26aulast%3DJasuja%26aufirst%3DHaneesh%26date%3D2014%26date%3D2014%26volume%3D18%26issue%3D2%26spage%3D253%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">AurÃ©lie  Orliac</span>, <span class="hlFld-ContribAuthor ">Julie  Routier</span>, <span class="hlFld-ContribAuthor ">Fabienne  BurgatâCharvillon</span>, <span class="hlFld-ContribAuthor ">Wolfgang H. B.  Sauer</span>, <span class="hlFld-ContribAuthor ">Agnes  Bombrun</span>, <span class="hlFld-ContribAuthor ">Santosh S.  Kulkarni</span>, <span class="hlFld-ContribAuthor ">Domingo  GomezâPardo</span>, <span class="hlFld-ContribAuthor ">Janine  Cossy</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis and Physicochemical Properties of Libraries of 3-Amino- and 3-Amidofluoropiperidines. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2014,</strong> <em>20 </em>
                                    (13)
                                     , 3813-3824. <a href="https://doi.org/10.1002/chem.201302423" title="DOI URL">https://doi.org/10.1002/chem.201302423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201302423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201302423%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DEnantioselective%252BSynthesis%252Band%252BPhysicochemical%252BProperties%252Bof%252BLibraries%252Bof%252B3-Amino-%252Band%252B3-Amidofluoropiperidines%26aulast%3DOrliac%26aufirst%3DAur%25C3%25A9lie%26date%3D2014%26date%3D2014%26volume%3D20%26issue%3D13%26spage%3D3813%26epage%3D3824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshiaki  Takahashi</span>, <span class="hlFld-ContribAuthor ">Siddappa N.  Byrareddy</span>, <span class="hlFld-ContribAuthor ">Christina  Albrecht</span>, <span class="hlFld-ContribAuthor ">Markus  Brameier</span>, <span class="hlFld-ContribAuthor ">Lutz  Walter</span>, <span class="hlFld-ContribAuthor ">Ann E.  Mayne</span>, <span class="hlFld-ContribAuthor ">Paul  Dunbar</span>, <span class="hlFld-ContribAuthor ">Robert  Russo</span>, <span class="hlFld-ContribAuthor ">Dawn M.  Little</span>, <span class="hlFld-ContribAuthor ">Tara  Villinger</span>, <span class="hlFld-ContribAuthor ">Ladawan  Khowawisetsut</span>, <span class="hlFld-ContribAuthor ">Kovit  Pattanapanyasat</span>, <span class="hlFld-ContribAuthor ">Francois  Villinger</span>, <span class="hlFld-ContribAuthor ">Aftab A.  Ansari</span>, . </span><span class="cited-content_cbyCitation_article-title">In Vivo Administration of a JAK3 Inhibitor during Acute SIV Infection Leads to Significant Increases in Viral Load during Chronic Infection. </span><span class="cited-content_cbyCitation_journal-name">PLoS Pathogens</span><span> <strong>2014,</strong> <em>10 </em>
                                    (3)
                                     , e1003929. <a href="https://doi.org/10.1371/journal.ppat.1003929" title="DOI URL">https://doi.org/10.1371/journal.ppat.1003929</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1003929&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1003929%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520Pathogens%26atitle%3DIn%252BVivo%252BAdministration%252Bof%252Ba%252BJAK3%252BInhibitor%252Bduring%252BAcute%252BSIV%252BInfection%252BLeads%252Bto%252BSignificant%252BIncreases%252Bin%252BViral%252BLoad%252Bduring%252BChronic%252BInfection%26aulast%3DTakahashi%26aufirst%3DYoshiaki%26date%3D2014%26date%3D2014%26volume%3D10%26issue%3D3%26spage%3De1003929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Massimo  Gadina</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in kinase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Rheumatology</span><span> <strong>2014,</strong> <em>26 </em>
                                    (2)
                                     , 237-243. <a href="https://doi.org/10.1097/BOR.0000000000000023" title="DOI URL">https://doi.org/10.1097/BOR.0000000000000023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/BOR.0000000000000023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FBOR.0000000000000023%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Rheumatology%26atitle%3DAdvances%252Bin%252Bkinase%252Binhibition%26aulast%3DGadina%26aufirst%3DMassimo%26date%3D2014%26volume%3D26%26issue%3D2%26spage%3D237%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  McDonnell</span>, <span class="hlFld-ContribAuthor ">Haiyan  Bian</span>, <span class="hlFld-ContribAuthor ">Jay  Wrobel</span>, <span class="hlFld-ContribAuthor ">Garry R.  Smith</span>, <span class="hlFld-ContribAuthor ">Shuguang  Liang</span>, <span class="hlFld-ContribAuthor ">Haiching  Ma</span>, <span class="hlFld-ContribAuthor ">Allen B.  Reitz</span>. </span><span class="cited-content_cbyCitation_article-title">Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (4)
                                     , 1116-1121. <a href="https://doi.org/10.1016/j.bmcl.2014.01.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.01.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAnilino-monoindolylmaleimides%252Bas%252Bpotent%252Band%252Bselective%252BJAK3%252Binhibitors%26aulast%3DMcDonnell%26aufirst%3DMark%2BE.%26date%3D2014%26volume%3D24%26issue%3D4%26spage%3D1116%26epage%3D1121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew L.  Hopkins</span>, <span class="hlFld-ContribAuthor ">GyÃ¶rgy M.  KeserÃ¼</span>, <span class="hlFld-ContribAuthor ">Paul D.  Leeson</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>, <span class="hlFld-ContribAuthor ">Charles H.  Reynolds</span>. </span><span class="cited-content_cbyCitation_article-title">The role of ligand efficiency metrics in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2014,</strong> <em>13 </em>
                                    (2)
                                     , 105-121. <a href="https://doi.org/10.1038/nrd4163" title="DOI URL">https://doi.org/10.1038/nrd4163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4163%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DThe%252Brole%252Bof%252Bligand%252Befficiency%252Bmetrics%252Bin%252Bdrug%252Bdiscovery%26aulast%3DHopkins%26aufirst%3DAndrew%2BL.%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D2%26spage%3D105%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benito  Alcaide</span>, <span class="hlFld-ContribAuthor ">Pedro  Almendros</span>. </span><span class="cited-content_cbyCitation_article-title">Four-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 85-113. <a href="https://doi.org/10.1016/B978-0-08-100017-5.00004-2" title="DOI URL">https://doi.org/10.1016/B978-0-08-100017-5.00004-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100017-5.00004-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100017-5.00004-2%26sid%3Dliteratum%253Aachs%26atitle%3DFour-Membered%252BRing%252BSystems%26aulast%3DAlcaide%26aufirst%3DBenito%26date%3D2014%26spage%3D85%26epage%3D113%26pub%3DElsevier%26date%3D2014%26volume%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Highly selective Janus kinase 3 inhibitors based on a pyrrolo[2,3-
              d
              ]pyrimidine scaffold: evaluation of WO2013085802. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (1)
                                     , 121-125. <a href="https://doi.org/10.1517/13543776.2014.851670" title="DOI URL">https://doi.org/10.1517/13543776.2014.851670</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.851670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.851670%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DHighly%252Bselective%252BJanus%252Bkinase%252B3%252Binhibitors%252Bbased%252Bon%252Ba%252Bpyrrolo%25255B2%25252C3-%252Bd%252B%25255Dpyrimidine%252Bscaffold%25253A%252Bevaluation%252Bof%252BWO2013085802%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2014%26date%3D2013%26volume%3D24%26issue%3D1%26spage%3D121%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yoshiaki  Takahashi</span>, <span class="hlFld-ContribAuthor ">Ann E.  Mayne</span>, <span class="hlFld-ContribAuthor ">Ladawan  Khowawisetsut</span>, <span class="hlFld-ContribAuthor ">Kovit  Pattanapanyasat</span>, <span class="hlFld-ContribAuthor ">Dawn  Little</span>, <span class="hlFld-ContribAuthor ">Francois  Villinger</span>, <span class="hlFld-ContribAuthor ">Aftab A.  Ansari</span>, . </span><span class="cited-content_cbyCitation_article-title">In Vivo Administration of a JAK3 Inhibitor to Chronically SIV Infected Rhesus Macaques Leads to NK Cell Depletion Associated with Transient Modest Increase in Viral Loads. </span><span class="cited-content_cbyCitation_journal-name">PLoS ONE</span><span> <strong>2013,</strong> <em>8 </em>
                                    (7)
                                     , e70992. <a href="https://doi.org/10.1371/journal.pone.0070992" title="DOI URL">https://doi.org/10.1371/journal.pone.0070992</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0070992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0070992%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520ONE%26atitle%3DIn%252BVivo%252BAdministration%252Bof%252Ba%252BJAK3%252BInhibitor%252Bto%252BChronically%252BSIV%252BInfected%252BRhesus%252BMacaques%252BLeads%252Bto%252BNK%252BCell%252BDepletion%252BAssociated%252Bwith%252BTransient%252BModest%252BIncrease%252Bin%252BViral%252BLoads%26aulast%3DTakahashi%26aufirst%3DYoshiaki%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D7%26spage%3De70992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen M.  Lynch</span>, <span class="hlFld-ContribAuthor ">Javier  DeVicente</span>, <span class="hlFld-ContribAuthor ">Johannes C.  Hermann</span>, <span class="hlFld-ContribAuthor ">Saul  Jaime-Figueroa</span>, <span class="hlFld-ContribAuthor ">Sue  Jin</span>, <span class="hlFld-ContribAuthor ">Andreas  Kuglstatter</span>, <span class="hlFld-ContribAuthor ">Hongju  Li</span>, <span class="hlFld-ContribAuthor ">Allen  Lovey</span>, <span class="hlFld-ContribAuthor ">John  Menke</span>, <span class="hlFld-ContribAuthor ">Linghao  Niu</span>, <span class="hlFld-ContribAuthor ">Vaishali  Patel</span>, <span class="hlFld-ContribAuthor ">Douglas  Roy</span>, <span class="hlFld-ContribAuthor ">Michael  Soth</span>, <span class="hlFld-ContribAuthor ">Sandra  Steiner</span>, <span class="hlFld-ContribAuthor ">Parcharee  Tivitmahaisoon</span>, <span class="hlFld-ContribAuthor ">Minh Diem  Vu</span>, <span class="hlFld-ContribAuthor ">Calvin  Yee</span>. </span><span class="cited-content_cbyCitation_article-title">Strategic use of conformational bias and structure based design to identify potent JAK3 inhibitors with improved selectivity against the JAK family and the kinome. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (9)
                                     , 2793-2800. <a href="https://doi.org/10.1016/j.bmcl.2013.02.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.02.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.02.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStrategic%252Buse%252Bof%252Bconformational%252Bbias%252Band%252Bstructure%252Bbased%252Bdesign%252Bto%252Bidentify%252Bpotent%252BJAK3%252Binhibitors%252Bwith%252Bimproved%252Bselectivity%252Bagainst%252Bthe%252BJAK%252Bfamily%252Band%252Bthe%252Bkinome%26aulast%3DLynch%26aufirst%3DStephen%2BM.%26date%3D2013%26volume%3D23%26issue%3D9%26spage%3D2793%26epage%3D2800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saul  Jaime-Figueroa</span>, <span class="hlFld-ContribAuthor ">Javier  De Vicente</span>, <span class="hlFld-ContribAuthor ">Johannes  Hermann</span>, <span class="hlFld-ContribAuthor ">Alam  Jahangir</span>, <span class="hlFld-ContribAuthor ">Sue  Jin</span>, <span class="hlFld-ContribAuthor ">Andreas  Kuglstatter</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Lynch</span>, <span class="hlFld-ContribAuthor ">John  Menke</span>, <span class="hlFld-ContribAuthor ">Linghao  Niu</span>, <span class="hlFld-ContribAuthor ">Vaishali  Patel</span>, <span class="hlFld-ContribAuthor ">Ada  Shao</span>, <span class="hlFld-ContribAuthor ">Michael  Soth</span>, <span class="hlFld-ContribAuthor ">Minh Diem  Vu</span>, <span class="hlFld-ContribAuthor ">Calvin  Yee</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (9)
                                     , 2522-2526. <a href="https://doi.org/10.1016/j.bmcl.2013.03.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252B5H-pyrrolo%25255B2%25252C3-b%25255Dpyrazine-2-phenyl%252Bethers%25252C%252Bas%252Bpotent%252BJAK3%252Bkinase%252Binhibitors%26aulast%3DJaime-Figueroa%26aufirst%3DSaul%26date%3D2013%26volume%3D23%26issue%3D9%26spage%3D2522%26epage%3D2526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of Tofacitinib (<b>1</b>), profiling hit <b>2</b>, and cyclopropyl analogue <b>3a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthesis of Pyrrolopyrazines <b>3a</b>â<b>t</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) formaldehyde, sodium hydroxide, 1,4-dioxane/water, (b) sodium hydroxide, tetrahydrofuran/water, (c) Jones reagent, acetone, (d) 2-silylethoxymethyl chloride, sodium hydride, <i>N</i>,<i>N</i>-dimethylformamide, 0 Â°Cârt, (42%); (ii) cyclopropylboronic acid, palladium diacetate, tricyclohexylphosphine, potassium phosphate, toluene/water, 100 Â°C (81%); (iii) sodium hypochlorite, potassium dihydrogen phosphate, sulfamic acid, 1,4-dioxane/water (87%); (iv) (a) <i>R</i><sup>1</sup>-NH<sub>2</sub>, amide coupling reagent, solvent, (b) trifluoroacetic acid, dichloromethane, (c) ethylene diamine/dichloromethane <i>or</i> sodium acetate/ethanol <i>or</i> triethylamine/MeOH/H<sub>2</sub>O (17â87%).</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Modeled structure of <b>3a</b> in JAK3. Carbon atoms of <b>3a</b> are in cyan, carbon atoms of the JAK3 protein are in orange, oxygen atoms are in red, and nitrogen atoms are colored in blue. Red-colored protein surface indicates protein areas identified for potential exploration and optimization of interactions. All visualizations generated with MOE.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of <b>3e</b> in JAK3 (PDB accession no. <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVD">4HVD</a>, 1.85 Ã resolution), demonstrating filling of the lower pocket by the <i>tert</i>-butyl group. Carbon atoms of <b>3e</b> are in yellow, carbon atoms of the JAK3 protein are in orange, oxygen atoms are in red, and nitrogen atoms are colored in blue. Molecular surface of <b>3e</b> is colored cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structures of <b>3f</b> (PDB accession no. <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVG">4HVG</a>, 2.75 Ã resolution) and <b>3g</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVH">4HVH</a>, 2.3 Ã) in JAK3, superimposed. Carbon atoms of <b>3f</b> are in cyan, carbon atoms of <b>3g</b> are in orange, oxygen atoms are in red, and nitrogen atoms are colored in blue. The assignment of methyl and hydroxyl in the tertiary alcohol moiety is tentative at the current resolution. Meshes are colored according to ligand carbon atom color and show the molecular surface for each ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray crystal structure of <b>3k</b> in JAK3 (PDB accession no. <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVI">4HVI</a>, 2.4 Ã resolution), demonstrating filling of the upper pocket by the tertiary amide. Carbon atoms of <b>3k</b> are in yellow, carbon atoms of the JAK3 protein are in orange, oxygen atoms are in red, and nitrogen atoms are colored in blue. Molecular surface of <b>3k</b> is colored cyan. Gray-colored mesh shows the molecular surface and shape of the binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of STAT phosphorylation in mice treated with compound <b>3q</b> in an acute PK/PD model.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/medium/jm-2012-01646k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. siRNA depletion studies on JAK1â3 in primary T-cells. Human primary T cells were transfected with siRNAs targeting JAK1, JAK2, JAK3, or scramble siRNA (Ctrl RNA) by Amaxa electrophoresis, and IL-2 induced phosphorylation of STAT5 was determined by flow cytometric analysis. The intensity of pSTAT5 (%) was normalized to control scramble siRNA treatment group represented as percentage (%). The experiment was repeated in three independent experiments on three different donors. Gene knockdown confirmation studies are included in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-1/jm301646k/production/images/large/jm-2012-01646k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301646k&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57703" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57703" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 32 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Takeshita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohtani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munakata, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span> </span><span class="NLM_article-title">Cloning of the Î³ chain of the human IL-2 receptor</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">257</span><span class="NLM_x"> (</span><span class="NLM_issue">5068</span><span class="NLM_x">) </span> <span class="NLM_fpage">379</span><span class="NLM_x">â</span> <span class="NLM_lpage">382</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1992&pages=379-382&issue=5068&author=T.+Takeshitaauthor=H.+Asaoauthor=K.+Ohtaniauthor=N.+Ishiiauthor=S.+Kumakiauthor=N.+Tanakaauthor=H.+Munakataauthor=M.+Nakamuraauthor=K.+Sugamura&title=Cloning+of+the+%CE%B3+chain+of+the+human+IL-2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTakeshita%26aufirst%3DT.%26aulast%3DAsao%26aufirst%3DH.%26aulast%3DOhtani%26aufirst%3DK.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DKumaki%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DMunakata%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DSugamura%26aufirst%3DK.%26atitle%3DCloning%2520of%2520the%2520%25CE%25B3%2520chain%2520of%2520the%2520human%2520IL-2%2520receptor%26jtitle%3DScience%26date%3D1992%26volume%3D257%26issue%3D5068%26spage%3D379%26epage%3D382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Rochman, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spolski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span> </span><span class="NLM_article-title">New insights into the regulation of T cells by Î³c family cytokines</span> <span class="citation_source-journal">Nature Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">480</span><span class="NLM_x">â</span> <span class="NLM_lpage">490</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1038%2Fnri2580" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=19543225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=480-490&issue=7&author=Y.+Rochmanauthor=R.+Spolskiauthor=W.+J.+Leonard&title=New+insights+into+the+regulation+of+T+cells+by+%CE%B3c+family+cytokines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into the regulation of T cells by Î³c family cytokines</span></div><div class="casAuthors">Rochman, Yrina; Spolski, Rosanne; Leonard, Warren J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">480-490</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Common cytokine receptor Î³-chain (Î³c) family cytokines have crucial roles in the development, proliferation, survival and differentiation of multiple cell lineages of both the innate and adaptive immune systems.  In this Review, the authors focus on the current understanding of the distinct and overlapping effects of interleukin-2 (IL-2), IL-7, IL-9, IL-15 and IL-21, as well as the IL-7-related cytokine thymic stromal lymphopoietin (TSLP), on the survival and proliferation of conventional Î±Î² T cells, Î³Î´ T cells and regulatory T cells.  This knowledge potentially allows for the therapeutic manipulation of immune responses for the treatment of cancer, autoimmunity, allergic diseases and immunodeficiency, as well as for vaccine development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6GBlSyD8_NLVg90H21EOLACvtfcHk0lhKf0M64Hk_HQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsVylu78%253D&md5=a6c7285b05193002b89be7233d11f271</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnri2580&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri2580%26sid%3Dliteratum%253Aachs%26aulast%3DRochman%26aufirst%3DY.%26aulast%3DSpolski%26aufirst%3DR.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DNew%2520insights%2520into%2520the%2520regulation%2520of%2520T%2520cells%2520by%2520%25CE%25B3c%2520family%2520cytokines%26jtitle%3DNature%2520Rev.%2520Immunol.%26date%3D2009%26volume%3D9%26issue%3D7%26spage%3D480%26epage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Macchi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giliani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacco, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frattini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugazio, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Candotti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vezzoni, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Notarangelo, L. D.</span><span> </span><span class="NLM_article-title">Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">377</span><span class="NLM_x"> (</span><span class="NLM_issue">6544</span><span class="NLM_x">) </span> <span class="NLM_fpage">65</span><span class="NLM_x">â</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=377&publication_year=1995&pages=65-68&issue=6544&author=P.+Macchiauthor=A.+Villaauthor=S.+Gilianiauthor=M.+G.+Saccoauthor=A.+Frattiniauthor=F.+Portaauthor=A.+G.+Ugazioauthor=J.+A.+Johnstonauthor=F.+Candottiauthor=J.+J.+O%E2%80%99Sheaauthor=P.+Vezzoniauthor=L.+D.+Notarangelo&title=Mutations+of+Jak-3+gene+in+patients+with+autosomal+severe+combined+immune+deficiency+%28SCID%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMacchi%26aufirst%3DP.%26aulast%3DVilla%26aufirst%3DA.%26aulast%3DGiliani%26aufirst%3DS.%26aulast%3DSacco%26aufirst%3DM.%2BG.%26aulast%3DFrattini%26aufirst%3DA.%26aulast%3DPorta%26aufirst%3DF.%26aulast%3DUgazio%26aufirst%3DA.%2BG.%26aulast%3DJohnston%26aufirst%3DJ.%2BA.%26aulast%3DCandotti%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DVezzoni%26aufirst%3DP.%26aulast%3DNotarangelo%26aufirst%3DL.%2BD.%26atitle%3DMutations%2520of%2520Jak-3%2520gene%2520in%2520patients%2520with%2520autosomal%2520severe%2520combined%2520immune%2520deficiency%2520%2528SCID%2529%26jtitle%3DNature%26date%3D1995%26volume%3D377%26issue%3D6544%26spage%3D65%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Russell, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tayebi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedy, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aman, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migone, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markert, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckley, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span> </span><span class="NLM_article-title">Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x"> (</span><span class="NLM_issue">5237</span><span class="NLM_x">) </span> <span class="NLM_fpage">797</span><span class="NLM_x">â</span> <span class="NLM_lpage">800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=797-800&issue=5237&author=S.+M.+Russellauthor=N.+Tayebiauthor=H.+Nakajimaauthor=M.+C.+Riedyauthor=J.+L.+Robertsauthor=M.+J.+Amanauthor=T.+S.+Migoneauthor=M.+Noguchiauthor=M.+L.+Markertauthor=R.+H.+Buckleyauthor=J.+J.+O%E2%80%99Sheaauthor=W.+J.+Leonard&title=Mutation+of+Jak3+in+a+patient+with+SCID%3A+essential+role+of+Jak3+in+lymphoid+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DS.%2BM.%26aulast%3DTayebi%26aufirst%3DN.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DRiedy%26aufirst%3DM.%2BC.%26aulast%3DRoberts%26aufirst%3DJ.%2BL.%26aulast%3DAman%26aufirst%3DM.%2BJ.%26aulast%3DMigone%26aufirst%3DT.%2BS.%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DMarkert%26aufirst%3DM.%2BL.%26aulast%3DBuckley%26aufirst%3DR.%2BH.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DMutation%2520of%2520Jak3%2520in%2520a%2520patient%2520with%2520SCID%253A%2520essential%2520role%2520of%2520Jak3%2520in%2520lymphoid%2520development%26jtitle%3DScience%26date%3D1995%26volume%3D270%26issue%3D5237%26spage%3D797%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Noguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenblatt, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filipovich, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modi, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, O. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, W. J.</span><span> </span><span class="NLM_article-title">Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">147</span><span class="NLM_x">â</span> <span class="NLM_lpage">157</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1993&pages=147-157&issue=1&author=M.+Noguchiauthor=H.+Yiauthor=H.+M.+Rosenblattauthor=A.+H.+Filipovichauthor=S.+Adelsteinauthor=W.+S.+Modiauthor=O.+W.+McBrideauthor=W.+J.+Leonard&title=Interleukin-2+receptor+gamma+chain+mutation+results+in+X-linked+severe+combined+immunodeficiency+in+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoguchi%26aufirst%3DM.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DRosenblatt%26aufirst%3DH.%2BM.%26aulast%3DFilipovich%26aufirst%3DA.%2BH.%26aulast%3DAdelstein%26aufirst%3DS.%26aulast%3DModi%26aufirst%3DW.%2BS.%26aulast%3DMcBride%26aufirst%3DO.%2BW.%26aulast%3DLeonard%26aufirst%3DW.%2BJ.%26atitle%3DInterleukin-2%2520receptor%2520gamma%2520chain%2520mutation%2520results%2520in%2520X-linked%2520severe%2520combined%2520immunodeficiency%2520in%2520humans%26jtitle%3DCell%26date%3D1993%26volume%3D73%26issue%3D1%26spage%3D147%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Witthuhn, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quelle, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">227</span><span class="NLM_x">â</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1993&pages=227-236&issue=2&author=B.+A.+Witthuhnauthor=F.+W.+Quelleauthor=O.+Silvennoinenauthor=T.+Yiauthor=B.+Tangauthor=O.+Miuraauthor=J.+N.+Ihle&title=JAK2+associates+with+the+erythropoietin+receptor+and+is+tyrosine+phosphorylated+and+activated+following+stimulation+with+erythropoietin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWitthuhn%26aufirst%3DB.%2BA.%26aulast%3DQuelle%26aufirst%3DF.%2BW.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DTang%26aufirst%3DB.%26aulast%3DMiura%26aufirst%3DO.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJAK2%2520associates%2520with%2520the%2520erythropoietin%2520receptor%2520and%2520is%2520tyrosine%2520phosphorylated%2520and%2520activated%2520following%2520stimulation%2520with%2520erythropoietin%26jtitle%3DCell%26date%3D1993%26volume%3D74%26issue%3D2%26spage%3D227%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Quelle, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witthuhn, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inhorn, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyajima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">4335</span><span class="NLM_x">â</span> <span class="NLM_lpage">4341</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=8007942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADyaK2cXksFSkt78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1994&pages=4335-4341&issue=7&author=F.+W.+Quelleauthor=N.+Satoauthor=B.+A.+Witthuhnauthor=R.+C.+Inhornauthor=M.+Ederauthor=A.+Miyajimaauthor=J.+D.+Griffinauthor=J.+N.+Ihle&title=JAK2+associates+with+the+beta+c+chain+of+the+receptor+for+granulocyte-macrophage+colony-stimulating+factor%2C+and+its+activation+requires+the+membrane-proximal+region"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">JAK2 associates with the Î²c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region</span></div><div class="casAuthors">Quelle, Frederick W.; Sato, Noriko; Witthuhn, Bruce A.; Inhorn, Roger C.; Eder, Matthias; Miyajima, Atsushi; Griffin, James D.; Ihle, James N.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4335-41</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">The high-affinity receptor for granulocyte-macrophage colony-stimulating factor (GM-CSF) consists of a unique Î± chain and a Î²c subunit that is shared with the receptors for interleukin-3 (IL-3) and IL-5.  Two regions of the Î²c chain have been defined; these include a membrane-proximal region of the cytoplasmic domain that is required for mitogenesis and a membrane-distal region that is required for activation of Ras, Raf-1, mitogen-activated protein kinase, and S6 kinase.  Recent studies have implicated the cytoplasmic protein tyrosine kinase JAK2 in signaling through a no. of the cytokine receptors, including the IL-3 and erythropoietin receptors.  In the studies described here, the authors demonstrate that GM-CSF stimulation of cells induces the tyrosine phosphorylation of JAK2 and activates its in vitro kinase activity.  Mutational anal. of the Î²c chain demonstrates that only the membrane-proximal 62 amino acids of the cytosolic domain are required for JAK2 activation.  Thus, JAK2 activation is correlated with induction of mitogenesis but does not, alone, activate the Ras pathway.  Carboxyl truncations of the Î± chain, which inactivate the receptor for mitogenesis, are unable to mediate GM-CSF-induced JAK2 activation.  Using baculovirus-expressed proteins, the authors further demonstrate that JAK2 phys. assocs. with the Î²c chain but not with the Î± chain.  Apparently, the JAK family of kinases are crit. to coupling cytokine binding to tyrosine phosphorylation and ultimately mitogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplCgSCu6SfKLVg90H21EOLACvtfcHk0lhnpoCM-hKGuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXksFSkt78%253D&md5=ab70a0456dcad5523fddd63b9bd23a5f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuelle%26aufirst%3DF.%2BW.%26aulast%3DSato%26aufirst%3DN.%26aulast%3DWitthuhn%26aufirst%3DB.%2BA.%26aulast%3DInhorn%26aufirst%3DR.%2BC.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DMiyajima%26aufirst%3DA.%26aulast%3DGriffin%26aufirst%3DJ.%2BD.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJAK2%2520associates%2520with%2520the%2520beta%2520c%2520chain%2520of%2520the%2520receptor%2520for%2520granulocyte-macrophage%2520colony-stimulating%2520factor%252C%2520and%2520its%2520activation%2520requires%2520the%2520membrane-proximal%2520region%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1994%26volume%3D14%26issue%3D7%26spage%3D4335%26epage%3D4341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">LÃ¼tticken, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegenka, U. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buschmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziemiecki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harpur, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taga, T.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x"> (</span><span class="NLM_issue">5143</span><span class="NLM_x">) </span> <span class="NLM_fpage">89</span><span class="NLM_x">â</span> <span class="NLM_lpage">92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=89-92&issue=5143&author=C.+L%C3%BCttickenauthor=U.+M.+Wegenkaauthor=J.+Yuanauthor=J.+Buschmannauthor=C.+Schindlerauthor=A.+Ziemieckiauthor=A.+G.+Harpurauthor=A.+F.+Wilksauthor=K.+Yasukawaauthor=T.+Taga&title=Association+of+transcription+factor+APRF+and+protein+kinase+Jak1+with+the+interleukin-6+signal+transducer+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DL%25C3%25BCtticken%26aufirst%3DC.%26aulast%3DWegenka%26aufirst%3DU.%2BM.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DBuschmann%26aufirst%3DJ.%26aulast%3DSchindler%26aufirst%3DC.%26aulast%3DZiemiecki%26aufirst%3DA.%26aulast%3DHarpur%26aufirst%3DA.%2BG.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DYasukawa%26aufirst%3DK.%26aulast%3DTaga%26aufirst%3DT.%26atitle%3DAssociation%2520of%2520transcription%2520factor%2520APRF%2520and%2520protein%2520kinase%2520Jak1%2520with%2520the%2520interleukin-6%2520signal%2520transducer%2520gp130%26jtitle%3DScience%26date%3D1994%26volume%3D263%26issue%3D5143%26spage%3D89%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Narazaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witthuhn, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taga, T.</span><span> </span><span class="NLM_article-title">Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2285</span><span class="NLM_x">â</span> <span class="NLM_lpage">2289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=2285-2289&issue=6&author=M.+Narazakiauthor=B.+A.+Witthuhnauthor=K.+Yoshidaauthor=O.+Silvennoinenauthor=K.+Yasukawaauthor=J.+N.+Ihleauthor=T.+Kishimotoauthor=T.+Taga&title=Activation+of+JAK2+kinase+mediated+by+the+interleukin+6+signal+transducer+gp130"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNarazaki%26aufirst%3DM.%26aulast%3DWitthuhn%26aufirst%3DB.%2BA.%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DYasukawa%26aufirst%3DK.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26aulast%3DKishimoto%26aufirst%3DT.%26aulast%3DTaga%26aufirst%3DT.%26atitle%3DActivation%2520of%2520JAK2%2520kinase%2520mediated%2520by%2520the%2520interleukin%25206%2520signal%2520transducer%2520gp130%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26issue%3D6%26spage%3D2285%26epage%3D2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Guschin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briscoe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witthuhn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watling, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellegrini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr, I. M.</span><span> </span><span class="NLM_article-title">A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1421</span><span class="NLM_x">â</span> <span class="NLM_lpage">1429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1995&pages=1421-1429&issue=7&author=D.+Guschinauthor=N.+Rogersauthor=J.+Briscoeauthor=B.+Witthuhnauthor=D.+Watlingauthor=F.+Hornauthor=S.+Pellegriniauthor=K.+Yasukawaauthor=P.+Heinrichauthor=G.+R.+Starkauthor=J.+N.+Ihleauthor=I.+M.+Kerr&title=A+major+role+for+the+protein+tyrosine+kinase+JAK1+in+the+JAK%2FSTAT+signal+transduction+pathway+in+response+to+interleukin-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuschin%26aufirst%3DD.%26aulast%3DRogers%26aufirst%3DN.%26aulast%3DBriscoe%26aufirst%3DJ.%26aulast%3DWitthuhn%26aufirst%3DB.%26aulast%3DWatling%26aufirst%3DD.%26aulast%3DHorn%26aufirst%3DF.%26aulast%3DPellegrini%26aufirst%3DS.%26aulast%3DYasukawa%26aufirst%3DK.%26aulast%3DHeinrich%26aufirst%3DP.%26aulast%3DStark%26aufirst%3DG.%2BR.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26aulast%3DKerr%26aufirst%3DI.%2BM.%26atitle%3DA%2520major%2520role%2520for%2520the%2520protein%2520tyrosine%2520kinase%2520JAK1%2520in%2520the%2520JAK%252FSTAT%2520signal%2520transduction%2520pathway%2520in%2520response%2520to%2520interleukin-6%26jtitle%3DEMBO%2520J.%26date%3D1995%26volume%3D14%26issue%3D7%26spage%3D1421%26epage%3D1429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ghoreschi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShea, J. J.</span><span> </span><span class="NLM_article-title">Janus kinases in immune cell signaling</span> <span class="citation_source-journal">Immunol Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">228</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">273</span><span class="NLM_x">â</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1111%2Fj.1600-065X.2008.00754.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=19290934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=228&publication_year=2009&pages=273-287&issue=1&author=K.+Ghoreschiauthor=A.+Laurenceauthor=J.+J.+O%E2%80%99Shea&title=Janus+kinases+in+immune+cell+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Janus kinases in immune cell signaling</span></div><div class="casAuthors">Ghoreschi, Kamran; Laurence, Arian; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">228</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">273-287</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">1600-065X</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The Janus family kinases (Jaks), Jak1, Jak2, Jak3, and Tyk2, form one subgroup of the non-receptor protein tyrosine kinases.  They are involved in cell growth, survival, development, and differentiation of a variety of cells but are critically important for immune cells and hematopoietic cells.  Data from exptl. mice and clin. observations have unraveled multiple signaling events mediated by Jaks in innate and adaptive immunity.  Deficiency of Jak3 or Tyk2 results in defined clin. disorders, which are also evident in mouse models.  A striking phenotype assocd. with inactivating Jak3 mutations is severe combined immunodeficiency syndrome, whereas mutation of Tyk2 results in another primary immunodeficiency termed autosomal recessive hyperimmunoglobulin E syndrome.  By contrast, complete deletion of Jak1 or Jak2 in the mouse are not compatible with life and, unsurprisingly, do not have counterparts in human disease.  However, activating mutations of each of the Jaks are found in assocn. with malignant transformation, the most common being gain-of-function mutations of Jak2 in polycythemia vera and other myeloproliferative disorders.  Our existing knowledge on Jak signaling pathways and fundamental work on their biochem. structure and intracellular interactions allow us to develop new strategies for controlling autoimmune diseases or malignancies by developing selective Jak inhibitors, which are now coming into clin. use.  Despite the fact that Jaks were discovered only a little more than a decade ago, at the time of writing there are 20 clin. trials underway testing the safely and efficacy of Jak inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp23ncK0nYqpbVg90H21EOLACvtfcHk0lhnpoCM-hKGuQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFGls7vJ&md5=adc282a9ad381ee18abe57a82c921f65</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00754.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00754.x%26sid%3Dliteratum%253Aachs%26aulast%3DGhoreschi%26aufirst%3DK.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJanus%2520kinases%2520in%2520immune%2520cell%2520signaling%26jtitle%3DImmunol%2520Rev.%26date%3D2009%26volume%3D228%26issue%3D1%26spage%3D273%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâShea, J. J.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of Janus kinases</span> <span class="citation_source-journal">Immunol Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">â</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1111%2Fj.1600-065X.2008.00644.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=18613833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2008&pages=132-142&author=M.+Pesuauthor=A.+Laurenceauthor=N.+Kishoreauthor=S.+H.+Zwillichauthor=G.+Chanauthor=J.+J.+O%E2%80%99Shea&title=Therapeutic+targeting+of+Janus+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Janus kinases</span></div><div class="casAuthors">Pesu, Marko; Laurence, Arian; Kishore, Nandini; Zwillich, Samuel H.; Chan, Gary; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytokines play pivotal roles in immunity and inflammation, and targeting cytokines and their receptors is an effective means of treating such disorders.  Type I and II cytokine receptors assoc. with Janus family kinases (JAKs) to effect intracellular signaling.  These structurally unique protein kinases play essential and specific roles in immune cell development and function.  One JAK, JAK3, has particularly selective functions.  Mutations of this kinase underlie severe combined immunodeficiency, indicative of its crit. role in the development and function of lymphocytes.  Because JAK3 appears not to have functions outside of hematopoietic cells, this kinase has been viewed as an excellent therapeutic target for the development of a new class of immunosuppressive drugs.  In fact, several companies are developing JAK3 inhibitors, and Phase II studies are underway.  Mutations of Tyk2 cause autosomal recessive hyperIgE syndrome, and in principle, Tyk2 inhibitors might also be useful as immunosuppressive drugs.  JAK2 gain-of-function mutations (V617F) underlie a subset of disorders collectively referred to as myeloproliferative diseases and phase 2 trials using JAK inhibitors are underway in this setting.  Thus, we are learning a great deal about the feasibility and effectiveness of targeting Janus kinases, and it appears likely that this will be a fruitful strategy in a variety of settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-VTmlwlhcv7Vg90H21EOLACvtfcHk0lgsHHV9lnxR_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D&md5=73dc15932d0eaa312bc2588bdbce404c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00644.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00644.x%26sid%3Dliteratum%253Aachs%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DTherapeutic%2520targeting%2520of%2520Janus%2520kinases%26jtitle%3DImmunol%2520Rev.%26date%3D2008%26volume%3D223%26spage%3D132%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Vijayakrishnan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkataramanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gulati, P.</span><span> </span><span class="NLM_article-title">Treating inflammation with the Janus kinase inhibitor CP-690,550</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">25</span><span class="NLM_x">â</span> <span class="NLM_lpage">34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=25-34&issue=1&author=L.+Vijayakrishnanauthor=R.+Venkataramananauthor=P.+Gulati&title=Treating+inflammation+with+the+Janus+kinase+inhibitor+CP-690%2C550"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVijayakrishnan%26aufirst%3DL.%26aulast%3DVenkataramanan%26aufirst%3DR.%26aulast%3DGulati%26aufirst%3DP.%26atitle%3DTreating%2520inflammation%2520with%2520the%2520Janus%2520kinase%2520inhibitor%2520CP-690%252C550%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26issue%3D1%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardanani, A.</span><span> </span><span class="NLM_article-title">JAK inhibitors in myeloproliferative neoplasms: rationale, current data and perspective</span> <span class="citation_source-journal">Blood Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">229</span><span class="NLM_x">â</span> <span class="NLM_lpage">237</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1016%2Fj.blre.2011.06.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=21742423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVGmsrbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=229-237&issue=5&author=A.+Tefferiauthor=A.+Pardanani&title=JAK+inhibitors+in+myeloproliferative+neoplasms%3A+rationale%2C+current+data+and+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">JAK inhibitors in myeloproliferative neoplasms: Rationale, current data and perspective</span></div><div class="casAuthors">Tefferi, A.; Pardanani, A.</div><div class="citationInfo"><span class="NLM_cas:title">Blood Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">229-237</span>CODEN:
                <span class="NLM_cas:coden">BLOREB</span>;
        ISSN:<span class="NLM_cas:issn">0268-960X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  JAK-STAT is an appealing but also problematic drug target in BCR-ABL1-neg. myeloproliferative neoplasms (MPN) - it is appealing because the majority of patients with MPN harbor gain-of-function JAK2 or MPL mutations - it is problematic because currently available JAK inhibitors do not distinguish between oncogenic and physiol. JAK-STAT activation.  Furthermore, JAK-STAT-relevant mutations in MPN do not always constitute the predominant or ancestral mutant clone.  Such complexities undermine the value of JAK-STAT as a robust drug target in MPN and partly explain the hitherto lack of histol. or mol. remissions assocd. with currently available JAK inhibitors.  Most of these drugs were, however, effective in alleviating constitutional symptoms and reducing spleen size; the mechanism of action in this instance includes drug-induced down-regulation of inflammatory cytokine activity.  In addn., non-specific myelosuppression contributes to both their salutary and detrimental effects on peripheral blood count.  Non-hematol. side effects include gastrointestinal disturbances, asymptomatic elevation of liver and pancreatic enzymes, peripheral neuropathy and hyperacute relapse of symptoms during treatment interruption.  It is our impression that many more JAK inhibitors need to be evaluated in order to identify the best-in-class in terms of efficacy, toxicity and suitability for future combination treatment programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_9cluqxFTkLVg90H21EOLACvtfcHk0lgsHHV9lnxR_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVGmsrbI&md5=6526aeabc9ebe50786992c03c4352899</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.blre.2011.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.blre.2011.06.002%26sid%3Dliteratum%253Aachs%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DPardanani%26aufirst%3DA.%26atitle%3DJAK%2520inhibitors%2520in%2520myeloproliferative%2520neoplasms%253A%2520rationale%252C%2520current%2520data%2520and%2520perspective%26jtitle%3DBlood%2520Rev.%26date%3D2011%26volume%3D25%26issue%3D5%26spage%3D229%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">QuintÃ¡s-Cardama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kantarjian, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verstovsek, S.</span><span> </span><span class="NLM_article-title">Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">127</span><span class="NLM_x">â</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=127-140&issue=2&author=A.+Quint%C3%A1s-Cardamaauthor=H.+Kantarjianauthor=J.+Cortesauthor=S.+Verstovsek&title=Janus+kinase+inhibitors+for+the+treatment+of+myeloproliferative+neoplasias+and+beyond"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuint%25C3%25A1s-Cardama%26aufirst%3DA.%26aulast%3DKantarjian%26aufirst%3DH.%26aulast%3DCortes%26aufirst%3DJ.%26aulast%3DVerstovsek%26aufirst%3DS.%26atitle%3DJanus%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520neoplasias%2520and%2520beyond%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D2%26spage%3D127%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kremer, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breedveld, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coombs, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgos-Vargas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerbini, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span> </span><span class="NLM_article-title">The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1895</span><span class="NLM_x">â</span> <span class="NLM_lpage">1905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1002%2Fart.24567" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=19565475" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD1MXptlKktLg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=1895-1905&issue=7&author=J.+M.+Kremerauthor=B.+J.+Bloomauthor=F.+C.+Breedveldauthor=J.+H.+Coombsauthor=M.+P.+Fletcherauthor=D.+Grubenauthor=S.+Krishnaswamiauthor=R.+Burgos-Vargasauthor=B.+Wilkinsonauthor=C.+A.+Zerbiniauthor=S.+H.+Zwillich&title=The+safety+and+efficacy+of+a+JAK+inhibitor+in+patients+with+active+rheumatoid+arthritis%3A+Results+of+a+double-blind%2C+placebo-controlled+phase+IIa+trial+of+three+dosage+levels+of+CP-690%2C550+versus+placebo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo</span></div><div class="casAuthors">Kremer, Joel M.; Bloom, Bradley J.; Breedveld, Ferdinand C.; Coombs, John H.; Fletcher, Mark P.; Gruben, David; Krishnaswami, Sriram; Burgos-Vargas, Ruben; Wilkinson, Bethanie; Zerbini, Cristiano A. F.; Zwillich, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1895-1905</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">To det. the efficacy, safety, and tolerability of 3 different dosages of CP-690,550, a potent, orally active JAK inhibitor, in patients with active rheumatoid arthritis (RA) in whom methotrexate, etanercept, infliximab, or adalimumab caused an inadequate or toxic response.  Patients (n = 264) were randomized equally to receive placebo, 5 mg of CP-690,550,15 mg of CP-690,550, or 30 mg of CP-690,550 twice daily for 6 wk, and were followed up for an addnl. 6 wk after treatment.  The primary efficacy end point was the American College of Rheumatol. 20% improvement criteria (ACR20) response rate at 6 wk.  By week 6, the ACR20 response rates were 70.5%, 81.2%, and 76.8% in the 5 mg, 15 mg, and 30 mg twice daily groups, resp., compared with 29.2% in the placebo group (P < 0.001).  Improvements in disease activity in CP-690,550-treated patients compared with placebo were seen in all treatment groups as early as week 1.  ACR50 and ACR70 response rates significantly improved in all treatment groups by week 4.  The most common adverse events reported were headache and nausea.  The infection rate in both the 15 mg twice daily group and the 30 mg twice daily group was 30.4% (vs. 26.2% in the placebo group).  No opportunistic infections or deaths occurred.  Increases in mean low-d. lipoprotein cholesterol and high-d. lipoprotein cholesterol levels, and increases in mean serum creatinine level (0.04-0.06 mg/dL) were seen in all CP-690,550 treatment arms.  Our findings indicate that CP-690,550 is efficacious in the treatment of RA, resulting in rapid, statistically significant, and clin. meaningful redns. in the signs and symptoms of RA.  Further studies of CP-690,550 in RA are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBhxBhh_mG7rVg90H21EOLACvtfcHk0lgsHHV9lnxR_Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXptlKktLg%253D&md5=ab5fb34e43d8643871560c67bbbca07d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fart.24567&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.24567%26sid%3Dliteratum%253Aachs%26aulast%3DKremer%26aufirst%3DJ.%2BM.%26aulast%3DBloom%26aufirst%3DB.%2BJ.%26aulast%3DBreedveld%26aufirst%3DF.%2BC.%26aulast%3DCoombs%26aufirst%3DJ.%2BH.%26aulast%3DFletcher%26aufirst%3DM.%2BP.%26aulast%3DGruben%26aufirst%3DD.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DBurgos-Vargas%26aufirst%3DR.%26aulast%3DWilkinson%26aufirst%3DB.%26aulast%3DZerbini%26aufirst%3DC.%2BA.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26atitle%3DThe%2520safety%2520and%2520efficacy%2520of%2520a%2520JAK%2520inhibitor%2520in%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%253A%2520Results%2520of%2520a%2520double-blind%252C%2520placebo-controlled%2520phase%2520IIa%2520trial%2520of%2520three%2520dosage%2520levels%2520of%2520CP-690%252C550%2520versus%2520placebo%26jtitle%3DArthritis%2520Rheum.%26date%3D2009%26volume%3D60%26issue%3D7%26spage%3D1895%26epage%3D1905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Fleischmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutolo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Genovese, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanik, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaswami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallenstein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, B. E.l</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span> </span><span class="NLM_article-title">Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">617</span><span class="NLM_x">â</span> <span class="NLM_lpage">629</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1002%2Fart.33383" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=21952978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVGjurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=617-629&issue=3&author=R.+Fleischmannauthor=M.+Cutoloauthor=M.+C.+Genoveseauthor=E.+B.+Leeauthor=K.+S.+Kanikauthor=S.+Sadisauthor=C.+A.+Connellauthor=D.+Grubenauthor=S.+Krishnaswamiauthor=G.+Wallensteinauthor=B.+E.l+Wilkinsonauthor=S.+H.+Zwillich&title=Phase+IIb+dose-ranging+study+of+the+oral+JAK+inhibitor+tofacitinib+%28CP-690%2C550%29+or+adalimumab+monotherapy+versus+placebo+in+patients+with+active+rheumatoid+arthritis+with+an+inadequate+response+to+disease-modifying+antirheumatic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs</span></div><div class="casAuthors">Fleischmann, Roy; Cutolo, Maurizio; Genovese, Mark C.; Lee, Eun Bong; Kanik, Keith S.; Sadis, Seth; Connell, Carol A.; Gruben, David; Krishnaswami, Sriram; Wallenstein, Gene; Wilkinson, Bethanie E.; Zwillich, Samuel H.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">617-629</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : To compare the efficacy, safety, and tolerability of 5 doses of oral tofacitinib (CP-690,550) or adalimumab monotherapy with placebo for the treatment of active rheumatoid arthritis (RA) in patients with an inadequate response to disease-modifying antirheumatic drugs.  Methods : In this 24-wk, double-blind, phase IIb study, patients with RA (n = 384) were randomized to receive placebo, tofacitinib at 1, 3, 5, 10, or 15 mg administered orally twice a day, or adalimumab at 40 mg injected s.c. every 2 wk (total of 6 injections) followed by oral tofacitinib at 5 mg twice a day for 12 wk.  The primary end point was the responder rate according to the American College of Rheumatol. 20% improvement criteria (ACR20) at week 12.  Results : Treatment with tofacitinib at a dose of â¥3 mg twice a day resulted in a rapid response with significant efficacy when compared to placebo, as indicated by the primary end point (ACR20 response at week 12), achieved in 39.2% (3 mg; P â¤ 0.05), 59.2% (5 mg; P < 0.0001), 70.5% (10 mg; P < 0.0001), and 71.9% (15 mg; P < 0.0001) in the tofacitinib group and 35.9% of patients in the adalimumab group (P = 0.105), compared with 22.0% of patients receiving placebo.  Improvements were sustained at week 24, according to the ACR20, ACR50, and ACR70 response rates as well as classifications of remission according to the 3-variable Disease Activity Score in 28 joints (DAS28) using C-reactive protein and the 4-variable DAS28 using the erythrocyte sedimentation rate.  The most common treatment-emergent adverse events (AEs) in patients across all tofacitinib treatment arms (n = 272) were urinary tract infection (7.7%), diarrhea (4.8%), headache (4.8%), and bronchitis (4.8%).  Conclusion : Tofacitinib monotherapy at â¥3 mg twice a day was efficacious in the treatment of patients with active RA over 24 wk and demonstrated a manageable safety profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuu7Uf_SwBXbVg90H21EOLACvtfcHk0lip4qRMvha9PA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVGjurs%253D&md5=99d7be4fd115ffa87410dcbd6c6ea860</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fart.33383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.33383%26sid%3Dliteratum%253Aachs%26aulast%3DFleischmann%26aufirst%3DR.%26aulast%3DCutolo%26aufirst%3DM.%26aulast%3DGenovese%26aufirst%3DM.%2BC.%26aulast%3DLee%26aufirst%3DE.%2BB.%26aulast%3DKanik%26aufirst%3DK.%2BS.%26aulast%3DSadis%26aufirst%3DS.%26aulast%3DConnell%26aufirst%3DC.%2BA.%26aulast%3DGruben%26aufirst%3DD.%26aulast%3DKrishnaswami%26aufirst%3DS.%26aulast%3DWallenstein%26aufirst%3DG.%26aulast%3DWilkinson%26aufirst%3DB.%2BE.l%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26atitle%3DPhase%2520IIb%2520dose-ranging%2520study%2520of%2520the%2520oral%2520JAK%2520inhibitor%2520tofacitinib%2520%2528CP-690%252C550%2529%2520or%2520adalimumab%2520monotherapy%2520versus%2520placebo%2520in%2520patients%2520with%2520active%2520rheumatoid%2520arthritis%2520with%2520an%2520inadequate%2520response%2520to%2520disease-modifying%2520antirheumatic%2520drugs%26jtitle%3DArthritis%2520Rheum.%26date%3D2012%26volume%3D64%26issue%3D3%26spage%3D617%26epage%3D629" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchetto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermes, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vangrevelinghe, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">284</span><span class="NLM_x">â</span> <span class="NLM_lpage">288</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101157q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=284-288&issue=1&author=G.+Thomaauthor=F.+Nuningerauthor=R.+Falchettoauthor=E.+Hermesauthor=G.+A.+Tavaresauthor=E.+Vangrevelingheauthor=H.-G.+Zerwes&title=Identification+of+a+potent+Janus+kinase+3+inhibitor+with+high+selectivity+within+the+Janus+kinase+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm101157q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101157q%26sid%3Dliteratum%253Aachs%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DNuninger%26aufirst%3DF.%26aulast%3DFalchetto%26aufirst%3DR.%26aulast%3DHermes%26aufirst%3DE.%26aulast%3DTavares%26aufirst%3DG.%2BA.%26aulast%3DVangrevelinghe%26aufirst%3DE.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DIdentification%2520of%2520a%2520potent%2520Janus%2520kinase%25203%2520inhibitor%2520with%2520high%2520selectivity%2520within%2520the%2520Janus%2520kinase%2520family%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D1%26spage%3D284%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Haan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolvering, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raulf, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DrÃ¼ckes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrmann, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zerwes, H.-G.</span><span> </span><span class="NLM_article-title">Jak1 has a dominant role over Jak3 in signal transduction through Î³c-containing cytokine receptors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">314</span><span class="NLM_x">â</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1016%2Fj.chembiol.2011.01.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=21439476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=314-323&issue=3&author=C.+Haanauthor=C.+Rolveringauthor=F.+Raulfauthor=M.+Kappauthor=P.+Dr%C3%BCckesauthor=G.+Thomaauthor=I.+Behrmannauthor=H.-G.+Zerwes&title=Jak1+has+a+dominant+role+over+Jak3+in+signal+transduction+through+%CE%B3c-containing+cytokine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Jak1 Has a Dominant Role over Jak3 in Signal Transduction through Î³c-Containing Cytokine Receptors</span></div><div class="casAuthors">Haan, Claude; Rolvering, Catherine; Raulf, Friedrich; Kapp, Manuela; Drueckes, Peter; Thoma, Gebhard; Behrmann, Iris; Zerwes, Hans-Guenter</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">314-323</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Genetic deficiency of Jak3 leads to abrogation of signal transduction through the common gamma chain (Î³c) and thus to immunodeficiency suggesting that specific inhibition of Jak3 kinase may result in immunosuppression.  Jak1 cooperates with Jak3 in signaling through Î³c-contg. receptors.  Unexpectedly, a Jak3-selective inhibitor was less efficient in abolishing STAT5 phosphorylation than pan-Jak inhibitors.  We therefore explored the roles of Jak1 and Jak3 kinase functionality in signaling using a reconstituted system.  The presence of kinase-inactive Jak1 but not kinase-inactive Jak3 resulted in complete abolishment of STAT5 phosphorylation.  Specific inhibition of the "analog-sensitive" mutant AS-Jak1 but not AS-Jak3 by the ATP-competitive analog 1NM-PP1 abrogated IL-2 signaling, corroborating the data with the selective Jak3 inhibitor.  Jak1 thus plays a dominant role over Jak3 and these data challenge the notion that selective ATP-competitive Jak3 kinase inhibitors will be effective.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUv04vX29Zk7Vg90H21EOLACvtfcHk0lip4qRMvha9PA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrtrw%253D&md5=0109f316cfe0bee40f80a79f244e6ba5</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.01.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.01.012%26sid%3Dliteratum%253Aachs%26aulast%3DHaan%26aufirst%3DC.%26aulast%3DRolvering%26aufirst%3DC.%26aulast%3DRaulf%26aufirst%3DF.%26aulast%3DKapp%26aufirst%3DM.%26aulast%3DDr%25C3%25BCckes%26aufirst%3DP.%26aulast%3DThoma%26aufirst%3DG.%26aulast%3DBehrmann%26aufirst%3DI.%26aulast%3DZerwes%26aufirst%3DH.-G.%26atitle%3DJak1%2520has%2520a%2520dominant%2520role%2520over%2520Jak3%2520in%2520signal%2520transduction%2520through%2520%25CE%25B3c-containing%2520cytokine%2520receptors%26jtitle%3DChem.%2520Biol.%26date%3D2011%26volume%3D18%26issue%3D3%26spage%3D314%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Lin, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickerson-Nutter, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appell, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohlmeyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimble, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quintero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Symanowicz, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrocklage, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lussier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelling, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewet, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xuan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krykbaev, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidl, K. J.</span><span> </span><span class="NLM_article-title">Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2283</span><span class="NLM_x">â</span> <span class="NLM_lpage">2293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1002%2Fart.27536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=20506481" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFOiu7jP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=2283-2293&issue=8&author=T.+H.+Linauthor=M.+Hegenauthor=E.+Quadrosauthor=C.+L.+Nickerson-Nutterauthor=K.+C.+Appellauthor=A.+G.+Coleauthor=Y.+Shaoauthor=S.+Tamauthor=M.+Ohlmeyerauthor=B.+Wangauthor=D.+G.+Goodwinauthor=E.+F.+Kimbleauthor=J.+Quinteroauthor=M.+Gaoauthor=P.+Symanowiczauthor=C.+Wrocklageauthor=J.+Lussierauthor=S.+H.+Schellingauthor=A.+G.+Hewetauthor=D.+Xuanauthor=R.+Krykbaevauthor=J.+Togiasauthor=X.+Xuauthor=R.+Harrisonauthor=T.+Mansourauthor=M.+Collinsauthor=J.+D.+Clarkauthor=M.+L.+Webbauthor=K.+J.+Seidl&title=Selective+functional+inhibition+of+JAK-3+is+sufficient+for+efficacy+in+collagen-induced+arthritis+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice</span></div><div class="casAuthors">Lin, Tsung H.; Hegen, Martin; Quadros, Elizabeth; Nickerson-Nutter, Cheryl L.; Appell, Kenneth C.; Cole, Andrew G.; Shao, Yuefei; Tam, Steve; Ohlmeyer, Michael; Wang, Bojing; Goodwin, Debra G.; Kimble, Earl F.; Quintero, Jorge; Gao, Min; Symanowicz, Peter; Wrocklage, Christopher; Lussier, Jennifer; Schelling, Scott H.; Hewet, Amha G.; Xuan, Dejun; Krykbaev, Rustem; Togias, Jenny; Xu, Xin; Harrison, Richard; Mansour, Tarek; Collins, Mary; Clark, James D.; Webb, Maria L.; Seidi, Katherine J.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2283-2293</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective. All Î³-chain cytokines signal through JAK-3 and JAK-1 acting in tandem.  We undertook this study to det. whether the JAK-3 selective inhibitor WYE-151650 would be sufficient to disrupt cytokine signaling and to ameliorate autoimmune disease pathol. without inhibiting other pathways mediated by JAK-1, JAK-2, and Tyk-2.  Methods. JAK-3 kinase selective compds. were characterized by kinase assay and JAK-3-dependent (interleukin-2 [IL-2]) and -independent (IL-6, granulocyte-macrophage colony-stimulating factor [GM-CSF]) cell-based assays measuring proliferation or STAT phosphorylation.  In vivo, off-target signaling was measured by IL-22- and erythropoietin (EPO)-mediated models, while on-target signaling was measured by IL-2-mediated signaling.  Efficacy of JAK-3 inhibitors was detd. using delayed-type hypersensitivity (DTH) and collagen-induced arthritis (CIA) models in mice.  Results. In vitro, WYE-151650 potently suppressed IL-2-induced STAT-5 phosphorylation and cell proliferation, while exhibiting 10-29-fold less activity against JAK-3-independent IL-6- or GM-CSF-induced STAT phosphorylation.  Ex vivo, WYE-151650 suppressed IL-2-induced STAT phosphorylation, but not IL-6-induced STAT phosphorylation, as measured in whole blood.  In vivo, WYE-151650 inhibited JAK-3-mediated IL-2-induced interferon-Î³ prodn. and decreased the natural killer cell population in mice, while not affecting IL-22-induced serum amyloid A prodn. or EPO-induced reticulocytosis.  WYE-151650 was efficacious in mouse DTH and CIA models.  Conclusion. In vitro, ex vivo, and in vivo assays demonstrate that WYE-151650 is efficacious in mouse CIA despite JAK-3 selectivity.  These data question the need to broadly inhibit JAK-1-, JAK-2-, or Tyk-2-dependent cytokine pathways for efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogcss6tt3iw7Vg90H21EOLACvtfcHk0lhJ5jIQivT9BQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFOiu7jP&md5=7fd4f4dae47df1d1a33d3fc0edf5e13d</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fart.27536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.27536%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.%2BH.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DQuadros%26aufirst%3DE.%26aulast%3DNickerson-Nutter%26aufirst%3DC.%2BL.%26aulast%3DAppell%26aufirst%3DK.%2BC.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DOhlmeyer%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DGoodwin%26aufirst%3DD.%2BG.%26aulast%3DKimble%26aufirst%3DE.%2BF.%26aulast%3DQuintero%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DSymanowicz%26aufirst%3DP.%26aulast%3DWrocklage%26aufirst%3DC.%26aulast%3DLussier%26aufirst%3DJ.%26aulast%3DSchelling%26aufirst%3DS.%2BH.%26aulast%3DHewet%26aufirst%3DA.%2BG.%26aulast%3DXuan%26aufirst%3DD.%26aulast%3DKrykbaev%26aufirst%3DR.%26aulast%3DTogias%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DHarrison%26aufirst%3DR.%26aulast%3DMansour%26aufirst%3DT.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DClark%26aufirst%3DJ.%2BD.%26aulast%3DWebb%26aufirst%3DM.%2BL.%26aulast%3DSeidl%26aufirst%3DK.%2BJ.%26atitle%3DSelective%2520functional%2520inhibition%2520of%2520JAK-3%2520is%2520sufficient%2520for%2520efficacy%2520in%2520collagen-induced%2520arthritis%2520in%2520mice%26jtitle%3DArthritis%2520Rheum.%26date%3D2010%26volume%3D62%26issue%3D8%26spage%3D2283%26epage%3D2293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Goldstein., D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span> </span><span class="NLM_article-title">High-throughput kinase profiling as a platform for drug discovery</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">391</span><span class="NLM_x">â</span> <span class="NLM_lpage">397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=391-397&issue=5&author=D.+M.+Goldstein.author=N.+S.+Grayauthor=P.+P.+Zarrinkar&title=High-throughput+kinase+profiling+as+a+platform+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein.%26aufirst%3DD.%2BM.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26atitle%3DHigh-throughput%2520kinase%2520profiling%2520as%2520a%2520platform%2520for%2520drug%2520discovery%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26issue%3D5%26spage%3D391%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Fabian, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biggs, I. I. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">William, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atteridge, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azimioara, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benedetti, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciceri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edeen, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerlach, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grotzfeld, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrgard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insko, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelias, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehta, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milanov, Z. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wodicka, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinkar, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, D. J.</span><span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span> <span class="citation_source-journal">Nature Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">329</span><span class="NLM_x">â</span> <span class="NLM_lpage">336</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&issue=3&author=M.+A.+Fabianauthor=I.+I.+I.+Biggsauthor=H.+Williamauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lhJ5jIQivT9BQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DI.%2BI.%2BI.%26aulast%3DWilliam%26aufirst%3DH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNature%2520Biotechnol.%26date%3D2005%26volume%3D23%26issue%3D3%26spage%3D329%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">Out of 293 wild-type kinases tested at Kinomescan, compound <b>2</b> at 10 Î¼M showed >90% bait ligand displacement for 156 kinases, including JAK1â3 (kinase domains) at the percentages indicated: JAK1 (100%), JAK2 (99%), and JAK3 (98%).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Chrencik, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korniski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">413</span><span class="NLM_x">â</span> <span class="NLM_lpage">433</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&issue=3&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.-C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26issue%3D3%26spage%3D413%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudlacz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lillie, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">8468</span><span class="NLM_x">â</span> <span class="NLM_lpage">8484</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&issue=24&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=S.-P.+Changauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Lillieauthor=K.+S.+Magnusonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%2C550%3A+a+potent+and+selective+Janus+kinase+%28JAK%29+inhibitor+for+the+treatment+of+autoimmune+diseases+and+organ+transplant+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span></div><div class="casAuthors">Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H.; Brown, Matthew F.; Casavant, Jeffrey M.; Chang, Shang-Poa; Doty, Jonathan L.; Elliott, Eileen A.; Fisher, Michael B.; Hines, Michael; Kent, Craig; Kudlacz, Elizabeth M.; Lillie, Brett M.; Magnuson, Kelly S.; McCurdy, Sandra P.; Munchhof, Michael J.; Perry, Bret D.; Sawyer, Perry S.; Strelevitz, Timothy J.; Subramanyam, Chakrapani; Sun, Jianmin; Whipple, David A.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8468-8484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a crit. need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis.  Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines important for various T cell functions.  Blockade of the JAK1/JAK3-STAT pathway with a small mol. was anticipated to provide therapeutic immunosuppression/immunomodulation.  The Pfizer compd. library was screened against the catalytic domain of JAK3 resulting in the identification of a pyrrolopyrimidine-based series of inhibitors represented by the hexahydrocarbazolyl pyrrolopyrimidine CP-352,664.  Synthetic analogs of CP-352,664 were screened against the JAK enzymes and evaluated in an IL-2 induced T cell blast proliferation assay.  Select compds. were evaluated in rodent efficacy models of allograft rejection and destructive inflammatory arthritis.  Optimization within this chem. series led to identification of the cyanoacetylpiperidinylamino pyrrolopyrimidine CP-690,550, a potential first-in-class JAK inhibitor for treatment of autoimmune diseases and organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFS_8DSHkDbVg90H21EOLACvtfcHk0lgJBVYqIS4ueg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP&md5=c1d31ce42ab3f1c1f3029c6f4f48df1a</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DChang%26aufirst%3DS.-P.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%252C550%253A%2520a%2520potent%2520and%2520selective%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%2520and%2520organ%2520transplant%2520rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26issue%3D24%26spage%3D8468%26epage%3D8484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span>Molecular Operating Environment (MOE), <span class="NLM_edition">2011.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Molecular+Operating+Environment+%28MOE%29%2C+2011.10%3B+Chemical+Computing+Group+Inc.%3A+1010+Sherbooke+St.+West%2C+Suite+%23910%2C+Montreal%2C+QC%2C+Canada%2C+H3A+2R7%2C+2011."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Operating%2520Environment%2520%2528MOE%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tanaka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohbo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeshita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugamura, K.</span><span> </span><span class="NLM_article-title">Physical association of Jak1 and Jak2 tyrosine kinases with the interleukin 2 receptor Î² and Î³ chains</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">7271</span><span class="NLM_x">â</span> <span class="NLM_lpage">7275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1994&pages=7271-7275&author=N.+Tanakaauthor=H.+Asaoauthor=K.+Ohboauthor=N.+Ishiiauthor=T.+Takeshitaauthor=M.+Nakamuraauthor=H.+Sasakiauthor=K.+Sugamura&title=Physical+association+of+Jak1+and+Jak2+tyrosine+kinases+with+the+interleukin+2+receptor+%CE%B2+and+%CE%B3+chains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanaka%26aufirst%3DN.%26aulast%3DAsao%26aufirst%3DH.%26aulast%3DOhbo%26aufirst%3DK.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DTakeshita%26aufirst%3DT.%26aulast%3DNakamura%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DSugamura%26aufirst%3DK.%26atitle%3DPhysical%2520association%2520of%2520Jak1%2520and%2520Jak2%2520tyrosine%2520kinases%2520with%2520the%2520interleukin%25202%2520receptor%2520%25CE%25B2%2520and%2520%25CE%25B3%2520chains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci%2520U.%2520S.%2520A.%26date%3D1994%26volume%3D91%26spage%3D7271%26epage%3D7275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Otwinowski, Z.; Minor, W.</span><span> </span><span class="NLM_article-title">Processing of X-ray diffraction data collected in oscillation mode</span>. In  <span class="citation_source-book">Macromolecular Crystallography, Part A</span>; <span class="NLM_contrib-group">Carter, C. W. J.; Sweet, R. M.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">307</span><span class="NLM_x">â</span> <span class="NLM_lpage">326</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1016%2FS0076-6879%2897%2976066-X" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=307-326&author=Z.+Otwinowski&author=W.+Minorauthor=C.+W.+J.+Carter&author=R.+M.+Sweet&title=Macromolecular+Crystallography%2C+Part+A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2897%2976066-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS0076-6879%252897%252976066-X%26sid%3Dliteratum%253Aachs%26aulast%3DOtwinowski%26aufirst%3DZ.%26atitle%3DProcessing%2520of%2520X-ray%2520diffraction%2520data%2520collected%2520in%2520oscillation%2520mode%26btitle%3DMacromolecular%2520Crystallography%252C%2520Part%2520A%26aulast%3DCarter%26aufirst%3DC.%2BW.%2BJ.%26pub%3DAcademic%2520Press%26date%3D1997%26spage%3D307%26epage%3D326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Likelihood-enhanced fast translation functions</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">â</span> <span class="NLM_lpage">464</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1107%2FS0907444905001617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=15805601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVeisrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=458-464&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Likelihood-enhanced+fast+translation+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Likelihood-enhanced fast translation functions</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">D61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-464</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">This paper is a companion to a recent paper on fast rotation functions [Storoni et al. (2004), Acta Cryst. D60, 432-438], which showed how a Taylor-series expansion of the max.-likelihood rotation function leads to improved likelihood-enhanced fast rotation functions.  In a similar manner, it is shown here how linear and quadratic Taylor-series expansions and least-squares approxns. of the max.-likelihood translation function lead to likelihood-enhanced translation functions, which can be calcd. by FFT and which are more sensitive to the correct translation than the traditional correlation-coeff. fast translation function.  These likelihood-enhanced translation targets for mol.-replacement searches have been implemented in the program Phaser using the Computational Crystallog. Toolbox (cctbx).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDd3wovyUbWLVg90H21EOLACvtfcHk0lj7MC1ki-W4sg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVeisrY%253D&md5=bac9cc121bcc0d5cd314955a0e65e746</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1107%2FS0907444905001617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905001617%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DLikelihood-enhanced%2520fast%2520translation%2520functions%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2005%26volume%3D61%26spage%3D458%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Boggon, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">996</span><span class="NLM_x">â</span> <span class="NLM_lpage">1002</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Boggon%2C+T.+J.%3B+Li%2C+Y.%3B+Manley%2C+P.+W.%3B+Eck%2C+M.+J.Blood+2005%2C+106%2C+996%E2%80%931002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoggon%26aufirst%3DT.%2BJ.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26jtitle%3DBlood%26date%3D2005%26volume%3D106%26spage%3D996%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of macromolecular structures by the maximum-likelihood method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">â</span> <span class="NLM_lpage">255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=15299926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+macromolecular+structures+by+the+maximum-likelihood+method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Refinement of macromolecular structures by the maximum-likelihood method</span></div><div class="casAuthors">Murshudov, Garib N.; Vagin, Alexei A.; Dodson, Eleanor J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">D53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Munksgaard</span>)
        </div><div class="casAbstract">A review with many refs. on the math. basis of max. likelihood.  The likelihood function for macromol. structures is extended to include prior phase information and exptl. std. uncertainties.  The assumption that different parts of a structure might have different errors is considered.  A method for estg. ÏA using "free" reflections is described and its effects analyzed.  The derived equations have been implemented in the program REFMAC.  This has been tested on several proteins at different stages of refinement (bacterial Î±-amylase, cytochrome c', cross-linked insulin and oligopeptide binding protein).  The results derived using the max.-likelihood residual are consistently better than those obtained from least-squares refinement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWg7mzQRNBhbVg90H21EOLACvtfcHk0lj7MC1ki-W4sg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXjs1Gnsb4%253D&md5=ec7f141ce1542f7ff458b98ecfe3f8af</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520macromolecular%2520structures%2520by%2520the%2520maximum-likelihood%2520method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3D53%26spage%3D240%26epage%3D255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: Model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">â</span> <span class="NLM_lpage">2132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm301646k&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm301646k&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm301646k&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+Model-building+tools+for+molecular+graphics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lj7MC1ki-W4sg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520Model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVD','PDB','4HVD'); return false;">PDB: 4HVD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVG','PDB','4HVG'); return false;">PDB: 4HVG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVH" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVH','PDB','4HVH'); return false;">PDB: 4HVH</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVI','PDB','4HVI'); return false;">PDB: 4HVI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YVJ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1YVJ','PDB','1YVJ'); return false;">PDB: 1YVJ</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i33"><a href="/doi/suppl/10.1021/jm301646k">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_15018"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures and analytical data for final compounds <b>3a</b>â<b>3p</b> and <b>3r</b>â<b>3t</b>, Kinomescan selectivity data for compound <b>3q</b>, CD4 and CD8 cell proliferation studies, response versus plasma concentration curves for the mouse acute PK/PD model studies, and gene knockdown confirmation studies for the siRNA study. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm301646k/suppl_file/jm301646k_si_001.pdf">jm301646k_si_001.pdf (689.81 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Protein crystal structure coordinates and structure factors are deposited in the RCSB Protein Data Bank with the accession numbers <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVD">4HVD</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVG">4HVG</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVH">4HVH</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4HVI">4HVI</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301646k&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-1%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm301646k" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301646k" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66797b8bfe52198b","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
